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BACKGROUND 
 
Introduction 
In this research, I have focused on post-entry determinants of mammalian 
Orthoreovirus (reovirus) replication. These studies have contributed to unifying 
principles of RNA virus biology within three major categories: post-entry mediated virus 
tropism, compartmentalization of viral replication machinery into specialized sites in the 
cytoplasm, and viral replication protein structure and function. I have focused primarily 
on reovirus protein μ2, a replication protein that contributes to reovirus tropism and 
organization of transcriptional machinery and modulates diverse functions during the 
viral life cycle.  
 Viral tropism, defined by the range of hosts, tissues, and cells productively 
infected, creates natural biologic groupings among viruses that correlate with infection 
pathology, clinical disease expression, and epidemiology. Viral tropism has historically 
been thought to be governed by receptor engagement via the virus attachment protein. 
Receptor-dependent tropism has been characterized for many virus families (118); 
however, receptor engagement does not ensure successful replication as productive 
interaction with the cellular machinery at each step in the viral life cycle is required (70). 
Species-, tissue- and cell-type specific differences leading to non-productive viral 
interaction with cellular factors and thus reduced replication efficiency can be thought of 
as post-entry determinants of viral tropism.  
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A notable example of a post-entry mediated viral tropism has been described for 
influenza virus replication (82, 83). Replication of avian influenza virus is inhibited in 
human cells (82, 83). The viral determinants controlling replication capacity in avian vs. 
human cells reside within the proteins that comprise the RNA-dependent RNA-
polymerase (RdRp), and inhibition of replication is observed during post-entry stages of 
the influenza life cycle (70). Picornaviruses also display post-entry mediated tropism; for 
example, poliovirus does not replicate in heart, lung, and kidney tissue despite high 
expression of the poliovirus receptor (122). Tissue-specific picornavirus tropism is 
thought to be determined by cell type-specific differences in factors required for IRES-
mediated translation (53, 64, 90). These examples highlight two models of virus cell 
tropism regulated at post-entry steps in the virus life cycle. Despite a few key examples 
where the basis of viral, cellular, or host-species tropism has been clearly delineated in 
molecular terms, the vast diversity of viral replication strategies and tropic patterns 
suggests that mechanisms of cell- and tissue-specific permissivity to viral infection 
remain largely undefined.  
A second major theme of my dissertation work is the capability of viruses to form 
specialized sites within a host cell to complete viral replication. RNA-containing viruses 
are challenged by the requirement for a unique biochemical apparatus that orchestrates 
the complex, and potentially competing, processes of genome amplification and new 
particle assembly while protecting viral RNAs from nuclease-mediated destruction. 
Furthermore, the replication program must proceed against potent antiviral defenses 
trained on molecular patterns and replicative intermediates shared by virtually all RNA 
viruses. Among single-stranded (ss) RNA viruses, a common strategy to coordinate RNA 
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regulation is compartmentalization of the viral replication machinery within reorganized 
cellular membranes. These structures recruit genomic RNAs, concentrate viral proteins 
and RNA for assembly, and likely shield viral products from the cellular antiviral 
response (1, 29, 81). Analogously, animal double-stranded (ds) RNA viruses generate 
nonmembranous intracytoplasmic structures—termed inclusions or factories—that have a 
characteristic morphology, contain viral proteins and RNA, and constitute the presumed 
site of (-)-strand RNA synthesis and particle assembly (24, 89, 110). Little is known 
about the nature of inclusions of dsRNA virus replication, including the individual and 
corporate roles of viral proteins. 
 The third major theme of my work is the organization of RNA virus functional 
domains that coordinate replication activities. The nature of RNA virus genomes dictates 
a sophisticated interplay of transcription, translation, replication, and encapsidation 
involving contributions by virus and cell to a biochemical apparatus that integrates these 
complex events required for productive viral infection. While the RNA replication 
proteins of different viral families coordinate similar replicative activities, the way in 
which their respective functional domains are arranged into proteins can be quite 
different. For example, rotavirus and reovirus are related dsRNA viruses that display 
similar life cycles; however, the viral proteins that mediate inclusion formation, protein 
recruitment to inclusions, and nucleotide triphosphatase (NTPase) activity are uniquely 
organized into two (rotavirus nsp2 and nsp5) or three (reovirus μNS, μ2, and σNS) 
proteins (113). A common strategy used by RNA viruses to organize replication domains 
is to encode multifunctional proteins that perform diverse activities during the viral life 
cycle. For example, the N protein of bunyaviruses binds viral RNA, interacts with the 
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viral polymerase, modulates ribonucleoprotein complex assembly, and interacts with 
proteins involved in cellular metabolism (56, 97). RNA viruses use a surprisingly small 
number of viral proteins to accomplish genome transcription and replication and often 
multifunctional proteins are a necessity. However, much remains unknown about the 
unique strategies used by RNA virus replication proteins to organize and coordinate 
diverse functions during the viral life cycle. 
These three themes have been integrated throughout my study of post-entry 
determinants of reovirus replication. Reoviruses are non-enveloped, dsRNA viruses that 
display broad cell, tissue, and host tropism and serve as tractable models for the study of 
virus-cell interactions that dictate unique tropic properties. Critical checkpoints mediating 
reovirus tropism are governed both at receptor engagement and post-entry steps in the 
viral life cycle (7, 41, 55, 93, 128). The majority of the viral life cycle following entry 
takes place within viral cytoplasmic inclusions, which are biosynthetic centers of genome 
multiplication and new particle assembly (24); therefore, post-entry mediated reovirus 
tropism is likely governed by steps that occur with viral inclusions. Reovirus replication 
protein μ2 has many functional and biochemical properties that are essential to post-entry 
steps in the viral life cycle (24). μ2 is a structurally minor subunit of the virion core (25) 
found both in the cytoplasm and nucleus of infected cells (60, 68). Additionally, μ2 is a 
polymerase cofactor, an essential component of viral inclusions (61, 88), and a regulator 
of virulence (44, 49, 103, 104). Investigation of the mechanism by which μ2 coordinates 
its diverse functions throughout the reovirus life cycle intersects the three themes of RNA 
virus biology described above. Therefore, my studies have expanded our understanding 
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of post-entry mediated tropism, formation and organization of viral inclusions, and viral 
replication protein structure and function.  
When this work was initiated, it was known that numerous strain-specific 
differences in reovirus replication potential for primary and transformed cells segregate 
with the μ2-encoded M1 gene, along with other components of the viral core (66, 67, 93, 
101-103). A study performed by Rodgers et al. using T1 x T3 reassortant viruses showed 
that the λ3-encoding L1 and μ2-encoding M1 genes segregate with differences in the 
replication efficiency of T1 and T3 infection of Madin Darby canine kidney (MDCK) 
cells (93). Interestingly, the S1 gene, encoding the attachment protein σ1, was not 
genetically linked to this tropism phenotype. λ3 and μ2 are thought to form the viral 
RdRp; therefore, it was hypothesized that replication in MDCK is restricted at a later 
time point of infection when these proteins carry out their functions. This dichotomy 
presented a useful experimental platform to rigorously address the individual and 
cooperative roles of μ2 and λ3 in reovirus cell tropism and identify μ2-sensitive steps in 
the viral life cycle. 
 In my dissertation research, I have attempted to elucidate viral determinants of 
reovirus tropism for MDCK cells. Data presented in Chapter II identifies contributions of 
individual reovirus gene segments to replication efficiency in MDCK cells and sequence 
polymorphisms of μ2 that affect replication efficiency. Furthermore, replication 
experiments that provide initial clues into the cellular determinants mediating tropism for 
MDCK cells are reported. Chapter III outlines a systematic analysis of post-entry steps in 
the reovirus life cycle and identifies the specific stage that T3 fails to complete in MDCK 
cells. In Chapter IV, the functionally abnormal inclusions formed in T3-infected cells are 
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characterized using transmission electron microscopy (TEM), and the effect of 
temperature on T3 replication in MDCK cells is determined. These studies further an 
understanding of the role of μ2 in the viral life cycle to include initiation of particle 
assembly within viral inclusions. Furthermore, these studies indicate that this step in the 
viral life cycle is subject to regulation by cellular factors. 
 
General Characteristics of Reovirus Biology 
The reovirus virion (Fig. 1.1A) is a non-enveloped, icosahedral particle consisting of two  
 
Figure 1.1. The reovirus virion particle. (A) Schematic of the reovirus virion. The 
virion is made of two concentric protein shells, the outer capsid and inner core which 
enclose the 10 dsRNA viral gene segments. The polymerase complex is located at the 
base of the vertex at the 5-fold axis of symmetry. The virus also encodes three 
nonstructural proteins. (B) Electropherotype of prototype strains of reovirus, type 1 
Lang (T1) and type 3 Dearing (T3). Positions of L, M, and S gene segments are 
indicated. 
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protein shells, the outer capsid and inner core. The core encloses ten double-stranded 
RNA gene segments, which encode eight structural proteins and three nonstructural 
proteins (69, 96). Gene segments are separated into three size classes based on their 
electrophoretic mobility in polyacrylamide gels (Fig. 1.1B)–small, medium, and large (S, 
M, L)–which encode the σ, μ, and λ proteins, respectively (69, 79, 100). The virion core 
is formed by the λ1, λ2, λ3, μ2, and σ2 proteins. λ1 and σ2 form the shell of the core. 
Pentamers of λ2 form turrets at the five-fold axes of symmetry; one copy of λ3 and 
presumably two copies of μ2 are located at the base of these turrets. The outer capsid 
consists of μ1-σ3 heterohexamers that overlay the core. Attachment protein σ1 forms 
trimers that extend from the λ2 turrets (31, 34, 91) (Fig. 1.1A). Reovirus also encodes 
three nonstructural proteins: μNS, σNS, and σ1s (52).  
Four reovirus serotypes have been identified based on neutralization and 
hemagglutination studies (4, 94, 95). The prototype strains for serotypes 1 and 3 are type 
1 Lang (T1) and type 3 Dearing (T3), respectively. T1 and T3 display numerous 
phenotypic differences, including receptor usage, activities of viral replication proteins, 
regulation of the interferon response to reovirus infection, apoptosis induction, growth in 
various types of primary and transformed cells, virulence, dissemination pathways, and 
cell and tissue tropism in newborn mice (96). The genetic basis of several biological 
polymorphisms has been defined using reassortant viruses derived from co-infections of 
T1 and T3 (96). Such analyses have provided key insights into viral replication and 
disease mechanisms.  
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Reovirus Replication 
The reovirus replication cycle (Fig. 1.2) begins with virion attachment to the host cell 
through interaction of reovirus protein σ1 with proteinaceious or carbohydrate receptors 
followed by receptor-mediated endocytosis (28). Following internalization of virions, the 
viral outer capsid disassembles within the endosome to generate transcriptionally active 
core particles (111), which are released into the cytoplasm. The viral cores synthesize 
full-length, message-sense, capped and nonpolyadenylated ssRNAs corresponding to  
 
Virion Core
Primary
transcription
Viral Inclusion
10Disassembly
(+)RNA
Translation
RNA 
assortment
Minus-strand
synthesis
Capsid 
assembly
Secondary
transcription
Figure 1.2. Model of reovirus replication. Following entry, transcriptionally active 
core particles initiate a primary round of transcription, generating 10 full-length, 
positive-sense, capped, and non-polyadenylated RNAs that serve as templates for 
translation and dsRNA synthesis. Nascent viral mRNA and protein localize to 
cytoplasmic viral inclusions where RNA assortment, minus strand synthesis, 
secondary transcription, and viral assembly take place.  
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each viral gene segment (86, 99, 106). These RNAs serve as templates for both 
translation and negative-strand synthesis. Newly synthesized viral RNA and protein are 
recruited to viral intracytoplasmic inclusions. Reovirus dsRNA synthesis and assembly 
are thought to occur within inclusions (96), which strictly depend on nonstructural 
proteins σNS and μNS and structural protein μ2 for proper formation and function in 
reovirus-infected cells (3). Viral inclusions are detectable within 4 h post-infection, lack a 
delimiting membrane, and contain viral proteins and dsRNA, virion particles at various 
stages of morphogenesis, and at late times of infection, paracrystalline arrays of virion 
particles (27, 35, 42, 92, 98, 105). Particle assembly is completed by the addition of outer 
capsid proteins to subviral particles. The mechanism of viral egress is unknown (24). 
 
Reovirus Inclusions 
The μNS, μ2, and σNS proteins participate in inclusion formation and maturation 
as indispensable components of viral replication (8, 9, 17, 60, 88). In infected cells, 
inclusions assume either filamentous or globular morphology depending upon residue 
208 of μ2 (Fig. 1.3). Virus strains that produce filamentous inclusions, such as T1, 
encode a Pro at position 208 of μ2, whereas strain T3, which produces globular 
inclusions, encode Ser208 (61, 88). T1 μ2 binds and stabilizes microtubules, and this 
property is thought to be responsible for the formation of filamentous inclusions (88). 
Studies of expressed proteins have defined the role of μNS, σNS, and μ2 in inclusion 
formation. μNS forms small oligomers when free in solution, and globular inclusion-like 
structures form following transfection of cells with μNS-expressing plasmid (17). In 
contrast, σNS and μ2 display diffuse cytoplasmic localization (and nuclear in the case of  
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 Figure 1.3. Morphology of reovirus inclusions. HeLa cells were infected with reovirus 
strain T3 (A) or T3-T1M1 (B) at an MOI of 20 PFU/cell, fixed at 24 h post-infection, 
and stained with anti-σNS antibody (green) and ToPro3 (blue, nucleus). Reovirus viral 
inclusions assume characteristic morphology, filamentous (A) or globular (B), based 
on amino acid residue 208 of μ2.  
μ2) localization when individually expressed in cells (9, 74). If σNS and μNS are co-
expressed in cells, the two proteins co-localize in globular inclusion-like structures (9, 
74). Interaction between σNS and μNS is likely RNA-mediated, as treatment with RNase 
diminishes the capacity of these proteins to co-precipitate with σNS and μNS antibodies 
(15). The localization of μ2 is also altered when co-transfected with μNS; the two 
proteins co-localize into inclusion-like structures. These structures assume inclusion 
morphology characteristic of the strain-origin of μ2 protein (88). In addition to recruiting 
σNS and μ2, μNS recruits λ1, λ2, λ3, σ2, and core particles to inclusions (15, 72). Taken 
together, these studies indicate that higher-order multimers of μNS establish viral 
inclusions by forming an essential matrix to which μ2, σNS, and other viral proteins are 
recruited. While significant progress has been made in determining how μNS, σNS, and 
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μ2 mediate inclusion formation, the precise role of viral inclusion-forming proteins in the 
reovirus replication pathway—including dsRNA synthesis, gene-segment assortment, 
genome packaging, and virion assembly—is poorly understood, owing largely to limited 
insights into structure-function relationship of these molecules. 
Viral RNA assortment, genome replication, secondary transcription, and particle 
morphogenesis are presumed to occur within reovirus inclusions (2, 27, 31, 77, 78, 92, 
130, 132). The process likely begins with assortment of positive-sense viral RNAs by a 
specific mechanism. Available data are congruous with an assembly model wherein 
equimolar amounts of the ten viral mRNAs associate with nonstructural and core proteins 
and condense to form nascent viral particles (2, 31), termed “replicase particles,” which 
are capable of synthesizing complementary negative-sense RNA to generate the dsRNA 
genome. Populations of particles with distinctive complements of viral RNA and protein, 
as well as specific transcriptional activities (i.e., positive- or negative-strand synthesis), 
can be separated physiochemically and are thought to represent particle intermediates on 
a pathway toward formation of mature virions (77, 78, 130, 132). Current concepts of 
individual steps in particle assembly are rooted mainly in biochemical analysis of these 
subparticle forms. However, the proposed assembly intermediates have not been 
correlated with specific morphogenic events in viral inclusions. 
 
Enzymatic Activity of the Reovirus Core 
 The reovirus core mediates production of capped, non-polyadenylated viral 
mRNAs representing each of the 10 gene segments. Viral mRNA is transcribed from the 
dsRNA genome template (6, 106) and extruded through the λ2 turrets of the core (40). λ3 
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is the catalytic subunit of the RNA-dependent RNA polymerase (33, 108, 112). It 
displays limited activity in vitro and likely must interact with μ2 and λ1 for complete 
functionality (108). The atomic structure of λ3 reveals an RdRp domain with right-
handed thumb, core, and palm subdomains, similar to other polymerases (112). This 
catalytic domain in enclosed by N- and C-terminal domains creating several channels that 
allow entry of template and nucleoside triphosphates and exit of template and newly 
synthesized mRNA (112). The structure of λ3 also suggests that it functions as a helicase, 
unwinding dsRNA prior to transcription; however, core shell protein λ1 exhibits some in 
vitro helicase activity (12). Following transcription, the 5’ γ-phosphate of the newly 
synthesized transcript is removed by an RNA triphosphatase (RTPase) to initiate capping. 
λ1 is thought to mediate this activity as the transcript is directed out of the core through a 
channel in the λ1 shell located at the base of the λ2 turret at the icosahedral vertex of the 
particle (11, 126). Capping is thought to be completed as the transcript exits through the 
λ2 turret because λ2 has both guanylyltransferase and methyltransferase activities (21, 65, 
112).  
 
Reovirus Replication Protein μ2 
The reovirus μ2 protein is a multifaceted regulator of reovirus replication and 
essential for the successful completion of the reovirus replication program. In addition to 
its role as an inclusion matrix protein, it is thought to be a polymerase cofactor, is a 
determinant of virulence, and is associated with tropism for a number of different cell 
types (14, 58, 61, 66, 67, 84, 85, 88, 102, 104, 123). The μ2 protein is a component of the 
reovirus core, which contains approximately 24 molecules of μ2 per virion particle (25). 
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Although the precise position of μ2 is unknown, several lines of evidence from 
biochemical, structural, and genetic studies suggest that μ2 resides at the vertex base in 
close approximation to λ3 (23, 58, 85, 91, 123, 126). μ2 is the only reovirus structural 
protein whose crystal structure has yet to be defined; nevertheless, numerous functional 
domains been mapped to the μ2 protein using biochemical and genetic studies (Fig.1.3) 
Although the μ2 protein coordinates diverse events during the reovirus replication cycle, 
a mechanistic understanding of the role of μ2 in replication remains unknown, primarily 
because its individual functional domains have not been linked to specific steps in the life 
cycle. 
The μ2 protein has been hypothesized to be part of the RdRp complex based on 
genetic analyses linking the M1 gene to strain-specific characteristics of T1 and T3 
replication and biochemical analysis of μ2 (14, 48, 58, 61, 84, 123, 124). Genetic 
association of the M1 gene with the λ3-expressing L1 gene was shown in an analysis of a  
 
Figure 1.4. Sequence-function correlations of reovirus μ2 protein. Sequences 
associated with recognized functions and motifs are indicated. Amino acids 
highlighted in red have been shown to influence the efficiency of viral growth.  
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large panel of reassortant viruses (84). The M1 and L1 genes displayed nonrandom 
segregation, suggesting specific protein-protein, protein-RNA or RNA-RNA interactions 
among μ2 and λ3 proteins and M1 and L1 gene segments (84). 
Despite showing significant sequence conservation between T1 and T3 (124), the 
M1 gene has been linked to numerous strain-specific phenotypes. The M1 gene 
determines the different temperature optima of in vitro transcription displayed by T1 and 
T3 cores (123). The L1 and M1 genes are also associated with the absolute amount of 
transcripts produced by cores in vitro (123). Reovirus replication displays strain-specific 
sensitivity to mycophenolic acid (which decreases intracellular levels of guanine 
nucleotides), with T1 being less sensitive than T3 (48). This phenotype maps to M1, and 
based on the mechanism of action of mycophenolic acid, suggests that μ2 may aid in the 
uptake and processing of GTP in viral transcription (48). In vitro nucleotide NTPase and 
RTPase activity (85) are also linked to the M1 gene and will be discussed further below. 
These genetic associations of M1 with strain-specific differences in transcription-related 
activities support the idea that μ2 is a cofactor of the viral RdRp.  
Biochemical evidence supporting the polymerase cofactor model of μ2 function 
includes RNA binding activity (14), NTPase and RTPase activity (58, 85), and λ3-
binding capacity (58). Expressed μ2 has RNA-binding activity in vitro; it binds ssRNA in 
a non-sequence specific manner, and it binds dsRNA and ssRNA analogs (14). μ2 has 
classical Walker A and Walker B nucleotide-binding motifs (Fig. 1.4) (85, 119), which 
are found in conserved regions of the μ2 protein (124). These motifs are associated with 
NTPase and RTPase activity, which is the removal of the γ-phosphate from the 5’ end of 
either an NTP or RNA molecule, respectively. NTPase activity is often associated with 
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helicase activity, and RTPase activity is required to initiate the addition of a 5’cap onto 
an mRNA molecule (37, 125). In vitro, reovirus cores display NTPase activity, and 
differences in T1 and T3 NTPase activity profiles based on NTP substrate, reaction 
temperature, and pH have been mapped to the M1 and λ1-encoding L3 genes (85). 
Furthermore, Kim et al. showed that purified μ2 is a divalent cation-dependent NTPase 
and RTPase (58). Mutation of lysine residues to alanine at positions 415 and 419 within 
the proposed Walker A motif abolished NTPase activity (58) and diminished viral 
replication capacity (61). The addition of purified λ3 stimulates μ2 triphosphatase 
activity, and μ2 and λ3 proteins display in vitro binding capacity to one another in co-
immunoprecipitation studies (58). Taken together, these biochemical data suggest that μ2 
modulates many activities performed by the reovirus core and may itself mediate 
enzymatic functions, thus supporting a model whereby μ2 acts as a polymerase cofactor.  
In addition to its central place in viral replication, μ2 regulates reovirus cell 
tropism and virulence. Strain-dependent viral replication efficiency has been genetically 
linked to μ2 in studies using primary and transformed cells, including murine cardiac 
myocytes (67, 102, 104), bovine aortic endothelial cells (66), human umbilical vein 
endothelial cells (66), and MDCK cells (93). Strain-specific virulence in severe combined 
immunodeficient (SCID) mice is determined by the S1, L2, M1, and L1 genes; M1 was 
independently important for virulence, including viral titer in the liver and severity of 
hepatitis (44).  
The capacity of reovirus to cause myocarditis in neonatal mice is regulated by μ2 
and tied to the innate antiviral response. Genetic analysis of myocarditic and 
nonmyocarditic reoviruses has identified M1 as a determinant of myocarditic potential 
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(102, 104). In cardiac myocytes, nonmyocarditic reoviruses induce greater levels of 
interferon (IFN)-β and are more sensitive to its antiviral affects (104). Furthermore, 
nonmycarditic reoviruses can cause myocarditis in mice depleted of IFN-α/β (104), 
showing that the IFN response to reovirus is essential for protection of the heart 
following infection. Reovirus strain-specific differences in induction of and sensitivity to 
IFN-α/β are associated with the viral M1, L2, and S2 genes. The μ2 protein of 
myocarditic strains such as T1 antagonizes the IFN response by mediating nuclear 
sequestration of interferon regulatory factor (IRF)-9, a key component of the complex 
that mediates the expression of IFN signaling genes (128), thus providing one possible 
explanation for the differences in myocarditic potential among reovirus strains. 
Furthermore, residue 208 of μ2 determines repression of IFN signaling in cardiac 
myocytes and modulates myocarditis in neonatal mice (49).  
 
Reovirus Reverse Genetics System 
I began my dissertation work shortly after a fully plasmid-based reovirus reverse 
genetics system was developed (59). This system is a powerful tool for carrying out 
reovirus research because it allows reoviruses with specific sequences to be designed and 
generated. The original system consisted of ten plasmids, each containing a full-length 
reovirus gene segment cDNA under transcriptional control of bacteriophage T7 RNA 
polymerase promoter and fused at the 3′ terminus with hepatitis delta virus (HDV) 
ribozyme sequences (Fig. 1.5A). These plasmids are thought to generate transcripts 
identical to reovirus-generated (+)-strand RNAs that serve as templates for translation 
and dsRNA synthesis in infected cells. In the original system, a primary round of reovirus  
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 Figure 1.5. Experimental strategy to generate reovirus from cloned cDNAs. (A) 
Prototype reovirus gene segment cDNA in plasmid. Cloned cDNAs representing each 
of the 10 full-length reovirus gene segments are flanked by the bacteriophage T7 RNA 
polymerase promoter (T7P) and the antigenomic hepatitis delta virus ribozyme (Rib). 
(B) Schematic of the approach using 10 reovirus cDNA constructs. Constructs are 
transfected into T7-RNA polymerase-expressing cells. Nascent transcripts contain the 
viral mRNA 5’ native end. Self-cleavage by HDV ribozyme generates the viral native 
3’end. Rescued viruses are recovered from cell lysates by plaque assay. (C, D) Two or 
four gene transcription cassettes encoding reovirus cDNAs flanked by the T7 RNA 
polymerase promoter and HDV ribozyme sequences were combined into single 
plasmids, creating four plasmids for the T1 (C) and T3 (D) reverse genetics systems. 
Image adapted from Kobayashi et al. 2007, Kobayashi et al. 2010. 
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replication is initiated by co-transfection of all ten plasmids into murine L cells infected 
with replication-defective vaccinia virus (rDIs-T7pol) expressing T7 RNA polymerase. 
Following five days of incubation, recombinant strain (rs) viruses are isolated from co-
transfection lysates by plaque assay using L cells (Fig. 1.5B). A second generation 
reverse genetics system was also developed which improved efficiency of virus recovery. 
In the improved system, the number of required plasmids was reduced from ten to four. 
Two or four gene transcription cassettes, each encoding T1 or T3 reovirus cDNAs 
flanked by the T7 RNA polymerase promoter and HDV ribozyme, were combined in a 
single plasmid (Fig. 1.5C, D). The new system also replaced rDis-T7pol-infected L cells 
with BHK-T7 cells that constitutively express T7 RNA polymerase. The improved 
system enhanced efficiency of virus recovery by reducing time to virus isolation and 
supporting increased total yields (62). Enhanced efficiency of the reverse genetics system 
has allowed for the recovery of viruses that were unrecoverable using the ten-plasmid 
system. For example, T1-T3M1, a virus with nine T1 gene segments and a T3 M1, could 
only be isolated using the improved methodology. The reovirus reverse genetics system 
has been crucial to my dissertation work as all of the viruses used were obtained through 
this means. 
  
Significance of my Research 
Viruses are constantly evolving to ensure continued propagation in a host system. 
Over the course of its evolution, each virus customizes a specific set of strategies to 
efficiently reprogram a host cell to further its proliferation. Divergent and convergent 
evolutionary processes lead to optimal strategies of replication. Therefore, diverse viruses 
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may exhibit similar strategies at certain points in their life cycles creating generalized 
themes of viral replication. Lessons learned from studies of the role of μ2 in reovirus 
inclusions that influence cell tropism can contribute to the identification of general 
mechanisms of post-entry-mediated cell tropism, compartmentalization of replication 
machinery within a host cell, and viral replication protein structure and function. For 
example, by the very nature of their genomes, reovirus (dsRNA) and influenza virus 
(negative-sense RNA) must utilize different mechanisms of replication. However, both 
reovirus and influenza virus display post-entry-mediated cell tropism that is controlled by 
viral polymerase proteins. Studies of reovirus can also inform studies of related dsRNA 
viruses such as the important human pathogen rotavirus. Rotavirus displays similar 
morphogenic and biochemical features to reovirus including confinement of enzymes 
required for transcription and replication within the inner capsid of the particle and 
completion of most post-entry steps of the viral life cycle within cytoplasmic inclusions. 
In this way, conclusions reached from work on reovirus have clear implications on 
strategies used by rotaviruses. Thus, studies of μ2 function, its interaction with other viral 
and cellular proteins, and its role in determining tropism contribute to virological 
principles that can be generally applied to many viruses. 
  In addition to advancing general virological principles, an exciting potential 
application of this work is development of reovirus for clinical use. Reovirus is oncolytic 
and currently undergoing clinical trials for cancer therapy (22, 109, 114). Reovirus is also 
being developed as a vaccine vector, targeting important human pathogens such as HIV 
(59). With the advent of reovirus reverse genetics as well as the availability of 
characterized strains with distinct phenotypes, it is conceivable that manipulation of the 
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μ2 protein and the viral replication machinery may facilitate the generation of reoviruses 
with favorable replication and tropism characteristics. Consequently, an understanding of 
reovirus replication properties in diverse cellular backgrounds may prove useful for 
application of reoviruses for clinical purposes. 
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CHAPTER II 
 
ANALYSIS OF REOVIRUS REPLICATION IN MDCK CELLS 
 
Introduction 
Productive viral infection requires a complex interplay between viral and cellular 
factors at each step in the viral life cycle. Cell-, tissue-, and host-specific differences can 
affect the capability of a virus to utilize cellular machinery and lead to distinct patterns of 
virus tropism. Conceivably, each step of the viral life cycle could determine tropic 
differences; however, the role of viral replication proteins in mediating tropism is not 
well defined. In a study of reovirus infection of MDCK cells, it was found that strains T1 
and T3 differ in their capacity to productively infect these cells (93). T1 efficiently 
replicates in MDCK cells but T3 does not. Analysis of a panel of T1 x T3 reassortant 
viruses showed that differences in replication efficiency between the two viruses in 
MDCK cells segregate primarily with the λ3-expressing L1 gene segment and 
secondarily with the μ2-expressing M1 gene segment (93). This phenotype presents a 
useful experimental model to study the individual and cooperative roles of μ2 and λ3 in 
reovirus cell tropism.  
In this work, I investigated the viral determinants of replication potential in 
MDCK cells. Using viruses generated by reverse genetics I examined the involvement of 
individual gene segments and μ2-polymorphisms that contribute to the replication 
phenotype. My studies indicate that μ2 is the primary determinant of viral replication 
efficiency in MDCK cells and that λ3 is a conditional co-regulator of μ2 function 
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depending on the viral genetic background. Furthermore, residue 347 is the primary 
determinant of μ2-mediated replication in these cells. Additionally, I conducted 
replication experiments to initially characterize cellular determinants of the restriction of 
T3 replication in MDCK cells. I found that T3 replication efficiency is increased if 
infection is initiated with a low dose of virus and no differences were observed in IFN-β 
induction between permissive and non-permissive infections. These results enhance our 
understanding of the viral replication apparatus and the viral and cellular requirements 
crucial for its activity.  
 This work was done is collaboration with Dr. Takeshi Kobayashi, a former 
postdoctoral fellow in the laboratory of Dr. Terry Dermody. Dr. Kobayashi generated 
many of the viruses used in these studies and was involved in the initial characterization 
of monoreassortant viruses in MDCK cells. 
 
Results 
Reovirus strain-specific replication in MDCK cells – The original study identifying the 
strain-specific capacity of reovirus T1 and T3 to replicate in MDCK cells used laboratory 
stocks of native T1 and T3 viruses (93). To confirm that viruses recovered using the 
plasmid-based reverse genetics system (59, 62) recapitulate growth characteristics of 
native T1 and T3 in MDCK cells, recombinant strain T1 and recombinant strain T3 were 
used to infect MDCK cells at a multiplicity of infection (MOI) of 2 plaque forming units 
(PFU)/cell, and viral titers in cell lysates were monitored over the course of infection. 
Consistent with previous findings, strain T1 achieved an approximately 100-fold increase 
in viral titer over 48 h of incubation (Fig. 2.1A). Conversely, strain T3 exhibited a 
  22
minimal increase in titer during the course of infection. In contrast to growth in MDCK 
cells, both strains replicated with similar kinetics and produced equivalently high titers in 
L cells (Fig. 2.1B). These results demonstrate that differences in tropism for MDCK cells 
displayed by the native viruses are recapitulated by the recombinant strains. Table 2.1 
provides the composition of all recombinant strain reoviruses used in these studies. 
 
 Identification of reovirus gene segments that influence replication in MDCK cells – To 
more fully understand the contributions of individual reovirus genes to viral replication 
efficiency in MDCK cells, monoreassortant viruses (containing nine gene segments from 
one strain, denoted first in the virus name, and one gene derived from a different strain, 
indicated second in the virus name) were generated, and production of infectious progeny 
virions was quantified. L1, M1, and S1 monoreassortant viruses were generated in both 
 
Figure 2.1. Growth of reovirus in cultured cells. MDCK cells (A) or L cells (B) were 
infected at an MOI of 2 PFU/cell, and viral titers in cell lysates were determined at 
the time points shown by plaque assay using L cell monolayers. Results represent the 
mean of triplicate experiments. Error bars indicate S.D. 
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Table 2.1 Genetic composition of reovirus strains used for these studies 
 Gene Segment Origin 
Virus Strain L1 L2 L3 M1 M2 M3 S1 S2 S3 S4 
T1 1 1 1 1 1 1 1 1 1 1 
T3 3 3 3 3 3 3 3 3 3 3 
T1-T3L1 3 1 1 1 1 1 1 1 1 1 
T1-T3M1 1 1 1 3 1 1 1 1 1 1 
T1-T3L1M1 3 1 1 3 1 1 1 1 1 1 
T3-T1L1 1 3 3 3 3 3 3 3 3 3 
T3-T1M1 3 3 3 1 3 3 3 3 3 3 
T3-T1L1M1 1 3 3 1 3 3 3 3 3 3 
Chimera 1 3 3 3 Ch1 3 3 3 3 3 3 
Chimera 2 3 3 3 Ch2 3 3 3 3 3 3 
Chimera 3 3 3 3 Ch3 3 3 3 3 3 3 
Chimera 4 3 3 3 Ch4 3 3 3 3 3 3 
T1 V300M 1 1 1 V300M 1 1 1 1 1 1 
T1 Q342R 1 1 1 Q342R 1 1 1 1 1 1 
T1 F347L 1 1 1 F347L 1 1 1 1 1 1 
T3 M300V 3 3 3 M300V 3 3 3 3 3 3 
T3 R342Q 3 3 3 R342Q 3 3 3 3 3 3 
T3 L347F 3 3 3 L347F 3 3 3 3 3 3 
T1-T3L1-M1F347L 3 1 1 F347L 1 1 1 1 1 1 
T3-T1L1-M1 L347F 1 3 3 L347F 3 3 3 3 3 3 
 
 
T1 and T3 genetic backgrounds. L1 and M1 were exchanged because these genes were 
previously identified as determinants of reovirus tropism for MDCK cells (93). 
Monoreassortant viruses encoding reciprocal exchanges of the S1 gene, encoding viral 
attachment protein σ1 and nonstructural protein σ1s, were tested for growth in MDCK 
cells since receptor engagement is responsible for differences in the infectivity of type 1 
and type 3 reoviruses for a variety of cells and tissues (32, 57, 96, 115, 121). Parental and 
monoreassortant viruses were used to infect MDCK cells at an MOI of 2 PFU/cell, 
followed by quantification of viral yields after 24 h of incubation. Consistent with the 
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 Figure 2.2. Growth of monoreassortant viruses in MDCK cells. Cells were infected 
with L1, M1, or S1 monoreassortant viruses at an MOI of 2 PFU/cell, and viral yields 
(relative to 0 h) at 24 h post-infection were determined by plaque assay using L cell 
monolayers. Results represent the mean of triplicate experiments. Error bars indicate 
S.D. *, p < 0.05 in comparison with strain T1 (Student’s t test).
 
earlier mapping study, the T1 M1 gene was sufficient to support growth of T3 to the level 
of T1, whereas the S1 gene was not associated with strain-specific differences in viral 
yield (Fig. 2.2). However, contrary to previous findings, an independent association of 
the L1 gene with viral replication was not observed using L1 monoreassortant viruses; 
T1-T3L1 and T3-T1L1 displayed high and low yields, respectively, mimicking their 
parental strains. Furthermore, the effect of M1 on viral replication was unidirectional; the 
T3 M1 gene segment, alone, did not diminish T1 yield. These results indicate that the μ2 
protein regulates reovirus replication efficiency in MDCK cells, but the effects of μ2 on 
replication are subject to modulation by other viral determinants. 
To test the hypothesis that there is cooperativity between the L1 and M1 genes in 
governing viral yield, experiments using L1/M1 double reassortant viruses in the T1 (T1-  
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Figure 2.3. Yields of L1/M1 reassortant viruses in cultured cells. MDCK cells (A) or L 
cells (B) were infected at an MOI of 2 PFU/cell, and viral yields (relative to 0 h) were 
determined at 24 h post-infection by plaque assay using L cell monolayers. Results 
represent the mean of triplicate experiments. Error bars indicate S.D. *, p < 0.05 in 
comparison with strain T1 (Student’s t test).  
T3L1M1) and T3 (T3-T1L1M1) backgrounds were performed. Pairing T3 L1 and T3 M1 
genes in the T1 background significantly reduced T1 viral yield in MDCK cells at 24 h 
post-infection (Fig. 2.3A). In contrast, growth of T3-T1M1 was unaffected by the strain 
origin of the L1 gene. Yields of M1 monoreassortant and L1/M1 double-reassortant 
viruses were also determined using L cells to control for potential constitutive effects of 
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the T1 and T3 L1 and M1 genes on viral replication. In these experiments, all strains 
produced high yields in L cells (Fig. 2.3B). Reassortant strain T1-T3L1M1 grew less 
efficiently in L cells compared to the T1 parental strain. However, the reduction in viral 
yield was 10-fold compared to a 100-fold difference in MDCK cells. The yield of T3-
T1L1M1 exceeded that of T3 by approximately 3-fold, but this difference was modest 
compared to the 70-fold increase in MDCK cells. Taken together, results of experiments 
using M1 and L1 reassortant viruses indicate that μ2 is a key determinant of reovirus 
tropism for MDCK cells and, additionally, provide evidence for co-regulation of viral 
replication by polymerase protein λ3, conditioned on the viral genetic background.  
 
Identification of sequences in μ2 that mediate reovirus tropism for MDCK cells – To 
identify μ2 sequence features of reovirus replication efficiency in MDCK cells, a panel of 
T1 x T3 μ2-chimeric viruses was generated in the T3 genetic background (Fig. 2.4A). 
Chimera (Ch) 1 and Ch2, containing T3 μ2-derived sequences 1-126 and 1-208, 
respectively, produced high viral yields similar to T1, whereas Ch3 and Ch4, containing 
T3 μ2-derived sequences 1-389 and 1-600, respectively, produced low yields similar to 
T3 (Fig. 2.4B). Relative replication efficiencies of the four chimeric viruses suggest that 
μ2 sequences regulating reovirus replication in MDCK cells are bounded by amino acid 
residues 209 and 389.  
Three sequence polymorphisms with respect to T1 and T3—300, 342, and 347—
are present within the μ2 region that controls viral replication efficiency in MDCK cells 
(Fig. 2.4C). The relative contribution of these amino acids to viral yield was assessed by 
reciprocal exchanges between the μ2 proteins of T1 and T3 using reverse genetics. 
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Figure 2.4. Identification of a μ2 domain that mediates reovirus tropism for MDCK 
cells. (A) Schematic of T1 x T3 chimeric (Ch) M1 gene segments. Chimeric junctions 
were introduced at the nucleotide position corresponding to the amino acid numbers 
shown. Viruses containing M1 chimeric gene segments were generated in a T3 strain 
background. (B) MDCK cells were infected with M1 chimeric viruses at an MOI of 2 
PFU/cell, and viral yields (relative to 0 h) were determined at 24 h post-infection by 
plaque assay using L cell monolayers. Results represent the mean of triplicate 
experiments. Error bars indicate S.D. *, p < 0.05 in comparison with strain T1 
(Student’s t test). (C) T1 and T3 μ2 proteins differ at nine amino acid positions.  
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Moderately increased yields (approximately 4-fold) resulted from replacement of T3 μ2 
amino acids with the corresponding T1 μ2 residues at positions 300 and 342. In contrast, 
substitution of Leu347 in T3 μ2 with Phe (T3-M1L347F), which is found at this position 
in T1 μ2, enabled T3 to replicate equivalently to T1 (approximate 100-fold yield). 
Conversely, the yield of T1-M1F347L, isogenic to T1 except for Leu at μ2 amino acid 
position 347, approximated that of T1 (Fig. 2.5A). Yields of μ2 point-mutant viruses T1-
M1Q342R and T1-M1F347L, which contain T3 residues at μ2 amino acid positions 342 
and 347, were modestly reduced in L cells relative to parental strain T1 (Fig. 2.5C). 
However, the other μ2 point-mutant strains and the parental viruses all exhibited 
equivalently high yields in L cells; no influence of the L1 gene was detected (Figs. 2.5C, 
D). Therefore, constitutive replication defects are unlikely to account for disparities in 
yields of μ2-mutant viruses when propagated in MDCK cells.  
Consistent with the cooperative relationship of wild type λ3 and μ2 proteins in 
viral growth (Fig. 2.3), a functional interaction was observed between λ3 and mutant μ2 
governed by the specific viral genetic environment; yield of T1-M1F347L in MDCK 
cells was reduced relative to wt parental strain T1 when the mutant μ2 protein was 
accompanied by the T3 (strain T1-T3L1-M1F347L), but not T1 (strain T1-M1F347L), λ3 
protein (Figs. 2.5A, 2.5B). Interestingly, the T1 λ3 protein acted synergistically with the 
μ2 L347F mutation to moderately suppress (approximately 13-fold reduction in yield) the 
growth of T3 (T3-T1L1- M1L347F) (Fig. 2.5B), which further substantiates the 
functional linkage of λ3 and μ2 in reovirus tropism for MDCK cells. These results 
indicate that a sequence polymorphism at amino acid position 347 is the primary 
determinant of μ2-mediated reovirus replication efficiency in MDCK cells. Furthermore, 
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Figure 2.5. Identification of residues in μ2 that mediate reovirus tropism for MDCK 
cells. MDCK cells (A) or L cells (C) were infected with μ2 point-mutant viruses at an 
MOI of 2 PFU/cell, and viral yields (relative to 0 h) were determined at 24 h post-
infection by plaque assay using L cell monolayers. MDCK cells (B) or L cells (D) 
were infected at an MOI of 2 PFU/cell with L1 monoreassortant viruses containing 
point mutations at residue 347 of μ2, and viral yields (relative to 0 h) were determined 
at 24 h post-infection by plaque assay using L cell monolayers. Results represent the 
mean of triplicate experiments. Error bars indicate S.D. *, p < 0.05 in comparison with 
strain T1 (Student’s t test).  
 
the λ3 protein acts as a modifier of tropic phenotypes manifested by sequence variation at 
this position in μ2.  
 
Dose-dependent reovirus replication in MDCK cells – In order to determine if the 
amount of virus initiating infection in MDCK cells alters the capacity of T3 to replicate 
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in MDCK cells, replication kinetics in MDCK cells following infection at different MOIs 
were quantified. MDCK cells were infected with T1 or T3 at an MOI of 0.02, 0.2, 2, or 
20 PFU/cell, and titer was monitored over 48 h (MOI of 2 or 20) or 120 h (MOI 0.02 or 
0.2) infection (Fig. 2.6A, B). Interestingly, at an MOI of 0.02, an approximate 300 fold  
 
 
Figure 2.6. MOI-dependent replication of reovirus in MDCK cells. MDCK cells were 
infected with T1 and T3 (A, B) or T3 and T3-T1M1 (C, D) at an MOI of 0.02, 0.2 (A, 
C) 2 or 20 (B, D).Viral titers in cell lysates were determined at the time points shown 
by plaque assay using L cell monolayers. Results represent the mean of triplicate 
experiments. Error bars indicate S.D.
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increase in titer of T3 was observed by 120 h post-infection compared to a 3000 fold 
increase in titer by T1. When the infection was initiated with an MOI of 0.2, 2, or 20 
PFU/cell, no substantial increase in T3 titer was observed over the time course of 
infection (Fig. 2.6A, B). This experiment was also carried out with T3 and T3-T1M1 (Fig. 
2.6C, D). T3-T1M1 displayed similar replication kinetics to T1, again highlighting the 
capacity of the T1 M1 gene to overcome the replication block in MDCK cells. 
Furthermore, a similar pattern of T3 dose-dependent replication was observed, whereby 
the greatest increase in T3 titer occurred following infection initiated at an MOI of 0.02 
PFU/cell. These results suggest that the restriction of T3 replication in MDCK cells is 
dependent on the inoculum of virus initiating the infection.  
 
Interferon-β production in MDCK cells – One hypothesis consistent with the observation 
of dose-dependent restriction of T3 replication in MDCK cells is that a negative regulator 
is induced following infection and a critical threshold of virus must be present produce 
enough factor to reduce viral replication. A common cellular defense mechanism against 
viruses is the production of type I IFN (α and β), which stimulates gene expression to 
establish an antiviral state within the host (38). Reovirus infection triggers IFN 
expression, and strains differ in the capacity to induce IFN in some cell types (104, 107). 
To assess IFN induction in MDCK cells, IFN-β mRNA was measured using reverse 
transcription quantitative PCR (RT-qPCR). MDCK cells were infected with T3 or T3-
T1M1 at an MOI of 0.02 or 2 PFU/cell and IFN-β mRNA was quantified in cell lysates 
after 24 h (Fig. 2.7). In mock-infected cells, IFN-β mRNA was barely detectable with a 
Ct value of 37.2. In cells infected at an MOI of 2 PFU/cell, the Ct values were much  
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 Figure 2.7. IFN-β production in MDCK cells. MDCK were infected with T3 or T3-
T1M1 at an MOI of 2 or 0.02, and IFN-β mRNA was measured in cell lysates by RT-
qPCR. Results represent the mean of triplicate experiments. Error bars indicate S.D. 
 
lower than mock, 27.8 for T3 and 26.7 for T3-T1M1, indicating that IFN-β mRNA is 
produced following infection. In cells infected at an MOI of 0.02 PFU/cell, Ct values 
were approximately 32, indicating that some IFN-β mRNA was produced but at lower 
levels in cells infected at an MOI of 2 PFU/cell. No significant differences in IFN-β 
mRNA production were observed between the two viruses. These results indicate that 
MOI inversely correlates with T3 viral yield, and induction of IFN-β gene expression and 
increased IFN-β mRNA production following infection initiated at high multiplicities 
leads to a stronger IFN-stimulated response. It is possible that the block to T3 replication 
in MDCK cells may involve the type I IFN response and that T3 may be more sensitive 
to the IFN-induced antiviral state than T1. In other experimental systems, T3 is more 
sensitive to the IFN-stimulated antiviral response (104), and T1 μ2 has been shown to 
specifically antagonize components of the IFN-signaling pathway, whereas T3 does not 
(128). Therefore, the observation that less IFN-β is produced at the lower MOI is 
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compatible with a model in which infection initiated at a low MOI does not induce a 
strong enough antiviral state required to inhibit replication of T3. 
 
Characterization of the MDCK cell-mediated restriction of T3 replication – Additional 
experiments have been carried out in order to better understand the nature of the 
replication block in MDCK cells. All preceding experiments described were performed 
using second-passage (P2) L cell-lysate stocks of virus. It is possible that a constituent of 
the L cell lysate causes MDCK cells to respond in such a way that impedes T3 replication. 
To test this hypothesis, MDCK cells were infected with T1 or T3 from P2 L cell-lysate 
stocks or virion particles (VPs) purified using CsCl gradients, and viral yields were 
quantified 24 h post-infection (Fig. 2.8A). No differences were observed between 
infections initiated with P2 vs. VP stocks of virus, indicating the block is not caused by a 
component of the infected L cell lysate. 
 If the replication block is mediated by an inducible factor, it is possible that the 
factor is only induced by T3 but T1 is still susceptible to it. To test this hypothesis, 
MDCK cells were infected with T3, T3-T1M1 (T3-T1M1 was used as a surrogate of T1 
to specifically test the contribution of M1 to the phenotype), or co-infected with T3 and 
T3-T1M1, and viral yields were quantified 24 h post-infection (Fig. 2.8B). The mixed 
infection displayed a similar viral yield to T3-T1M1. These results do not confirm or 
refute the possibility that T3 specifically induces a restriction factor. However, if an 
inducible restriction factor exists, T3-T1M1 is not susceptible to it whether induced only 
by T3 or both T3 and T3-T1M1.  
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 Figure 2.8. Viral yield of reovirus in MDCK cells. (A) MDCK cells were infected at 
an MOI of 2 PFU/cell with virus from P2 L cell-lysate stocks virion particles (VPs) 
purified on CsCl gradients, and viral yields (relative to 0 h) at 24 h post-infection were 
determined by plaque assay using L cell monolayers. (B) MDCK cells were infected 
with T3, T3-T1M1, or co-infected (Mix) with these strains at an MOI of 2 PFU/cell, 
and viral yields (relative to 0 h) at 24 h post-infection were determined by plaque 
assay using L cell monolayers. Results represent the mean of triplicate experiments. 
Error bars indicate S.D. 
 
Discussion 
Initial studies of reovirus replication in MDCK cells revealed a genetic 
association of the λ3 and μ2 proteins with viral replication efficiency using classical 
reassortant analysis (93). Subsequent development of a reverse genetics system for 
reovirus has permitted the generation of viruses containing specific combinations of T1 
and T3 gene segments which clearly defined the relative contributions of μ2 and λ3 to 
this phenotype (Figs. 2.2 and 2.3). T1 μ2 is associated with efficient reovirus replication 
in MDCK cells irrespective of the viral genetic background. The influence of T3 μ2 on 
viral replication is more complex; its quantitative effect on production of infectious 
progeny undergoes modulation by T3 λ3. The μ2 protein is thought to be a cofactor of the 
viral RdRp (14, 23, 58, 85, 123). However, there is limited insight into interactions 
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between μ2 and λ3. Biochemical data have shown that the NTPase and RTPase activities 
of μ2 are enhanced in the presence of λ3, and the two proteins interact in 
immunoprecipitation assays (58). Furthermore, the L1 and M1 genes display nonrandom 
segregation in T1 x T3 reassortant viruses (84), suggesting co-evolution of λ3 and μ2 to 
optimize concerted roles in viral replication. Data presented in this chapter showing the 
unidirectional μ2-mediated regulation of replication efficiency in MDCK cells and viral 
background-dependent co-regulation by λ3 suggest a unique structural or functional 
interaction between μ2 and λ3 in specific viral and cellular contexts. These findings 
provide additional genetic evidence linking the function of these two proteins and 
implicate the role of the polymerase complex in determining viral cell tropism. 
Using recombinant viruses containing chimeric and point-mutant μ2 proteins, I 
systematically defined sequence determinants of reovirus replication efficiency in MDCK 
cells. The results indicate that residue 347 is primarily responsible (Fig. 2.5A). The 
influence of this polymorphic position on viral replication potential is modulated by λ3 in 
a manner consistent with the effect of λ3 on full-length μ2 (Fig. 2.5B). A crystal structure 
of μ2 has not been reported; however, a number of functional sequence determinants 
have been defined (Fig. 1.4, [23, 49, 58, 61, 85, 88]). It is possible that critical residues 
identified in this study are part of a larger domain of μ2 that controls reovirus tropism for 
different types of cells. For example, a temperature-sensitive (ts) strain of reovirus 
(tsH11.2) containing mutations at residues 399 and 414 of μ2 displays defective dsRNA 
synthesis at restrictive temperatures. The sequence proximity of these residues to amino 
acid position 347 raises the possibility that all three are part of a functional unit 
responsive to the host cell environment. Residue 347 is also near a predicted leucine-rich 
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nuclear export signal spanning residues 328-335 (NetNES 1.1 [63]). Since μ2 is localized 
to both the cytoplasm and nucleus (61, 88) and contains two predicted nuclear 
localization signals, one of which has been shown to be important for viral replication 
(61), it is plausible that a polymorphism at position 347 could deleteriously shift the 
nucleocytoplasmic balance of μ2. 
 It is not possible to rule out an interaction of residue 347 with other structural or 
functional domains distantly located in primary sequence, such as the nucleotide binding 
motifs located at residues 414-420 and 445-450 (58). These sequences are required for 
NTPase and RTPase activities of μ2 (58) and are necessary for viral replication using an 
RNAi trans-complementation system (61). Therefore, changes at μ2 residue 347 
plausibly could alter the function of these domains, with a resultant impact on viral 
replication efficiency in MDCK cells.  
 RdRp complexes of diverse RNA viruses may function in viral adaptation to 
different intracellular environments (71, 82, 83). In the influenza A paradigm, host-range 
restriction involves an active inhibitory process that protects against cross-species 
transmission of non-adapted viruses. It is provocative that reovirus strains T1 and T3 
sharply contrast in their capacity to grow in canine cells, whereas both strains 
productively infect cells derived from several other species, including mouse (L [Fig. 
2.1]), human (HeLa and 293T [18, 60]), and non-human primates (Vero and CV-1 [10, 
19]), raising the possibility that μ2 is a host-range determinant of reovirus infection. 
However, this hypothesis awaits formal testing.  
The capacity of MDCK cells to discriminate reovirus strains T1 and T3 in a μ2- 
and λ3-dependent manner indicates the existence of a tightly controlled post-entry 
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replication checkpoint responsive to structural or functional features of the viral 
polymerase complex. Conceivably, the regulatory mechanism could be positive or 
negative, i.e. active stimulation of T1 replication or suppression of T3 replication. A 
passive mechanism also is possible in which MDCK cells fail to provide a function 
essential for T3, but not T1, replication. The mediator of replication permissivity might 
be as simple as a single protein or as complex as a biochemical pathway. 
 One factor determining species-specific retroviral infection occurs through the 
anti-viral activity of TRIM5α (80), which mediates restriction of retroviruses at a post-
entry step in the viral replication cycle. A key experiment in the characterization of 
TRIM5α regulation of infection was high-dose infection. When non-permissive cells 
were infected a high MOI, the replication block could be overcome, suggesting the 
presence of a dominant, saturable restriction factor (45, 80). In an effort to characterize 
the blockade to T3 in MDCK cells, I tested the affect of MOI to determine if a similar 
mechanism was occurring. Interestingly, altering the MOI had the opposite effect. High 
MOI did not enhance replication; however, at low MOI, T3 displayed greater replication 
efficiency (Fig. 2.6). This result is consistent with a model whereby reovirus infection of 
MDCK cells induces a restriction factor that blocks T3 infection. As the IFN signaling 
pathway is a common anti-viral defense mechanism, it plausible that the hypothetical 
restriction factor is IFN-inducible. Initial experiments commonly used to assess the 
involvement of IFN-stimulated genes on a phenotype involve stimulation of the IFN 
signaling pathway with exogenous IFN-α/β or blocking IFN signaling with anti-IFN-α/β 
antibody. However, neither canine-specific IFN nor anti-IFN-antibody was readily 
available. Therefore, I designed an RT-qPCR assay to measure production of IFN-β 
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mRNA. No strain-specific differences were observed in IFN-β production (Fig 2.7); 
however, these results do not preclude the possibility of different levels of activity of 
downstream mediators of the IFN signaling pathway. Indeed, in L cells, T1, but not T3, 
antagonizes IFN signaling by causing IRF-9 accumulation in the nucleus (128). Less 
IFN-β mRNA production was observed in low MOI infection, which is consistent with 
the notion that an IFN-induced restriction factor is not expressed at a high enough level to 
fully block T3 replication under these conditions. However, further experimentation is 
required to fully understand the involvement, if any, of the IFN signaling pathway on 
reovirus replication efficiency in MDCK cells.  
The purpose of this study was to define the functional domains of reovirus genes 
that govern reovirus cell tropism. The main findings emerging from this study are the 
following: 1) μ2 controls efficiency of reovirus growth in MDCK cells; 2) residue 347 is 
the primary determinant of μ2-mediated viral replication potential in these cells; 3) 
polymerase protein λ3 is a co-regulator of viral replication in a strain-dependent manner; 
and 4) replication efficiency is increased when infection is initiated at a low MOI. These 
findings suggest a unique structural or functional interaction between μ2 and λ3 that 
facilitates productive viral replication in a manner responsive to specific viral and host-
cell environments. A key question raised by this study is what is the mechanism whereby 
T3 replication is blocked In MDCK cells? Experiments addressing this question are 
described in Chapters III and IV.  
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CHAPTER III 
 
IDENTIFICATION OF THE μ2-SENSITIVE STEP OF VIRAL REPLICATION IN 
MDCK CELLS  
 
Introduction 
Results presented in Chapter II indicate a unique structural or functional 
interaction between μ2 and λ3 that facilitates productive viral replication in a manner 
responsive to specific viral and host-cell environments. The strain-dependent capacity of 
reovirus to replicate in MDCK cells provided a useful experimental platform to 
systematically examine discrete steps in the viral replication program in permissive and 
non-permissive infection. As key viral mediators of this phenotype are replication 
proteins μ2 and λ3, I hypothesized that a post-entry step in the replication cycle is 
inhibited in T3-infected MDCK cells. I found this system of particular interest because 
post-entry determinants of reovirus tropism have not been defined. Following reovirus 
entry, the core mediates a primary round of transcription and translation. Viral inclusions 
are formed from newly synthesized viral proteins, and viral mRNA and protein and cores 
are recruited to inclusions. Within the inclusion RNA assortment and replication complex 
assembly, dsRNA synthesis, and secondary transcription and translation take place. 
These steps in the viral life cycle are plausible targets of a replication protein-determined 
block to infection based on known functions of μ2 and λ3. Capsid assembly and viral 
egress are also post-entry steps that could be inhibited; however, there is no evidence 
linking μ2 and λ3 to these final stages of the viral replication program. 
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Therefore, I designed experiments to study inclusion formation, viral RNA 
production, and viral protein synthesis to assess post-entry steps in the life cycle where 
T3 replication in MDCK cells may be blocked. I focused specifically on μ2 protein as T1 
μ2 can independently enhance replication efficiency of T3 in MDCK cells. These studies 
provide insight into steps in the viral replication program that require μ2 function and are 
modulated by the host-cell environment.  
 
Results 
Viral inclusion formation in reovirus-infected cells – As an initial approach to define the 
μ2-sensitive step in viral replication in MDCK cells, I imaged viral inclusions over a time 
course of infection using confocal immunofluorescence microscopy. Cells were infected 
with T1 or T3, fixed at various intervals, and stained with anti-μ2 and anti-σNS antisera. 
In both T1- and T3- infected L cells, inclusions initially appeared as small, punctuate 
structures that gradually enlarged and assumed strain-dependent filamentous and globular 
features characteristic of T1 and T3, respectively (Fig. 3.1). Strain-dependent 
morphology was observed in MDCK cells; however, T1 inclusions in MDCK cells also 
displayed globular structures intermingled with filamentous forms, resulting in a more 
intermediate phenotype. Although the progress of inclusion formation for both T1 and T3 
was slightly delayed in MDCK cells in comparison to L cells, inclusion development was 
comparable between MDCK cells and L cells by 12 h post-infection. Thus, kinetics of T3 
inclusion maturation in MDCK cells was not overtly impaired. Typical inclusion 
maturation and abundant expression of σNS, a nonstructural protein, in  
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 Figure 3.1. Reovirus inclusion formation. MDCK or L cells were infected with T1 or 
T3 at an MOI of 20 PFU/cell, fixed at the time points shown, stained with anti-μ2 
(green) and anti-σNS (red) antibodies and ToPro3 (blue, nuclear), and imaged using 
confocal microscopy. Scale bars, 20 μm.
 
T3-infected MDCK cells indicate that viral attachment, entry, and early rounds of 
transcription and translation proceed normally. 
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Trafficking of viral proteins to inclusions – The analysis of inclusion formation presented 
in Figure 3.1 indicates normal kinetic and morphologic development of viral inclusions in 
T3-infected MDCK cells. However, as only σNS and μ2 were visualized, the possibility 
of aberrant inclusion composition or localization of other viral proteins cannot be ruled 
out from these results. To more precisely characterize viral inclusions in T3-infected 
MDCK cells, I visualized the localization of other viral proteins using confocal 
microscopy. Strain T3-T1M1 served as a reference for efficient μ2-regulated reovirus 
replication. Consistent with previous experiments (Fig. 2.2, 2.3), T3-T1M1 replicated to 
high titers, whereas T3 exhibited minimal titer increase over a 48 h incubation interval 
(Fig. 3.2A). Nonstructural proteins σNS and μNS physically associate in the formation of 
an inclusion scaffold (74). In cells infected with T3 or T3-T1M1, large inclusions with 
usual strain-dependent morphology were observed using σNS- and μNS-specific antisera 
to stain cells at 24 h post-infection (Fig. 3.2B, C). No alterations in σNS or μNS 
localization were apparent in T3-infected cells. These data indicate that the viral proteins 
required to form inclusions are properly recruited and assembled in T3-infected MDCK 
cells. 
The localization of viral core proteins μ2 and λ2 and outer-capsid proteins μ1 and 
σ3 in T3- and T3-T1M1-infected MDCK cells (Fig. 3.3A) and L cells (Fig. 3.3B) was 
examined. In MDCK cells, the μ2 and λ2 proteins of both T3 and T3-T1M1 were found 
throughout the cytoplasm and concentrated in viral inclusions (Fig. 3.3A). A similar 
distribution of these proteins was observed in L cells. Outer-capsid protein σ3 was highly 
abundant in both T3- and T3-T1M1-infected MDCK cells. It was found distributed 
throughout the cytoplasm, colocalized with σNS in inclusion puncta, and frequently in  
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 Figure 3.2 Replication and inclusion formation of T3 and T3-T1M1. (A) MDCK cells 
were infected with T3 or T3-T1M1 at an MOI of 2 PFU/cell, and viral titers in cell 
lysates were determined at the time points shown by plaque assay using L cells. 
Results represent the mean of triplicate experiments. Error bars indicate S.D. (B, C) 
MDCK cells were infected with T3 (B) or T3-T1M1 (C) at an MOI of 100 PFU/cell, 
fixed at 24 h post-infection, stained with anti-σNS (green) and anti-μNS (red) 
antibodies and ToPro3 (blue, nuclear), and imaged using confocal microscopy. Scale 
bar, 50 μm.  
 
the nucleus (Fig. 3.3A). The distribution of σ3 in L cells was similar except for reduced 
distribution to the nucleus compared with MDCK cells. Outer-capsid protein μ1 was 
observed diffusely throughout the cytoplasm and in punctate structures associated with 
inclusions (Fig. 3.3). Fewer μ1-containing punctate structures were observed in T3- vs. 
T3-T1M1-infected MDCK cells (Fig. 3.3A). However, this quantitative difference 
correlates with diminished levels of μ1 expression overall (Fig. 3.5). In summary, no 
qualitative differences in the distribution of non-structural, core, or outer-capsid viral 
proteins were discernable in comparison of T3- and T3-T1M1-infected MDCK cells, 
indicating that viral protein recruitment to inclusions in cells infected by both strains 
occurs normally. 
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Figure 3.3. Distribution of reovirus proteins μ2, σ3, μ1, and λ2 in infected cells. 
MDCK cells (A) and L cells (B) were infected with either T3 or T3-T1M1 at an MOI 
of 20 PFU/cell, fixed at 24 h post-infection, stained with anti-σNS (green) and anti-μ2, 
anti-σ3, anti-μ1, or anti-λ2 (red) antibodies. Nuclei were visualized using ToPro3 
(blue). Images were captured using confocal microscopy. Scale bar, 20 μm.  
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Quantification of reovirus RNA in infected cells – While the presence of viral inclusions 
in T3-infected MDCK cells confirms that viral transcription and translation occur, these 
findings cannot distinguish possible temporal defects occurring during primary and 
secondary rounds of gene expression. To monitor production of viral RNA over the 
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course of infection, I developed an RT-qPCR approach to specifically quantify positive- 
and negative-sense S4-gene RNA, which encodes viral structural protein σ3. Standard 
curves relating total viral genomic RNA to Ct were used for calculations of S4 total, 
double-stranded, and mRNA in RNA extracts from virus-infected cells. MDCK cells and 
L cells were infected at an MOI of 10 PFU/cell with either T3-T1M1 or T3. Strain T3-
T1M1 was used in place of T1 because the T3 and T3-T1M1 S4 alleles are identical. At 
12 h post-infection and following time points, high levels of total S4 RNA were detected 
in T3-T1M1-infected MDCK cells compared to the minimal amount of RNA produced in 
T3-infected cells (Fig. 3.4A). Conversely, in L cells, significant levels of total RNA were 
present in both T3-T1M1- and T3-infected cells at 12 h post-infection and beyond (Fig. 
3.4B). Similar patterns of S4 dsRNA production by T3-T1M1 and T3 were observed in L 
cells (Fig. 3.4C, D). Significant levels of S4 mRNA were detected in MDCK cells at 12, 
18, and 24 h post-infection with strain T3-T1M1 (Fig. 3.4E), whereas little S4 mRNA 
was detected in T3-infected cells at 12 and 18 h post-infection (Fig. 3.4E). The amount of 
S4 mRNA in T3-infected cells at 24 h post-infection was below the limit of detection 
(<10 copies of S4 RNA). These results indicate roughly equivalent efficiencies of early 
viral RNA synthesis in T3-T1M1 and T3-infected MDCK cells. However, late RNA 
synthesis is markedly diminished in T3-infected cells in comparison to that in T3-T1M1-
infected cells, consistent with attenuated dsRNA production by T3 in MDCK cells.  
 
Protein synthesis in reovirus-infected cells – Viral protein synthesis in infected MDCK 
cells and L cells was assessed by radiolabelling proteins during the course of infection. 
Strains T1 and T3 differ in the capacity to inhibit host cell protein synthesis, a phenotype  
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 Figure 3.4. Analysis of viral RNA synthesis. Cells were infected with T3-T1M1 or T3 
at an MOI of 10 PFU/cell, and total RNA was extracted from cell lysates at the 
indicated time points. RT-qPCR of total S4 RNA in MDCK cells (A) and L cells (B) 
was performed using an S4-specific reverse primer (complementary to the (+)-strand) 
in the reverse transcription step, followed by qPCR. A standard curve relating Ct to 
the amount of S4 RNA isolated from purified virion particles was used to determine 
S4 (+)-strand RNA copy number. RT-PCR of dsRNA in infected MDCK cells (C) and 
L cells (D) was performed using an S4-specific forward primer (complementary to the 
(–)-strand) in the reverse transcription step, followed by qPCR. A standard curve 
relating Ct to the amount of S4 RNA isolated from purified virion particles was used 
to determine S4 (–)-strand RNA copy number. Amounts of viral mRNA in MDCK 
cells (E) and L cells (F) are expressed as the difference between total RNA and 
dsRNA at each time point shown. Results represent the mean of triplicate experiments. 
Error bars indicate S.D. 
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unrelated to the M1 gene segment (98, 131). Therefore, T3-T1M1 was used instead of T1 
to eliminate this possible confounder. MDCK cells and L cells were infected at an MOI 
of 100 PFU/cell with either T3-T1M1 or T3. One hour prior to harvest, cells were 
incubated with [35S]methionine-cysteine, and solublized whole-cell proteins were 
resolved using SDS-PAGE followed by autoradiography. New viral protein synthesis was 
observed at 12, 18, and 24 h post-infection in T3-T1M1-infected MDCK cells, yet only at 
12 h post-infection in T3-infected cells (Fig. 3.5A). These data generally mirror T3-
T1M1 and T3 RNA production in MDCK cells. In contrast, the kinetics and magnitude of 
new viral protein synthesis by T3-T1M1 and T3 did not significantly differ in infected L 
cells (Fig. 3.5B). Thus, early viral protein synthesis was roughly equivalent between T3-
T1M1 and T3 in MDCK cells, but late protein synthesis by T3 was undetectable, 
consistent with diminished mRNA production at later time points. 
 
Discussion 
 In this chapter, I set out to elucidate the role of μ2 protein in viral replication 
efficiency and cell tropism by determining the step in the viral replication program 
blocked in T3 replication. Additionally, the precise steps in the viral life cycle that occur 
following the release of transcriptionally active core particles into the cytoplasm and 
release of progeny virions remain poorly defined. Therefore, I designed experiments to 
assess inclusion morphology and kinetics, viral protein localization, and viral RNA and 
protein synthesis in T3-infected MDCK cells. The results indicate normal morphologic 
and kinetic formation of viral inclusions and normal viral protein recruitment to 
inclusions. Furthermore, no apparent alteration of initial transcription and translation  
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 Figure 3.5. Analysis of viral protein synthesis. MDCK cells (A) or L cells (B) were 
infected at an MOI of 100 PFU/cell with reovirus strain T3-T1M1 or T3 and incubated 
for 1 h with [35S]methionine/cysteine at the indicated times post-infection. 
Radiolabeled polypeptides were resolved by SDS-PAGE and visualized using 
autoradiography. Positions of viral λ, μ, and σ proteins are indicated. Molecular mass 
standards (in kDa) are shown.  
 
was observed; however, secondary rounds of transcription and translation and dsRNA 
synthesis were significantly diminished in T3-infected MDCK cells. Collectively, these 
results indicate that the μ2-sensitive step in replication occurs at a point in the reovirus 
life cycle subsequent to primary rounds of viral transcription and translation but prior to 
dsRNA synthesis.  
 As an initial step to characterize the replication block in T3-infected MDCK cells, 
I used confocal microscopy to assess inclusion formation and kinetics. Interestingly, no 
differences in kinetics of inclusion formation were observed between T1 and T3 (Fig. 
3.1). As expected, T1 and T3 displayed characteristic strain-dependent inclusion 
morphology. In this initial experiment, only σNS and μ2 were visualized. Normal 
localization of these two proteins does not ensure typical localization of other viral 
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proteins. Therefore, I conducted a more comprehensive analysis of viral protein 
trafficking to inclusions to determine whether one or more inclusion components display 
abnormal localization in non-productively infected MDCK cells. Using confocal 
microscopy, no discernable cell-type-specific differences in the distribution of μ2, other 
major inclusion proteins (μNS and σNS), core protein λ2, or outer-capsid proteins μ1 and 
σ3 were observed in T3-infected MDCK cells (Figs. 3.2, 3.3A). Although a relative 
reduction (compared with T3-T1M1) in the expression of μ1 was observed, the 
significance of this reduction to T3 replication in MDCK cells is unclear, as expression of 
all viral proteins markedly declines at late times post-infection (Fig. 3.5). Thus, results of 
confocal microscopy studies confirm the expected pattern of viral protein localization to 
T3 inclusions in MDCK cells, indicating structurally or functionally abnormal 
interactions within the inclusion that prevent production of infectious progeny.  
An unexpected finding of this study was the co-existence of filamentous and 
globular inclusions in T1-infected MDCK cells (Fig. 3.1-3.3). Such mixture of inclusion 
morphologies contrasts with the uniformly filamentous appearance of T1 inclusions in 
previous studies using L, CV-1, Mv1Lu, and HEK 293T cells (60, 61, 88). Thus, 
inclusion morphologic phenotypes may be cell-type, as well as virus-strain, dependent. 
The significance of this novel pattern is unclear but congruous with previous studies that 
failed to show a relationship between viral replication capacity and inclusion morphology 
(61). 
While negative-stand RNA synthesis and particle assembly have been ascribed to 
viral inclusions, the discrete series of steps that occur between entry of transcriptionally 
active core particles into the cytoplasm and appearance of mature progeny particles 
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within viral inclusions remains poorly defined. The absence of detectable viral RNA and 
protein synthesis at late times of infection in T3-infected MDCK cells (Figs. 3.2 and 3.3) 
despite normal-appearing inclusions (Fig. 3.1) indicates that the impasse occurs at one or 
more of these undefined steps.  
Several potential but non-mutually exclusive mechanisms can be proposed to 
explain the replication block in T3-infected MDCK cells, including 1) mislocalization of 
RNA, 2) malfunction of the viral replicase during positive- or negative-strand synthesis, 
and 3) defective genome packaging or particle assembly. Significant effort was made to 
visualize RNA production in reovirus-infected cells to determine whether RNA is 
mislocalized in MDCK cells. Newly synthesized RNA can be visualized in infected cells 
by short-term labeling with 5’-bromouridine 5’-triphosphate (BrUTP) (47). In this 
method, cellular transcription is inhibited by actinomycin D, and BrUTP-containing viral 
RNA is visualized using BrdU-specific antibodies. This technique has been used to 
visualize production of reovirus RNA, and newly synthesized RNA was found to co-
localize with viral inclusions (73). Unfortunately, I was unable to successfully use this 
technique because specific detection of BrUTP-labeled RNA, both viral and cellular, was 
not observed. Experiments designed to answer the second possible mechanism—
malfunction of the viral replicase during positive- or negative-strand synthesis—also 
were not conducted; however, studies addressing this question may lead to further 
mechanistic understanding of the reovirus transcription machinery. Experiments designed 
to answer the third possible mechanism, defective genome packaging or particle 
assembly, are presented in Chapter IV. 
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Based on these results, the capacity of μ2 to mediate viral tropism at the post-
entry level can be added to the list of μ2 functions in the reovirus replication program. 
Further investigation of μ2 interactions with the viral and cellular metabolic machineries 
will provide sharper insights into mechanisms of cellular permissivity to reovirus 
infection. 
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CHAPTER IV 
 
REOVIRUS REPLICATION PROTEIN μ2 INFLUENCES CELL TROPISM BY 
PROMOTING PARTICLE ASSEMBLY WITHIN VIRAL INCLUSIONS 
 
Introduction 
Results presented in Chapter II implicate the μ2 and λ3 proteins as key viral 
determinants of reduced T3 replication efficiency in MDCK cells. The blockade to T3 
replication takes place subsequent to primary transcription and translation but prior to 
dsRNA synthesis (Chapter III). Steps between these two stages of the viral life cycle 
likely take place within the reovirus inclusion; therefore, T3 infection of MDCK cells 
provides an excellent model to better understand the function of viral inclusions and how 
these novel organelles influence viral tropism. 
In work described here, thin-section transmission electron microscopy (TEM) was 
used to more precisely define the role of μ2 protein in productive reovirus replication and 
virion particle production. The results indicate that particle assembly in T3-infected 
MDCK cells is defective and dependent on μ2 protein in a cell type-specific and 
temperature-dependent manner. Thus, reovirus infection of some cells is governed by 
interactions between viral replication proteins and the unique cell environment that 
promote genesis of functional viral inclusions. 
This work was assisted by Dr. Jay Jerome, director of the electron microscopy 
core in Vanderbilt’s Cell Imaging Shared Resource. Dr. Jerome provided guidance in 
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analyzing electron micrographs of reovirus-infected cells and determining appropriate 
quantitative methods to analyze inclusion ultrastructure. 
 
Results 
Ultrastructural analysis of viral inclusions – As confocal microscopy did not reveal overt 
abnormalities in the morphology or viral protein composition of T3 inclusions in MDCK 
cells, I used thin-section TEM to visualize viral particles within inclusions. In both T3- 
and T3-T1M1-infected cells, mature virion particles (i.e., containing electron-dense 
centers representing genomic viral RNA (27, 92) and empty virion particles were 
observed in a variety of arrangements. Some sections contained only a few mature virions 
scattered in the cytoplasm (Fig. 4.1A, B). Virus was occasionally visualized outside of 
the cell, attached to, or near the plasma membrane (Fig. 4.1B). Other sections contained 
large groups of viral particles surrounded by material having a heterogeneous consistency 
clearly distinct from cytoplasm (Fig. 4.2). The latter structures presumably correspond to 
the filamentous or globular inclusions observed using confocal microscopy; these are 
referred to as particle-containing inclusions. Representative images of particle-containing 
inclusions in T3-T1M1-infected MDCK cells are shown in Fig. 4.2A. These large 
aggregates of virions contain a significant fraction of complete particles in paracrystalline 
arrays. Occasionally, particles were interspersed with coated microtubules (Fig. 4.1C), 
which have been previously described in reovirus infected cells (27). This coat is thought 
to be composed primarily of viral protein μNS (16, 76). The arrangement of particles in 
T3-infected MDCK cells sharply contrasted with that observed in T3-T1M1-infected 
MDCK cells. Sections containing only a few scattered particles were most frequently  
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Figure 4.1. Ultrastructural analysis of viral inclusions. MDCK cells were infected with 
either T3 (A, D) or T3-T1M1 (B, C) at an MOI of 100 PFU/cell and fixed at 24h post-
infection. Ultra-thin sections (65-70 nm) were examined using transmission electron 
microscopy. (A, B) Sections containing small numbers of particles scattered within the 
cytoplasm or outside of the cell. (C) Inclusion containing particles and coated 
microtubules. (D) Section depicting a presumed “particle-free” inclusion. Black 
arrows indicate particles. Asterisks, mitochondria. N, nucleus. Arrow heads indicate 
particle-free inclusions. Scale bar, 500 nm.
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Figure 4.2. Large particle-containing inclusions in infected cells. MDCK cells (A) and 
L cells (B) were infected with either T3 or T3-T1M1 at an MOI of 100 PFU/cell and 
fixed at 24 h post-infection. Ultra-thin sections (65-70 nm) were examined using 
transmission electron microscopy. Boxed regions correspond to high-magnification 
images shown below. Scale bars: low-magnification images, 2 μm; high-magnification 
images, 500 nm.  
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observed (Fig. 4.1A), although some organized particle-containing inclusions were 
detected (Fig. 4.2A). Inclusions in T3-infected cells were less frequent, smaller, displayed 
decreased organization, and harbored fewer genome-containing particles compared to T3-
T1M1-infected cells. The size, frequency, and particle content of T3 and T3-T1M1 
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inclusions in L cells were similar to each other and to those in T3-T1M1-infected MDCK 
cells (Fig. 4.2B).  
 
Quantification of ultrastructural features in infected cells – To validate observations of 
T3 and T3-T1M1 ultrastructural morphology, certain features of inclusions captured in 
electron micrographic images were quantified. The fraction of cytoplasm containing 
virion particles or inclusion matrix was measured using the point counting stereology 
method (120). I defined the viral fraction of cytoplasm to be viral particles and 
surrounding milieu (i.e., inclusion matrix) that was clearly distinct from normal 
cytoplasm. Structures resembling viral inclusions but devoid of viral particles (Fig. 4.1D) 
were counted as cytoplasm since I could not be certain that these were of viral origin. 
However, such “empty inclusions” were not observed frequently. This experiment was 
performed on two separate occasions. In T3-T1M1-infected MDCK cells, 19.2% or 
13.5% of the cytoplasm was occupied by inclusion matrix, whereas this fraction was only 
2.9% or 0.38% in T3-infected cells (Table 4.1). The corresponding values in L cells were 
27.8% or 13.5% in T3-T1M1-infected cells and 14.9% or 11.4% in T3-infected cells. The 
proportion of inclusion matrix occupied by particles was 11.2% or 10.4% and 17.8% or 
21.9% in T3- and T3-T1M1-infected MDCK cells, respectively, and 23.4% or 25.3% and 
32.1% or 24.3% in L cells. These data are consistent with my observation that particles 
within inclusions of T3-infected MDCK cells were less densely packed. Following 
infection with either T3 or T3-T1M1, a spectrum of particle organization was observed, 
with the greatest degree of order being a paracrystalline array. Figure 4.3 depicts 
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inclusions in infected L cells with highly ordered particles. Particles in T3 inclusions did 
not achieve the same high degree of organization as particles in T3-T1M1 inclusions. 
 
Table 4.1. Quantitative analysis of reovirus replication using thin-section electron 
micrographs of reovirus-infected cells* 
Cell type Exp. Virus strain Fraction of 
cytoplasm 
containing virion 
particles or 
inclusion matrix  
Fraction of 
viral inclusion 
matrix 
occupied by 
particles 
Mature 
fraction of 
virion particles
MDCK  1 T3 2.9% 11.2% 36.3% 
MDCK  1 T3-T1M1 19.2% 17.8% 76.7% 
MDCK  2 T3 0.38% 10.4% 32.1% 
MDCK  2 T3-T1M1 13.5% 21.9% 55.0% 
L  1 T3 14.9% 23.4% 79.7% 
L  1 T3-T1M1 27.8% 32.1% 94.9% 
L  2 T3 11.4% 25.3% 86.2% 
L  2 T3-T1M1 13.5% 24.3% 91.8% 
*28-36 images collected for each sample condition.  
 
 The ratios of complete and empty particles in inclusions formed in both cell types 
were determined. The fraction of complete particles in T3- and T3-T1M1-infected 
MDCK cells was 36.3% or 32.1% and 76.7% or 55%, respectively. The corresponding 
values in L cells were 79.7% or 86.2% and 94.9% or 91.8%, respectively. The smaller 
fraction of inclusion matrix observed in T3-infected MDCK cells suggests that particle 
assembly is defective and, furthermore, that this process is dependent on the μ2 protein. 
While some inter-experimental variability was observed, in all three quantitative 
categories, the overall trends were consistent. T3-infected cells displayed a smaller 
fraction of cytoplasm containing virion particles or inclusion matrix, viral inclusion 
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 Figure 4.3. Paracrystalline arrangement of particles. L cells were infected with either 
T3 (A) or T3-T1M1 (B) at an MOI of 100 PFU/cell and fixed at 24 h post infection. 
Ultra-thin sections (65-70 nm) were examined using transmission electron 
microscopy. Paracrystalline arrays of particles are shown. Scale bar, 500 nm.  
 
matrix occupied by particles, and mature fraction of virion particles in MDCK cells. 
Taken together, qualitative and quantitative TEM analysis of reovirus inclusions under 
conditions of productive and abortive infection of MDCK cells points to viral assembly 
as a μ2-sensistive step in viral replication. 
 
Identification of size differences of reovirus particles in non-permissive infection – While 
examining the ultrastructure of reovirus inclusions in MDCK cells, I observed that empty 
T3 particles appeared smaller than empty T3-T1M1 particles. Therefore, complete and 
empty particle diameters were quantified and compared. A high-magnification image of 
virion particles in T3-T1M1-infected MDCK cells (Fig. 4.4) illustrates the specific  
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 Figure 4.4. High-magnification image of T3-T1M1-infected MDCK cells. The 
diameter of the inner electron dense center of complete particles (Inner), the outer 
diameter of complete particles (Outer), and outer diameter of empty particles (Empty) 
are demarcated by horizontal bars. Scale bar (lower right), 100 nm. 
 
diameter measurements recorded: 1) electron-dense centers of mature particles, 2) outer 
rim of mature particles, and 3) outer rim of empty particles. Large numbers of 
observations (86-1000) for each category were made to statistically validate size 
differences. This experiment was carried out on two separate occasions. The mean inner 
diameter of mature T3 and T3-T1M1 particles in both MDCK and L cells was 
approximately 38 nm, whereas the mean outer diameters of mature particles were 
approximately 71 – 72 nm (Table 4.2). In contrast, the mean diameter of empty particles 
in T3-infected MDCK cells was significantly less than the empty-particle diameters in 
T3-T1M1-infected MDCK cells, 67.3 ±0.27 nm vs. 73.5 ±0.34 nm in Experiment 1 and 
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67.8 ±0.25 nm vs 72.8 ±0.30 nm in Experiment 2. Diameters of empty particles of T3 and 
T3-T1M1 in L cells were not significantly different and were approximately 71 – 72 nm. 
These results reveal a difference in the size of T3 and T3-T1M1 empty particles produced 
in MDCK cells but not L cells, indicating that some aspects of T3 particle assembly in 
MDCK cells follow an anomalous path. Furthermore, these findings are consistent with a 
μ2-associated block to the morphogenesis of mature T3 virions in MDCK cells.  
 
Table 4.2: Quantification of viral particle diameters in reovirus infected cells 
Cell 
type 
Exp. Virus 
strain 
Mature 
particle outer 
diameter 
(nm)* 
 
n§ 
Mature particle 
inner diameter 
(nm) 
 
n 
Empty particle 
outer diameter 
(nm) 
 
n 
1 T3 72.3 ± 0.44  110 38.3 ± 0.22 116 67.3 ± 0.27 306 
MDCK  
1 T3-T1M1 72.0 ± 0.21# 311 37.9 ± 0.12# 323 73.5 ± 0.34& 177 
1 T3 71.3 ± 0.24 380 38.5 ± 0.11 417 71.2 ± 0.40 119 
L  
1 T3-T1M1 71.0 ± 0.22# 385 38.3 ± 0.11# 413 72.0 ± 0.42# 138 
2 T3 71.3 ± 0.34 251 39.0 ± 0.15 329 67.8 ± 0.25 497 
MDCK  
2 T3-T1M1 71.1 ± 0.25# 657 38.9 ± 0.12# 985 72.8 ± 0.30& 445 
2 T3 71.1 ± 0.25 496 38.4 ± 0.11 973 71.4 ± 0.78 86 
L 
2 T3-T1M1 70.6 ± 0.19# 727 38.2 ± 0.08# 1000 70.8 ± 0.37# 163 
*Values represent mean ± SEM 
§n, number of particles measured 
#t-test, not significant (vs. T3) 
&t-test, P < 0.0001 (vs. T3) 
 
Replication of reovirus at low temperature – A previous study suggested that the 
T3 μ2 protein is subject to temperature-dependent misfolding (75), which led us to 
consider whether strain-dependent differences in viral replication efficiency in MDCK 
cells might be influenced by the temperature of infection. To test this hypothesis, viral 
titers were monitored in MDCK cells (Fig. 5A, 5C) and L cells (Fig. 5B, 5D) infected 
with either T3 or T3-T1M1 and incubated at either 31ºC (Fig. 5A, 5B) or 37ºC (Fig. 5C, 
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5D) for 96 h post-infection. Replication of T3 in MDCK cells at 31ºC greatly exceeded 
that at 37ºC, closely approaching the yield of T3-T1M1 at 31ºC. In L cells infected at 
31ºC, T3 displayed significantly lower yield at 24 h post-infection compared to T3-
T1M1, but attained a similarly high level of replication at later times post-infection. T3-
T1M1 replicated efficiently in both cell types at 31ºC. However, the rise in titer was  
 
 
Figure 4.5. Temperature-dependence of reovirus replication in MDCK cells. MDCK 
cells (A, C) or L cells (B, D) were infected at an MOI of 2 PFU/cell and incubated at 
31ºC (A, B) or 37ºC (C, D) for the times shown. Viral titers in cell lysates were 
determined by plaque assay using L cells. Viral yields were calculated as the 
difference between log10 titer at the indicated time points and log10 titer at 0 h. Results 
represent the mean of triplicate experiments. Error bars indicate S.D. *, p < 0.05 in 
comparison to T3-T1M1 (Student’s t test).
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delayed relative to 37ºC. Taken together, these results indicate that replication of T3 in 
MDCK cells is temperature-dependent. 
One line of evidence that was used to suggest that T3 μ2 is subject to temperature-
dependent folding (75) was the observation that T3 formed filamentous inclusions at low 
temperature. Confocal microscopy of MDCK cells infected at 31ºC was used to assess 
the effect of temperature on inclusion morphology in these cells. MDCK cells were 
infected with T3, T3-T1M1, and T3-M1L347F, incubated at 31ºC or 37ºC, and fixed at 
24 h post-infection. At both temperatures, T3 displayed characteristic globular inclusions 
and T3-T1M1 displayed predominantly filamentous inclusions. T3-M1L347F, a virus  
 
 
Figure 4.6. Confocal microscopy of viral inclusions in MDCK cells infected at low 
temperature. MDCK cells were infected with T3, T3-T1M1, or T3-M1L347F at an 
MOI of 20 PFU/cell, fixed 24 h post infection at 31ºC or 37ºC, stained with anti-σNS 
(green) antibody and ToPro3 (blue, nuclear), and imaged using confocal microscopy. 
Scale bars, 50 μm.  
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containing a single amino acid polymorphism in μ2 that confers replicative capacity in 
MDCK cells (Fig. 2.5), also displayed globular inclusions at both temperatures. In cells 
infected at 31ºC, inclusions were smaller and less developed than inclusions in cells 
infected at 37ºC. This observation is consistent with the slower kinetics of replication 
observed at 31ºC in comparison to 37ºC (Fig. 4.5); however, in contrast to results 
presented by Miller et al. (75), temperature did not affect inclusion morphology.  
 
Ultrastructural analysis of viral inclusions in cells infected at low temperature – Thin-
section TEM of MDCK cells infected at the lower temperature was used to determine  
whether enhanced replication kinetics of T3 in MDCK cells at 31ºC correlates with 
restoration of normal inclusion ultrastructure. Since the replication kinetics of infection 
are delayed at 31ºC, infected cells were fixed at 48 and 72 h post-infection. At both time 
points, large particle-containing inclusions enclosing mature and empty particles were 
observed in both T3- and T3-T1M1-infected cells (Fig. 4.7). At 48 h post-infection, the 
fraction of cytoplasm occupied by viral inclusion matrix was 13.0% and 27.0% in T3- 
and T3-T1M1-infected MDCK cells, respectively, while the proportion of inclusion 
matrix occupied by particles was 7.5% in T3-infected cells and 12.9% in T3-T1M1-
infected cells (Table 4.3). Complete particles comprised 42.0% and 40.0% of total virions 
in T3- and T3-T1M1-infected cells, respectively. At 72 h post-infection, the fraction of 
cytoplasm occupied by viral inclusion matrix was 17% and 28.0% in T3- and T3-T1M1-
infected cells, respectively, while the proportion of inclusion matrix occupied by particles 
was 12.7% in T3-infected cells and 16.8% in T3-T1M1-infected cells (Table 4.3). 
Complete particles comprised 29.7% and 36.3% of total virions in T3- and T3-T1M1-  
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Figure 4.7. Ultrastructural analysis of viral inclusions in MDCK cells infected at low 
temperature. MDCK cells were infected with either T3 or T3-T1M1 at an MOI of 100 
PFU/cell and fixed at 48 (A) or 72 (B) h post-infection. Ultra-thin sections (65-70 nm) 
were examined using transmission electron microscopy. Boxed regions correspond to 
high-magnification images shown below. Scale bars: low-magnification images, 2 μm; 
high-magnification images, 500 nm. 
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infected cells, respectively. The substantial increase in the fraction of inclusion matrix 
from 2.9% to 17.0% at 72 h post-infection in T3-infected MDCK cells incubated at 31ºC 
vs. 37ºC provides further evidence that the inhibition to T3 replication in MDCK cells is 
eased at low temperature. Additionally, the mean diameters of empty particles in MDCK 
cells infected with T3 (72.9 ± 0.22 nm [48 h], 72.6 ±0.29 nm [72 h]) and T3-T1M1 (73.3 
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± 0.21 nm [48 h], 71.9 ± 0.20 nm [72 h]) were equivalent at reduced incubation 
temperature (Table 4.4). Thus, lowering the temperature of infection partially relieved 
μ2-mediated restriction of T3 replication in MDCK cells and reversed the block to mature 
particle assembly, consistent with the hypothesis that the conformational state of μ2 
influences success of the reovirus life cycle through a mechanism involving virion 
morphogenesis.  
 
Table 4.3. Quantitative analysis of reovirus replication at 31ºC using thin-section 
electron micrographs of reovirus-infected MDCK cells* 
Virus 
strain 
Time 
post 
infection  
Fraction of cytoplasm 
containing virion 
particles or inclusion 
matrix 
Fraction of viral 
inclusion matrix 
occupied by 
particles 
Mature fraction of 
virion particles 
T3  48 h 13.0% 7.5% 42.0% 
T3-T1M1  48 h 27.0% 12.9% 40.0% 
T3  72 h 17.2% 12.7% 29.7% 
T3-T1M1  72 h 28.0% 16.8% 36.3% 
*36 images collected for each sample condition. 
 
 
Table 4.4. Quantification of viral particle diameters following infection at 31ºC 
Virus 
strain 
Time 
post 
infection 
Mature 
particle outer 
diameter 
(nm)* 
 
n§ 
Mature 
particle inner 
diameter 
(nm) 
 
n 
Empty 
particle outer 
diameter 
(nm) 
 
n 
T3  48 h  72.2 ± 0.25 324 38.6 ± 0.12 360 72.9 ± 0.22 388 
T3-T1M1  48 h 72.6 ± 0.21# 435 38.4 ± 0.17# 451 73.3 ± 0.21# 483 
T3  72 h 71.9 ± 0.35 203 38.0 ± 0.16 225 72.6 ± 0.29 284 
T3-T1M1  72 h 71.5 ± 0.23# 306 37.9 ± 0.13# 312 71.9 ± 0.20# 472 
*Values represent mean ± SEM 
§n, number of particles measured 
#t-test, not significant (vs. T3) 
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Discussion 
A common strategy of virus replication is the formation of neo-organelles—i.e., 
inclusions—that concentrate and protect viral components required for genome 
multiplication and particle assembly. An understanding of viral inclusion composition 
and organization is essential to illuminate strategies by which viruses direct a successful 
replication program. The specific steps that occur within reovirus inclusions have not 
been precisely defined; however, viral RNA assortment, genome replication, secondary 
transcription, and particle morphogenesis are presumed to occur within these structures 
(2, 27, 31, 77, 78, 92, 129, 130). In this study, I made use of a post entry-determined, 
strain-specific replication defect in MDCK cells to enhance knowledge of key activities 
within reovirus inclusions that are sensitive to the specific host cell milieu. These 
findings suggest that reovirus tropism for some types of cells is governed by interactions 
between viral replication proteins and the unique cell environment that favor 
development of inclusions capable of generating fully assembled infectious particles. 
TEM analysis of MDCK cells infected with T3 revealed a much smaller fraction 
of cytoplasm containing particles and inclusion matrix compared with strain T3-T1M1 
(0.38% - 2.9% vs 13.5% - 19.2%) (Fig. 4.2A, Table 4.1). Mature particles with electron-
dense (i.e., genome-containing) centers and empty particles were observed in MDCK 
cells infected with either T3 or T3-T1M1. However, the mature fraction of T3 particles 
was less than that for T3-T1M1 (32.1% - 36.0% vs. 55.0% - 77%) (Table 4.1). Assembly 
intermediates that escape the blocked step appear competent to reach full structural 
maturity, consistent with the finding that conditions can be modified to permit partial 
relief of the restriction to T3 replication in MDCK cells. Collectively, the substantial 
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decrease in particle-containing inclusion matrix and mature virion particles suggest that 
assembly of T3 particles is blocked in MDCK cells, leading to a significant reduction in 
viral yield. 
Although results of confocal microscopy studies indicate that a majority of cells 
are infected (Fig. 3.2), not all TEM sections contained identifiable viral structures. I 
defined inclusions in electron micrographs by the presence of virion particles. Structures 
resembling particle-free inclusions were rarely observed (Fig. 4.1D), and inclusion matrix 
could not be identified with complete confidence in the absence of particles. It is possible 
that the TEM method lacks the sensitivity necessary to identify particle-free inclusion 
matrix. Alternatively, the large difference in section thickness between the two methods 
(900 nm confocal z-slice vs. 70 nm EM thin section) may explain preferential detection 
of infected cells using confocal microscopy.  
A higher degree of particle organization in T1- vs. T3-infected cells has been 
previously described (5). This difference is also observed in electron micrographs of cells 
infected with T3- vs. T3-T1M1 (Fig. 4.2). Increased organization of particles and a larger 
fraction of viral inclusion matrix occupied by particles in T3-T1M1-infected cells in 
comparison to T3-infected cells (Table 4.1) suggest that this phenotype can at least 
partially be attributed to μ2. Increased particle organization could be caused by a specific 
function of μ2 in inclusions or could be the result of increased particle numbers in cells 
infected with T1-μ2-containing viruses.  
The observation that empty particles are smaller in T3- vs. T3-T1M1-infected 
MDCK cells offers corroborating evidence of aberrant assembly of T3 virion particles. It 
is not known whether the empty particles represent precursors to mature virions or 
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replication byproducts, but the latter possibility is generally favored (27, 46). In either 
case, these structures inevitably share some assembly steps with complete virion particles 
and signal the possibility for a global μ2-dependent defect in particle assembly. Possible 
explanations for the smaller size of empty T3 particles include missing or 
stoichiometrically incorrect protein subassemblies or misfolding of key protein 
constituents. The cell-type-specific nature of this phenotype further suggests that discrete 
cellular factors are essential to coordinate successful particle maturation. 
The capacity of T3 to replicate in MDCK cells at 31ºC provides insight into a 
possible mechanism of the μ2-regulated replication phenotype. The T3 μ2 protein is 
highly ubiquitylated in a temperature-dependent manner, and ubiquitylation is reduced 
when the temperature of viral infection is lowered (75). These findings are consistent 
with the idea that T3 μ2 misfolds at higher temperature, causing increased aggregation 
and ubiquitylation. Enhanced yield of T3 in MDCK cells at 31ºC (Fig. 4.5) suggests that 
temperature-sensitive conformations of μ2 influence a important early step in viral 
assembly. Importantly, the μ2 ubiquitylation phenotype segregates with a polymorphism 
at amino acid position 208 (75), while temperature-dependent replication efficiency in 
MDCK cells is regulated by amino acid 347, with no detectable contribution by the 
residue at position 208 (Fig. 2.4). The effect of amino acid variability at position 347 on 
μ2 conformational states has not been examined; however, reversal of the block to T3 
replication at decreased temperature suggests that a temperature-sensitive property of μ2, 
possibly protein-folding, governs reovirus strain-specific interactions with the host-cell 
environment during viral assembly. These interactions could involve stimulation of 
replication complexes containing T1 μ2 or inhibition of complexes containing T3 μ2. 
  72
Alternatively, the replication block could be passive in nature, caused by a failure of T3 
μ2 to successfully interact with cellular factors. In either model, conformational variation 
in μ2 could conceivably influence a critical association of viral and host-cell factors 
required for virion assembly.  
The non-productive infection of T3 in MDCK cells is similar to that of reovirus 
strain tsH11.2, which contains lesions in μ2 protein that restrict viral replication to low 
temperature (23). Like T3 infection of MDCK cells, tsH11.2 synthesizes normal amounts 
of ssRNA but displays significantly diminished dsRNA production and secondary 
translation (23). However, unlike T3 infection of MDCK cells, tsH11.2 μ2 does not 
concentrate in viral inclusions at restrictive temperature (68). Thus, the replication block 
to tsH11.2 might operate through mechanisms affecting μ2 localization. Although the 
precise step in viral replication blocked in tsH11.2 may differ from or complement that of 
T3 in MDCK cells at non-permissive temperature, both of these models of conditional 
reovirus replication confirm the importance of μ2 protein for progression of the viral life 
cycle beyond primary rounds of RNA and protein synthesis.  
Reovirus inclusions are generally thought to contain cellular proteins repurposed 
for viral use. Nevertheless, identities of these putative host cell molecules remain largely 
unknown. Early studies using electron microscopy identified inclusion-associated 
cytoskeletal elements, including coated microtubules and thick, kinked fibrils 
interspersed among the particles (27, 35). Known cellular proteins recruited to reovirus 
inclusions include chaperone Hsc70 (54) and clathrin (51). Hsc70 associates with viral 
inclusions independent of its chaperone function (54), whereas clathrin recruitment 
results in disruption of its normal cellular function (51). However, the roles played by 
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these proteins in inclusion formation and function await further investigation. A 
comprehensive study of cellular factors required for reovirus replication, in particular 
those required for inclusion development and maturation, will further define post-entry 
mechanisms of viral tropism and the precise activities of μ2 and other viral replication 
proteins in virion morphogenesis.  
In summary, microscopic techniques were used to characterize functionally 
abnormal reovirus inclusions that form in non-permissive cells to more fully understand 
the role played by μ2 in promoting productive viral replication and tropism for host cells. 
Findings presented in this chapter established that virion particle assembly is a μ2-
regulated step in the reovirus replication program and suggested that a temperature-
sensitive property of μ2, perhaps protein conformation, controls key events within 
inclusions that culminate in assembly of mature particles. Additional characterization of 
this system may identify novel cellular regulators of reovirus infection that participate in 
virion morphogenesis and serve as determinants of viral cell tropism. 
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CHAPTER V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Introduction 
Coordination of viral replication requires successful and often complex 
interactions of viral proteins and cellular factors. Although much progress has been made 
in understanding the formation of specialized sites of replication where viral proteins and 
repurposed cellular factors direct genome multiplication and particle assembly, much 
remains unknown about the specific mechanisms of post-entry determinants of viral 
replication efficiency and cell tropism. The goal of my dissertation research has been to 
determine how reovirus μ2, and its cooperation with other viral proteins, support 
progression of the viral replication cycle and contribute to reovirus cell tropism. Toward 
that goal, I characterized the genetic basis of strain-dependent reovirus replication in 
MDCK cells (Chapter II). μ2 controls efficiency of reovirus replication in these cells, and 
amino acid residue 347 is the primary determinant. Furthermore, polymerase protein λ3 is 
a co-regulator of viral replication in a strain-dependent manner. I systematically tested 
post-entry steps in the reovirus life cycle to identify the critical step in reovirus tropism 
for MDCK cells (Chapter III). The replication block occurs following inclusion formation 
but prior to dsRNA synthesis, indicating that inclusions formed during non-permissive 
infection are morphologically normal but functionally abnormal. I also analyzed 
inclusion ultrastructure under permissive and non-permissive conditions of infection 
(Chapter IV) and found that particle assembly is inhibited in non-productively infected 
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cells. In this chapter I will discuss implications of this work and future directions for this 
research. 
 
Model of Reovirus Replication in MDCK Cells 
The precise mechanism regulating reovirus replication capacity in MDCK cells 
has not been fully defined; however, this body of work significantly advances an 
understanding of viral and cellular determinants governing reovirus replication in MDCK 
cells. Therefore, I will present several plausible models of reovirus replication in MDCK 
cells that are consistent with the current experimental evidence. It is possible that 
inhibition of T3 in MDCK cells is mediated by an inducible restriction factor that 
specifically recognizes T3 μ2 and not T1 μ2. Strain-dependent recognition of μ2 could 
occur because T3 μ2 is subject to temperature-dependent misfolding. When T3 μ2 is 
present in a misfolded conformation, it can be antagonized by a MDCK-specific factor 
that inhibits the assembly of replication complexes that mediate minus-strand synthesis 
and subsequently secondary transcription of viral mRNA. Reducing the temperature of 
infection prevents T3 μ2 from assuming an unfavorable conformation and therefore is not 
recognized by the restriction factor. In addition to lowering the temperature of infection, 
T3 μ2 could also be modulated to mediate productive infection by the presence of other 
T1 proteins such as λ3 (evidenced by the ability of T1-T3M1 to replicate efficiently in 
MDCK cells). Other mechanisms of inhibition of T3 in MDCK cells are also possible. 
For example, a μ2-containing complex could specifically antagonize an inducible 
restriction factor. At high temperature, T3 μ2 may assume an unfavorable conformation 
that can no longer mediate its function in blocking the factor. It is also conceivable that 
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the block to T3 μ2 replication is caused by failure of T3 μ2 to interact cooperatively with 
cellular components that provide an essential function during reovirus replication. Low 
temperature or interaction with other T1 proteins could modulate T3 μ2 to allow 
successful interaction with the required cellular components. This model of reovirus 
replication in MDCK cells still contains numerous testable hypotheses, some of which 
will be addressed by experiments proposed in the future directions outlined below.  
 
Identification of Other Reovirus Determinants of Replication Capacity in MDCK 
Cells 
 The genetic analysis of recombinant virus strains presented in Chapter II 
thoroughly defines the determinants of μ2 that control replication efficiency in MDCK 
cells; however, the role of other viral proteins, determinants of λ3, and μ2-λ3 interactions 
in promoting replication efficiency in MDCK cells have yet to be defined.  
 T1 μ2 promotes efficient replication in MDCK cells irrespective of the viral 
genetic background. The influence of T3 μ2 on replication efficiency is more complex 
because its presence does not ensure poor replication. A schematic representation of 
replication capacity of reovirus strains in MDCK cells is presented in Figure 5.1 and 
highlights that each μ2/λ3 combination is present in two genetic backgrounds. T1-T3M1 
and T3-T1L1 both have T1 λ3 and T3 μ2; however, T1-T3M1 replicates efficiently while 
T3-T1L1 does not. These results suggest that the viral genetic background in which T1 
λ3 is presented to T3 μ2 influences its capacity to compensate for T3 μ2. To investigate 
which viral proteins modulate the effect of λ3 on μ2 function, reassortant viruses could be 
generated to ascertain which T1 genes, aside from M1, can enhance the replication of 
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Figure 5.1. Schematic representation of T1 and T3 μ2/λ3 combinations in recombinant 
viruses tested in MDCK cells. Four possible combinations of μ2 and λ3 from strains 
T1 and T3 are depicted and each combination is present in two different virus genetic 
backgrounds. Red represents strain T1 and blue represents strain T3. (+), replicates 
efficiently in MDCK cells. (–), replicates inefficiently in MDCK cells.   
 
T3-T1L1 and which T3 genes, aside from L1, reduce the replication of T1-T3M1. Based 
on their proximity to μ2 and λ3 within in the virion, other core proteins –λ2, λ1, and σ2– 
are likely determinants of this phenotype. Other possible determinants are σNS and μNS, 
as these proteins are thought to be involved in assortment and initial core assembly within 
the inclusion (2, 26, 50). Identification of other proteins that influence replication 
efficiency in MDCK cells will provide further insight into mechanisms by which μ2 
controls replication efficiency and may illuminate important interactions between other 
reovirus proteins that control replication activities within inclusions. 
The conditional regulation of μ2 function by λ3 during replication in MDCK cells 
raises the question of what determinants of λ3 confer replication capacity. T1-T3M1 
replicates efficiently, whereas T1-T3M1L1 does not. Which domains and ultimately 
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residues of T1 λ3 bestow enhanced replication capacity to T1-T3M1? To address this 
question, T1 x T3 L1 chimeras could be generated in a T1-T3M1 background. The λ3 
protein contains 3 domains: N-terminal (N), central polymerase (P), and C-terminal 
bracelet (C) (112), which would make logical junctions for T1 x T3 L1 chimeras. Viruses 
containing chimeric L1 genes, T3 M1, and the remaining 8 T1 gene segments can be 
obtained using reverse genetics, and the replication capacity of the resultant viruses can 
be compared to T1-T3M1 and T1-T3M1L1. If one region of L1 confers replication 
capacity, T1 x T3 polymorphisms can be tested by generating viruses with individual 
point mutations and testing viral yield in MDCK cells. The structure of λ3 is known 
(112); therefore, domains or individual polymorphisms that modulate replication may 
provide insight into the mechanism of regulation and identify potential points of contact 
between μ2 and λ3.  
Several lines of evidence from biochemical and genetic studies suggest that μ2 
and λ3 functionally cooperate. L1 and M1 genes display nonrandom segregation in 
reassortant viruses (84). NTPase and RTPase activities of μ2 are enhanced in the 
presence of λ3, and the two proteins co-immunoprecipitate (58). Genetic linkage of the 
M1 and L1 genes to replication efficiency in MDCK cells (Chapter II, [93]) provides 
further evidence that these proteins functionally if not directly interact with one another. 
However, further study is required to understand the role μ2-λ3 interactions in viral 
infection. The co-immunoprecipitation studies of μ2 and λ3 were carried out in vitro 
using purified proteins (58). However, it is unknown if this interaction would be 
maintained in the complex cellular milieu. The capacity of μ2 and λ3 from different 
genetic backgrounds—i.e., T1 or T3—to interact is also unknown. To test whether μ2 and 
  79
λ3 interact within cells and whether strain differences affect this putative interaction, the 
four combinations of T1 and T3 μ2 and λ3 proteins could be expressed in permissive 
cells, followed by immunoprecipitation of μ2 or λ3. Antibodies that can effectively 
immunoprecipitate μ2 and λ3 are not available; therefore, μ2 and λ3 expression plasmids 
might be generated containing HA or FLAG N-terminal tags. Following transfection of 
tagged μ2 and λ3 proteins in L cells, HA or FLAG antibodies can be used to 
immunoprecipitate μ2 or λ3, and immunoblots of immunoprecipitated complexes can be 
used to visualize μ2 and λ3. Any results identified using this technique should be 
confirmed by an in cyto strategy as a potential caveat of this experiment is the 
opportunity for abnormal association of μ2 and λ3 due to overexpression or the presence 
of tags. If direct interactions are observed in permissive cells, these experiments could be 
repeated in MDCK cells to determine if there are differences in μ2-λ3 interaction that 
correlate with tropism. Additionally, genetic analysis can be used to determine domains 
that determine differential interactions. These studies may reveal unique interactions 
between μ2 and λ3 and possibly other viral and cellular proteins that have yet to be 
functionally linked to μ2.  
 
Cellular Determinants of Post-entry Mediated Reovirus Tropism 
 Much of my dissertation work has been focused on deciphering viral genetic 
determinants of tropism for MDCK cells and understanding the mechanisms that leads to 
reduced T3 replication in MDCK cells. An equally intriguing question is what are the 
cellular determinants of restriction of T3 replication in MDCK cells. I have suggested 
that there is a factor in MDCK cells that interacts differentially with T1 and T3 μ2 
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leading to the strain-specific difference in reovirus replication efficiency exhibited in 
these cells. This factor could be as simple as a single protein or as complex as a 
biochemical pathway. It is possible that μ2-mediated replication capacity is only a 
MDCK-associated phenomenon. However, this phenotype could represent a host-species 
(canine) or tissue-type (kidney) tropism. To test this possibility, the capacity of T1 and 
T3 to replicate in a panel of available cell types was ascertained. Cell types tested 
included L cells (mouse fibroblast), AGMK (African green monkey kidney), Caco-2 
(human colorectal adenocarcinoma), HEK293 (human embryonic kidney), MA104 
(Rhesus monkey kidney), MDBK (Madin Darby bovine kidney), and DK (dog kidney) 
(Fig. 5.2). Replication of T1 and T3 was similar in all cells with the exception of AGMK  
 
Figure 5.2. Yields of T1 and T3 viruses in cultured cells. A. The indicated cell line 
was infected with T1 or T3 at an MOI of 2 PFU/cell, and viral yields (relative to 0 h) 
at 24 h post-infection were determined by plaque assay using L-cell monolayers. 
Results represent the mean of triplicate experiments. Error bars indicate S.D. *, p < 
0.05 in comparison with strain T1 in corresponding cell line (Student’s t test). 
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and DK cells. In AGMK cells, the yield of T1 exceeded that of T3 by ~10 fold. However, 
T3 achieved an ~100 fold increase in viral titer by 24 h post-infection, which is 
significantly greater than that measured in T3-infected MDCK cells. Replication of T1 
and T3 in DK cells was similar to MDCK cells. A precise characterization of DK cells is 
unavailable, and it is possible that DK cells represent the same kidney cell type as MDCK 
cells. Therefore, this result neither confirms nor contradicts the hypothesis that the block 
is canine-specific. A number of kidney cell lines are represented in this panel; therefore, 
the inhibition of T3 replication is likely not related to a kidney-specific factor. 
 Many other cell types could be obtained and tested; however, a potentially more 
productive approach to study questions of μ2-dependent cell-type specific tropism would 
utilize the neonatal mouse model of reovirus pathogenesis. Previous studies have linked 
the M1 gene to virulence and liver tropism in adult severe combined immunodeficient 
(SCID) mice (44) and myocarditis in newborn immunocompetent mice (102, 103) using 
classical reassortant analysis. The M1 gene also independently modulates myocarditis in 
newborn mice (49). However, the importance of μ2 and other reovirus replication 
proteins have not been systematically investigated in vivo. One possible approach to 
characterize the role of μ2 in vivo would be to monitor survival and organ-specific 
replication and pathology following infection with T1 and T1-T3M1 or T3 and T3-
T1M1. If differences in μ2-determined organ-specific replication efficiency or tropism 
are identified, further experimentation using viruses containing T1 x T3 μ2-
polymorphisms can be used to identify specific μ2 residues involved. Primary cells of 
target organs displaying these differences can be used to investigate the replication cycle 
using the imaging and PCR strategies utilized in Chapters III and IV. These studies will 
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allow differences in replication efficiency and tropism to be correlated with patterns of 
disease expression and will enhance our understanding of the role of μ2 in reovirus 
pathogenesis. 
Identification of the specific cellular component or components responsible for 
strain-specific replication capacity in MDCK cells will provide insight into the role of 
cellular factors in promoting or inhibiting reovirus replication steps that occur within 
inclusions. The proposed MDCK-specific factor could work actively, by antagonizing T3 
μ2, or passively by failing to interact with T3 μ2. Classification of the mechanism of 
action of the MDCK-specific factor as active or passive will provide the rationale 
required to design a discovery-based approach for factor identification. Analysis of 
reovirus replication in heterokaryons generated from permissive and non-permissive cells 
could be used to distinguish if the factor acts through an active or passive mechanism.  
During the course of this work, some progress was made in generating 
heterokaryons of MDCK cells and HeLa cells (protocol modified from Gottesman et al. 
[43]) (Fig. 5.3). Fusion was mediated by co-culturing fluorescently dyed, MDCK and 
HeLa cells that transiently expressed vesicular stomatitis virus G protein. Fused and 
unfused cells were separated by flow cytometry. Results of experiments using 
heterokaryons may provide evidence into the regulatory mechanism present in MDCK 
cells that facilitates the discrimination of T1 and T3. If the factor specifically inhibits T3 
replication, it is expected that T3 will fail to replicate in MDCK-HeLa heterokaryons. A 
logical discovery-based approach would utilize a siRNA screen to identify the factor that, 
when knocked down, rescues replication of T3. Alternatively, if replication block is 
mediated by an inability of MDCK cells to support T3 replication, it is expected that T3  
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 Figure 5.3. Formation of MDCK-HeLa cell heterokaryons. A. Schematic of 
heterokaryon generation. MDCK cells and HeLa cells are individually transfected with 
a vesicular stomatitis virus G protein-expressing plasmid, stained with CellTrace Far 
Red DDAO or CellTracker Orange CMTMR, and then co-cultured. Fusion was 
initiated by washing with pH 6 fusion buffer. Single positive and double positive cells 
were sorted by flow cytometry into culture dishes. B. Heterokaryon visualized by 
confocal immunofluorescence microscopy. Images obtained using 543 nm laser 
channel (CMTMR, left), 633nm laser channel (DDAO, middle), and overlay (right). 
 
would replicate in heterokaryons. Therefore, a rational method would use a HeLa cell 
cDNA library transfected in MDCK cells to identify the cellular components that enhance 
T3 replication. Very little is known about the identity and function of cellular proteins in 
viral inclusions. Therefore, discovery of an MDCK-specific factor that mediates the 
discrimination of reovirus strains will illuminate a cellular target or targets that interact 
with reovirus during post-entry steps of the life cycle.  
 
  84
Analysis of Inclusion Architecture 
An understanding of the composition and organization of viral inclusions is 
essential to elucidate strategies by which viruses direct a successful replication program. 
Findings presented in Chapter IV suggest that reovirus tropism for some types of cells is 
governed by interactions between viral replication proteins and the unique cell 
environment that favor development of inclusions capable of generating fully assembled 
infectious particles. However, these results also highlight our limited understanding of 
inclusion architecture, including the organization of viral particles and replication 
intermediates within inclusions as well as cellular components in these structures. 
Significant advances in understanding the architecture of positive-sense RNA virus 
replication factories have been made using three-dimensional electron microscopy 
techniques (29). These advances have allowed the detailed characterization of cellular 
membrane reorganization induced by these viruses to form their replication factories (30). 
Three-dimensional reconstruction of serial sections of reovirus-infected cells using TEM 
imaging would significantly enhance an understanding of the unique architecture of 
reovirus inclusions. This technique could be used to image inclusions in infected MDCK 
cells and HeLa cells (or some other permissive cell line) following infection with either 
T3 or T3-T1M1. μ2 mediates differences in inclusion ultrastructure in both permissive 
and non-permissive cell lines. Therefore, the ability to analyze different inclusion 
phenotypes will provide significant strength to this analysis as comparison of inclusions 
in permissive and non-permissive infection can be correlated with successful replication. 
These studies will further an understanding of viral inclusion composition and 
organization and illuminate strategies by which viruses coordinate productive infection. 
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Conclusions 
My research has enhanced an understanding of post-entry determinants of 
reovirus replication. These studies have identified particle assembly within viral 
inclusions to be a key checkpoint of reovirus cell-type specific replication. This work has 
further expanded knowledge of the complex role that μ2 plays during the viral replication 
program as a determinant of replication efficiency and post-entry mediated tropism. 
Studies of reovirus replication in MDCK cells have also provided additional evidence for 
a functional interaction between the μ2 and λ3 proteins. However, many unanswered 
questions still exist, including: what specific biochemical functions does μ2 serve in 
reovirus replication? How does μ2 interact with other viral proteins to mediate productive 
infection? How does reovirus repurpose the cellular environment for its own benefit, and 
which cellular factors are involved? How are viral inclusions organized with respect to 
structure and function? Further experimentation, such as the studies outlined above, will 
reveal interconnections between μ2 and the host-cell machinery and provide insights into 
the molecular architecture and functional organization of reovirus inclusions. 
Additionally, these studies will contribute to the identification of fundamental strategies 
of post-entry mediated virus tropism, compartmentalization of viral replication 
machinery, and viral replication protein structure and function. 
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CHAPTER VI 
 
MATERIALS AND METHODS 
 
Cells and Viruses 
L cells were grown in Joklik’s modified Eagle’s minimal essential medium 
(Lonza, Walkersville, MD) supplemented to contain 5% fetal calf serum (Cellgro, 
Manassas, VA), 2 mM L-glutamine (Gibco, Grand Island, NY), 100 U of penicillin G/ml 
(Gibco), 100 μg of streptomycin/ml (Gibco), and 0.25 μg amphotericin B/ml (Sigma, St. 
Louis, MO). MDCK, AGMK, Caco2, HEK293, MA104, MDBK, DK, and HeLa cells 
were grown in DMEM supplemented to contain 4.5g/L sodium pyruvate (Cellgro), 10% 
fetal calf serum, 2 mM L-glutamine, 100 U of penicillin G/ml, 100 μg of streptomycin/ml, 
and 0.25 μg amphotericin B/ml. BHK-T7 cells were grown in DMEM (Invitrogen, 
Eugene, OR) supplemented to contain 5% fetal calf serum, 2 mM L-glutamine, 2% MEM 
Amino Acid Solution (Invitrogen), and 1 mg/ml geneticin (Invitrogen). Strains T1, T3, 
T1-T3M1, T3-T1M1, and all other reassortant strains used in this study were recovered 
by reverse genetics as described (59, 62). Virus was purified from L cells by CsCl 
gradient centrifugation (36). Viral titers were determined by plaque assay using L-cell 
monolayers as described (116).  
 
Construction of Mutant Viruses 
T1 x T3 M1 chimeric cDNAs were generated by inserting the EcoRV-RsrII (Ch1), 
MfeI-RsrII (Ch2), PsiI-RsrII (Ch3), and NdeI-RsrII (Ch4) fragments of pT7-M1T1L (62) 
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into the pT7-M1T3D vector (59). M1 point mutants were generated using PCR with 
mutagenic primers and the pT7-M1T1L and pT7-M1T3D plasmids. Vectors containing 
mutant M1 genes were substituted for WT M1 to recover recombinant viruses using 
reverse genetics. Plasmid sequences of determined to confirm fidelity of mutagenesis and 
cloning.  
 
Quantification of Virus Infectivity 
Monolayers of cells (approximately 5 x 105 cells) seeded in 24-well plates (Costar, 
Corning, NY) were adsorbed with virus at an MOI of 2 PFU/cell (unless otherwise 
specified). After 1 h adsorption at room temperature, the viral inoculum was removed, 
cells were washed with PBS, and fresh medium was added. Cells were incubated at 37ºC 
(unless otherwise specified) for various intervals and removed to -80ºC. Viral titers in 
cell lysates were determined by plaque assay using L cells (116). Viral yield was 
calculated as the difference between log10 titer at the time indicated and log10 titer at 0 h. 
Negative differences were assigned a value of zero. For the purpose of calculating fold 
differences in viral yields, non log transformed data were used, and a yield of less than 1 
was considered to be 1.  
 
Quantification of IFN-β mRNA in MDCK Cells by Reverse Transcription-
Quantitative PCR  
 Monolayers of MDCK cells (approximately 5 x 105 cells) seeded in 24-well 
plates were adsorbed with virus at an MOI of 0.02 or 2 PFU/cell. After 1 h adsorption at 
RT, the viral inoculum was removed, cells were washed with PBS, and fresh medium 
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was added. Following incubation at 37ºC for various intervals, cultures were placed at -
80ºC, and total RNA was extracted from 140 μl of thawed lysate using an RNeasy Mini 
Kit (Qiagen, Valencia, CA). DNA contamination was removed by DNAse digestion 
(RNase Free DNase set, Qiagen). IFN-β RNA in 10 μl of RNA extract was quantified 
using the SuperScript III Platinum One-Step qRT-PCR System (Invitrogen). PCR 
reactions were prepared according to the manufacturer’s specifications. The published 
canine IFN-β1 sequence (accession number: NM_001135787) was used to design an 
IFN-β-specific fluorogenic probe ( 5’ d FAM-CCATGAGCAACGACTTG-BHQ-1 3’), 
forward primer (5’ TGTATTTCTCCACCATGGCTCTT 3’) and reverse primer (5’ 
GCTGCTTAGCTGGGATCGAA 3’). 
 
Immunofluorescence Detection of Reovirus Infection 
 L cells plated on untreated glass coverslips and MDCK cells plated on poly-L-
lysine (Sigma)-treated glass coverslips in 24-well plates were adsorbed with virus at an 
MOI of 20 PFU/cell. Following incubation at 37ºC (or 31ºC were indicated) for various 
intervals, cells were fixed and stained with rabbit μ2-specific (127), guinea pig σNS-
specific (8), rabbit μNS-specific (60), mouse σ3-specific (4F2, [117]), mouse μ1-specific 
(8H6, [117]), or rabbit λ2-specific (7F4, [116]) antibodies followed by Alexa 546-
conjugated and Alexa 488-conjugugated secondary antibodies (Invitrogen). Nuclei were 
visualized with ToPro3 (Invitrogen). Images were acquired using a Zeiss LSM 510 
META inverted confocal microscope.  
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Analysis of Viral RNA Production Using Reverse Transcription-Quantitative PCR 
 Monolayers of L or MDCK cells (approximately 5 x 105 cells) seeded in 24-well 
plates were adsorbed with virus at an MOI of 10 PFU/cell. After 1 h adsorption at room 
temperature, the viral inoculum was removed, cells were washed with PBS, and fresh 
medium was added. Following incubation at 37ºC for various intervals, cultures were 
frozen at -80ºC, and total RNA was extracted from 140 μl of thawed lysate using an 
RNeasy Mini Kit (Qiagen, Valencia, CA). RNA was incubated at 95ºC for 3 min and 
immediately placed on ice. Reovirus S4 RNA in 10 μl of RNA extract was quantified 
using the SuperScript III Platinum One-Step qRT-PCR System (Invitrogen). PCR 
reactions were prepared according to the manufacturer’s specifications with minor 
modifications. The S4-specific fluorogenic probe used was 5’ d FAM-
AGCGCGCAAGAGGGATGGGA-BHQ-1 3’ (Biosearch Technologies, Novato, CA). 
Either forward (S4 83F [5’ CGCTTTTGAAGGTCGTGTATCA 3’]) or reverse (S4 153R 
[5’ CTGGCTGTGCTGAGATTGTTTT 3’]) primer corresponding to the viral S4 gene 
was used for reverse transcription performed at 50ºC for 15 min. Following 3 min 
incubation at 95ºC, the second primer was added, and 40 cycles of quantitative PCR was 
performed at 95ºC for 15 sec followed by 60ºC for 30 sec. Total S4 RNA (combined 
dsRNA and mRNA) was quantified using the S4-specific reverse primer (complementary 
to the positive strand) in the reverse transcription step, and double-stranded S4 RNA was 
quantified using the S4-specfic forward primer (complementary to the negative strand) in 
the reverse transcription step. Inclusion of only the reverse or forward primer in the 
reverse-transcription step resulted in specific detection of the positive or negative strand 
of S4 RNA, respectively. Total S4 RNA is represented by the amount of positive-sense 
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template, whereas dsRNA is equivalent to the amount of negative-sense template. S4 
mRNA was calculated by subtracting the amount of dsRNA from total RNA. Standard 
curves relating Ct values to copies of positive- or negative-sense RNA template were 
generated using 10-fold dilutions of viral RNA extracted from purified virion particles 
(QIAamp Viral RNA Purification Kit [Qiagen]) and quantified by spectrophotometry. 
The amount of total and dsRNA in each sample was then extrapolated from standard 
curves generated with the reverse and forward primers, respectively. Standard curves 
generated using forward and reverse primers in the reverse-transcription step were 
consistently similar, reflecting comparable amplification efficiencies of S4 RNA positive- 
and negative-sense strands.  
 
Analysis of Viral Protein Synthesis 
Monolayers of L or MDCK cells (approximately 5 x 105 cells) seeded in 24-well 
plates were adsorbed with virus at an MOI of 100 PFU/cell. After 1 h adsorption at room 
temperature, the inoculum was removed, fresh medium was added, and cells were 
incubated at 37ºC for various intervals. Cells were incubated with 50 μCi 
[35S]methionine-cysteine (PerkinElmer, Waltman, MA) in methionine-free medium (MP 
Biomedicals, Solon, OH) for 1 h prior to harvest, the medium was removed, and 50 μl 
lysis buffer (0.1M NaCl, 1mM EDTA, 10mM Tris [pH 7.4], and 0.5% IGEPAL) was 
added. Cell lysates were centrifuged at 14,000 x g at 4ºC for 15 min, and 20 μl of the 
resultant supernatant was mixed with an equal volume of Laemmli sample buffer (Bio 
Rad, Hercules, CA). Samples were incubated at 95ºC for 5 min and electrophoresed in a 
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10% SDS-polyacrylamide gel, which was dried onto filter paper and exposed to film 
(BioMax MR Film, Kodak, Rochester, NY).  
 
Electron Microscopy 
L cells or MDCK cells grown in T75 flasks (Corning) were adsorbed at an MOI 
of 100 PFU per cell using L-cell lysate stocks of virus. Following adsorption of virus at 
RT for 1h, cells were incubated at 31ºC or 37ºC for 24 or 72 h. Cells were trypsinized, 
pelleted, washed with PBS, fixed at room temperature for at least 1 h with 2.5% 
glutaraldehyde buffered with 0.1M sodium cacodylate, and stored at 4 ºC. Following 
fixation cells were washed in 0.1M sodium cacodylate, postfixed in 1% osmium 
tetroxide/0.1M sodium cacodylate for 1 h, washed in 0.1M sodium cacodylate, and 
dehydrated using a graded series of ethanol. After dehydration, cells were subjected to 
two changes of propylene oxide and embedded in epoxy resin. Ultra-thin (65-70 nm) 
serial sections obtained using a Leica Ultracut microtome were collected on copper grids. 
Samples were contrast stained with 2% uranyl acetate followed by Reynold’s lead citrate 
and examined using a Phillips CM10 transmission electron microscope or FEI T-12 
transmission electron microscope operated at 80 KeV.  
 
Quantification of TEM Images 
The fraction of cytoplasm containing virion particles or inclusion matrix in 
electron micrographs was quantified using point count stereology (120). Images were 
collected in a systematic, unbiased fashion using a FEI T-12 transmission electron 
microscope at a magnification of 30,000x. Thirty-six images were collected for each 
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sample. A grid of points was superimposed over the images (grid size 43 x 43nm), and 
points overlaying cytoplasm or virus-specific material were counted. The volume of 
virus-occupied cytoplasm was calculated by dividing the number of points that fell on 
virus-specific material by the total number points on the cytoplasm. Particle diameters 
were measured using ImageJ (http://rsb.info.nih.gov/ij/index.html). A Student’s t-test was 
used to determine statistical significance between the different groups. The fraction of 
viral inclusion matrix occupied by particles was calculated from the images collected for 
point counting. Particle area was estimated by assuming that particles are spherical and 
calculating area using πr2 where r is half the mean diameter of mature and empty particles 
measured using imageJ. Areas of mature and empty particles were calculated 
independently using appropriate diameters and combined to yield total particle area. 
 
Generation of Heterokaryons 
HeLa cells or L cells were transfected with a vesicular stomatitis virus G protein-
expressing plasmid using TransIT-LT1 (Mirus Bio, Madison, WI). Two days post-
infection, cells were trypsinized and resuspended in cell dyes diluted in incomplete 
DMEM at a concentration of 1x107 cells/ml. HeLa cells were dyed with 20 μM CellTrace 
Far Red DDAO-SE (Invitrogen) and MDCK cells with 0.5 μM CellTracker Orange 
CMTMR (Invitrogen). HeLa and MDCK cells were dyed for 30 minutes, washed twice in 
PBS, resuspended in complete DMEM, and co-cultured. 1 day later, fusion was initiated 
with PBS, pH 6.0 (fusion buffer). After 30 minutes, fusion buffer was removed from cells 
and replaced with complete medium. Cells were incubated for 2 hours and sorted using a 
FACSAria III (BD Biosciences) cell sorter into 96-well plates (Costar) or 24-well plates 
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containing glass coverslips. Cells plated in 96-well plates were infected and viral 
infectivity was measured as described above. Cells plated in 24-well plates containing 
glass coverslips were fixed for confocal immunofluorescence microscopy as described 
above. 
 
Mutagenesis and Expression of μ2 
The μ2 expression vector, pM1T1L, in which the complete T1 μ2 open reading 
frame is cloned into pcDNA3, was generated using a T1 M1 cDNA originally obtained 
from Earl Brown (127). The expression vectors containing alanine substitutions in the 
NLS1 and NLS2 sequences were generated using the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene), specific primers, and pM1T1L template. L cells were 
transfected with M1 constructs using Lipofectamine 2000 (Invitrogen, La Jolla, CA) 
according to the manufacturers’ instructions. Distribution of μ2 was analyzed by confocal 
immunofluorescence microscopy as described above.  
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APPENDIX A 
 
NUCLEAR LOCALIZATION OF μ2 PROTEIN 
 
The reovirus replication cycle is thought to be entirely cytoplasmic (96); yet μ2 
localizes to the nucleus of infected (61, 68) and transfected (15, 17, 61, 88) cells. The 
molecular mass of μ2 exceeds the exclusion limit for passive diffusion into the nucleus 
(~40kDa) (13, 87), suggesting that μ2 contains specific nuclear localization signals 
(NLSs). μ2 has two sequence motifs fitting the consensus NLS (124), which are 
sequences characterized by short stretches of basic amino acids (20, 39). The two 
predicted μ2 NLSs are R100RLRKRLMLKK110 (NLS1) and K261RLR264 (NLS2). NLS1 
has the capacity to traffic GFP to the nucleus in the absence of other μ2 sequences. 
Expression of μ2 lacking the N-terminal l06 residues (pM1Δ1-106) resulted in 
diminished nuclear localization in comparison to wt μ2 expression (Appendix B, Fig. 6 
[61]). However, mutagenesis of residues 100 and 101 or 103-105 did not disrupt the 
nuclear-cytoplasmic distribution of μ2 (Appendix B, Fig. 6 [61]). Conversely, mutation 
of basic residues in NLS1 diminished the capability of μ2 to support viral replication in 
trans-complementation assays (Appendix B, Fig. 5 [61]) indicating that these residues are 
essential for viral replication. The capacity of NLS2 to shuttle GFP to the nucleus or 
support replication was not tested. 
  The predominantly cytoplasmic localization of pM1Δ1-106 suggests that there is 
a nuclear localization signal within the μ2 protein that can be disrupted. To more fully 
test the capacity of NLS1 and NLS2 to direct nuclear localization, I replaced basic  
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Figure A.1. Mutagenesis of putative μ2 NLSs. A. WT and mutant T1 μ2 constructs. 
Basic residues in putative NLSs were replaced with alanine residues (red). B. 
Intracellular distribution of WT and μ2-mutant proteins. L cells were transfected with 
plasmid constructs encoding the indicated μ2 proteins, fixed at 24 h post-transfection, 
and stained with anti-μ2 antibody (red). Nuclei were visualized using ToPro3 (blue). 
Images of μ2 expression are shown with (left) and without (right) nuclear staining. 
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residues within NLS1 and NLS2 with alanine residues (Fig. A.1A). L cells were 
transfected with wt μ2 or NLS mutant μ2 constructs. Cells were fixed and imaged using 
confocal microscopy at 24 h post-infection. No NLS mutant, including a mutant lacking 
all basic residues in NLS1 and NLS2, displayed significantly altered μ2 localization 
(Figure A1.B). From these results I concluded that sequences other than those within 
NLS1 and NLS2 possess the capacity to direct nuclear localization of μ2. 
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Mammalian reoviruses are nonenveloped particles containing a genome of 10 double-stranded RNA
(dsRNA) gene segments. Reovirus replication occurs within viral inclusions, which are specialized nonmem-
branous cytoplasmic organelles formed by viral nonstructural and structural proteins. Although these struc-
tures serve as sites for several major events in the reovirus life cycle, including dsRNA synthesis, gene segment
assortment, and genome encapsidation, biochemical mechanisms of virion morphogenesis within inclusions
have not been elucidated because much remains unknown about inclusion anatomy and functional organiza-
tion. To better understand how inclusions support viral replication, we have used RNA interference (RNAi) and
reverse genetics to define functional domains in two inclusion-associated proteins, NS and 2, which are
interacting partners essential for inclusion development and viral replication. Removal of NS N-terminal
sequences required for association with 2 or another NS-binding protein, NS, prevented the capacity of
NS to support viral replication without affecting inclusion formation, indicating that NS-2 and NS-NS
interactions are necessary for inclusion function but not establishment. In contrast, introduction of changes
into the NS C-terminal region, including sequences that form a putative oligomerization domain, precluded
inclusion formation as well as viral replication. Mutational analysis of 2 revealed a critical dependence of
viral replication on an intact nucleotide/RNA triphosphatase domain and an N-terminal cluster of basic amino
acid residues conforming to a nuclear localization motif. Another domain in 2 governs the capacity of viral
inclusions to affiliate with microtubules and thereby modulates inclusion morphology, either globular or
filamentous. However, viral variants altered in inclusion morphology displayed equivalent replication effi-
ciency. These studies reveal a modular functional organization of inclusion proteins NS and 2, define the
importance of specific amino acid sequences and motifs in these proteins for viral replication, and demonstrate
the utility of complementary RNAi-based and reverse genetic approaches for studies of reovirus replication
proteins.
Mammalian reoviruses are the type species of the genus
Orthoreovirus, within the Reoviridae family, which includes im-
portant human and veterinary pathogens, such as rotavirus and
bluetongue virus, respectively. Reoviruses serve as highly trac-
table experimental models for studies of viral replication and
pathogenesis (51). Reovirus virions are nonenveloped, double-
shelled particles that display icosahedral symmetry and contain
10 segments of double-stranded RNA (dsRNA). Following
internalization of virions by receptor-mediated endocytosis,
the viral outer capsid undergoes acid-dependent proteolysis
within endosomes to generate core particles containing all
components of the viral transcriptional machinery (3, 18, 58).
Transcriptionally active core particles released into the cyto-
plasm synthesize full-length, message-sense, single-stranded
RNAs (ssRNAs) corresponding to each viral gene segment (4,
14). These ssRNAs are competent for translation and serve as
templates for minus-strand synthesis to generate nascent
genomic dsRNA (33, 52, 53). Synthesis of the complementary
strand appears to be concomitant with assortment of the 10
genome segments into progeny particles (1). The viral replica-
tion cycle is completed by condensation of outer capsid pro-
teins onto newly formed dsRNA-containing particles, produc-
ing fully assembled infectious progeny (70).
Reovirus replication and assembly are thought to occur
within viral inclusions that form in the cytoplasm of infected
cells (19). Viral inclusions contain dsRNA (56), viral proteins
(19), and both complete and incomplete virion particles (19).
The viral nonstructural proteins NS and NS and minor core
protein 2 are collectively required for the genesis and matu-
ration of viral inclusions in reovirus-infected cells (2, 28). Ex-
pression of these proteins from cloned cDNAs in the absence
of infection results in spontaneous assembly of intracytoplas-
mic structures exhibiting inclusion morphology (6, 39). Virus-
like inclusions recruit constituent proteins of the viral core
(10), indicating that viral inclusion-forming proteins create an
organizing center for the ultimate development of a functional
replication matrix. However, the precise role of viral inclusions
in the reovirus replication pathway, including dsRNA synthe-
sis, gene segment assortment, genome packaging, and virion
assembly, is poorly understood, owing largely to limited mech-
anistic insight into the individual and corporate functions of
inclusion-forming proteins.
The 80-kDa NS protein, encoded by the M3 genome
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segment, is 721 amino acid residues in length (38, 41). The
NS protein associates with viral mRNA (1), core protein 2
(12), and nonstructural protein NS (6, 39). Transiently ex-
pressed NS, in the absence of other viral proteins, forms
inclusion-like structures that are similar in appearance and
localization to the globular inclusions observed in cells infected
with prototype strain type 3 Dearing (T3D) (12). In addition,
NS associates with intact viral cores and recruits core pro-
teins 1, 2, 3, and 2 into viral inclusion-like structures in
transient-transfection assays (10, 12). Interactions of NS with
cores prevent assembly of the virion outer capsid and prolong
transcription (11), which may benefit viral replication at earlier
stages of infection by maximizing RNA and protein produc-
tion. Thus, NS protein plays a fundamental role in viral in-
clusion formation and provides a protected environment in
which RNA replication, assortment, and packaging converge in
particle assembly.
A truncated isoform of NS naturally produced during reo-
virus infection, known as NSC (32), lacks the 40 N-terminal
residues and has been proposed to result from initiation of
translation at an alternative in-frame AUG codon in M3
mRNA (64). The N-terminal 40 residues of NS contain in-
teracting domains for 2 and NS (12, 39), neither of which
associates with NSC (12, 39). Using RNA interference
(RNAi)-based trans-complementation approaches, NSC was
found to be incapable of supporting viral growth in NS-
silenced cells (2, 28), pointing to the significance of interac-
tions between NS, 2, and NS for viral replication. How-
ever, the concerted activities of NS and other replication
proteins within inclusions have not been defined in structural
or functional terms.
The approximately 83-kDa 2 protein, encoded by the M1
genome segment, is 736 amino acid residues in length and
forms a structurally minor component of the reovirus core (17,
38, 41). The 2 protein binds ssRNA and dsRNA (8) and
demonstrates both nucleoside triphosphatase (NTPase) and
RNA 5-triphosphatase (RTPase) activities (26). Reassortant
studies suggest that 2 determines viral strain differences in
transcriptional efficiencies of core particles (66). Phenotypes
associated with a temperature-sensitive lesion in 2 indicate
that it also participates in RNA replication and particle assem-
bly (16).
The 2 protein binds to cellular microtubules and deter-
mines virus strain-specific differences in inclusion morphology,
either globular or filamentous, in infected cells (45, 67). Se-
quence analysis of M1 segments belonging to independent viral
isolates has revealed a correlation between inclusion morphol-
ogy and a single amino acid polymorphism at position 208 (45).
Virus strains that produce filamentous inclusions, such as pro-
totype strains type 1 Lang (T1L) and type 2 Jones (T2J),
contain Pro208, whereas strain T3D, which produces globular
inclusions, contains Ser208 (45, 67). Inclusion-like structures
arising from coexpression of plasmid-encoded NS and 2 in
the absence of viral infection adopt a morphology predicted by
the amino acid residue at position 208, independent of the 2
strain origin (45). The presence of Pro at position 208 in 2 is
genetically linked to more efficient 2-microtubule association
and increased microtubule stabilization in reovirus-infected
cells (45). In contrast, the 2 proteins of strains encoding a Ser
at position 208 are more prone to temperature-dependent mis-
folding that correlates with reduced efficiency of microtubule
binding (39). Taken together, these findings indicate that
amino acid position 208 of 2 determines inclusion morphol-
ogy by influencing its capacity to assume a conformation com-
mensurate with microtubule binding and stabilization.
In studies reported here, we extended application of RNAi-
based replication complementation and plasmid-based reverse
genetics to define sequences and functional domains in NS
and 2 proteins involved in viral replication. Our findings
demonstrate the importance of extreme amino-terminal se-
quences in NS that interact with 2 and NS proteins and
sequences in the C-terminal one-half of NS that mediate
inclusion formation. Furthermore, these studies reveal the sig-
nificance of 2 sequences that specify or predict NTPase and
RTPase activities, constitute a predicted nuclear localization
motif, and determine inclusion morphology. An understanding
of NS and 2 structure-function relationships gained through
these studies will provide new insights into the genesis of viral
inclusions and their role in reovirus replication.
MATERIALS AND METHODS
Cells, viruses, and antibodies. Murine L929 (L) cells were grown in Joklik’s
modified Eagle’s minimal essential medium (Irvine Scientific, Santa Ana, CA)
supplemented to contain 5% fetal calf serum (Gibco-BRL, Gaithersburg, MD),
2 mM L-glutamine, 100 U of penicillin G/ml, 100 g of streptomycin/ml, and 0.25
g of amphotericin B/ml (Gibco-BRL). Human embryonic kidney 293T cells
stably expressing reovirus-specific short hairpin RNAs (shRNAs) were main-
tained as described previously (28).
Reovirus prototype strains T1L and T3D are laboratory stocks. Recombinant
strain (rs) T3D is a stock rescued by plasmid-based reverse genetics from cloned
T3D cDNAs (27). Viral titers were determined by plaque assay using L-cell
monolayers (60). Attenuated vaccinia virus strain rDIs-T7pol expressing T7
RNA polymerase was propagated in chicken embryo fibroblasts (25).
The 1/1C-specific monoclonal antibody 8H6 (61) and antisera to NS (28)
and 2 (68) proteins have been described previously.
Plasmid construction. The construction of NS expression vectors pM3 (en-
coding full-length NS) and pM3(41-721) (encoding NS amino acids 41 to 721),
previously referred to as pcM31861m and pcM3dN138, respectively, has been de-
scribed elsewhere (28). The expression vectors pM3(14-721) (encoding NS
amino acids 14 to 721), pM3(14-40) (encoding NS amino acids 1 to 13 and 41
to 721), pM3(1-675) (encoding NS amino acids 1 to 675), and pM3(1-716)
(encoding NS amino acids 1 to 716) were generated by inserting PCR ampli-
cons derived from pM3 into the KpnI-XhoI site of pcDNA3 (Invitrogen, Carls-
bad, CA). The NS expression vector pH570Q, H572S, containing His-to-Gln
and His-to-Ser amino acid substitutions at positions 570 and 572, respectively,
was generated using the QuikChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA) with specific primers and pM3 as template. Plasmid vector pT7-
M3T3DM41I, which contains an ATG-to-ATC modification of the NSC trans-
lation initiation codon, was generated using QuikChange with pT7-M3T3D tem-
plate (27) and specific primers. This plasmid was used to recover the NSC-
negative virus rsT3D-NSC-null.
The 2 expression vector, pM1T1L, in which the complete T1L 2 open reading
frame is cloned into pcDNA3, was generated using a T1L M1 cDNA originally
obtained from Earl Brown (68). The expression vectors containing single, double, or
triple substitutions in the T1L 2 protein—pK415A, pG416A, pK419A, pD446A,
pG449A, pR100G,R101G, pRKR103-5GQG, pL106QL108Q, and pK109Q
K110Q—were generated using QuikChange, specific primers, and pM1T1L tem-
plate. The rescue vector pT7-M1T1L, encoding the entire T1L M1 gene, was con-
structed by inserting an M1 cDNA amplicon fused at its native 5 terminus to the T7
RNA polymerase promoter into the SmaI-RsrII site of p3E5EGFP (62), resulting in
complete replacement of sequences encoding green fluorescent protein (GFP) and
the Ebola virus leader and trailer, thereby ligating the native M1 3 terminus to the
HDV ribozyme sequence. Two amino acid differences in the cDNA obtained from
E. G. Brown (68), Phe302 and Leu383, compared to the published T1L M1 sequence
(45) were changed to match the published sequence (Phe302 to Leu and Leu383 to
Pro) using QuikChange. QuikChange also was used to generate constructs for
rescue of the following T1L and T3D 2 mutant viruses (summarized in Table 1):
pT7-M1T1LP208S (pT7-M1T1L template), pT7-M1T1LL383P (pT7-M1T1L tem-
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plate), pT7-M1T1LF302L (pT7-M1T1L template), pT7-M1T3DS208P (pT7-
M1T3D template) (27), and pT7-M1T3DS208PL383P (pT7-M1T3D template)
(27).
Expression constructs encoding 2 protein mutagenized within the N-terminal
region were generated using pM1T1L template, specific primers, and either
QuikChange (substitution mutants) or PCR (N-terminal deletion mutant).
Expression plasmid pGFP-2(99-110), encoding GFP fused C-terminally to
2 amino acid residues 99 to 110, was engineered by cloning oligonucleotides
specifying D99RRLRKRLMLKK110 into the XhoI-EcoRI site of pEGFP-C2
(Clontech, Mountain View, CA). Plasmid pGFP-2(99-110m), containing Ala
substitutions of 2 basic amino acids in pGFP-2(99-110), was generated using
oligonucleotides encoding D99AALAAALMLAA110.
All mutations were confirmed by nucleotide sequence analysis. Primer se-
quences used for plasmid construction are available upon request.
Transient protein expression. 293T cells and L cells were transfected using
Lipofectamine 2000 (Invitrogen) and TransIT-LT1 (Mirus, Madison, WI) trans-
fection reagents, respectively, according to the manufacturers’ instructions. To
detect expressed proteins by immunofluorescence, cells grown on glass coverslips
(Fisher Scientific, Pittsburgh, PA) were sequentially transfected with plasmid
vectors, incubated for 24 h, fixed in 10% formalin, permeabilized with 1% Triton
X-100, and incubated with antisera specific for viral proteins, a 1:1,000 dilution
of Alexa Fluor anti-immunoglobulin G secondary antibody (Molecular Probes,
Eugene, OR), and TO-PRO3 (Molecular Probes). GFP fusion proteins were
detected by intrinsic GFP fluorescence. Cells were visualized using an inverted
LSM510 confocal microscope (Carl Zeiss, New York, NY).
To detect expressed proteins by immunoblotting, lysates from transfected cells
were prepared as described previously (28). Proteins were detected using en-
hanced chemiluminescence (Amersham Biosciences, Piscataway, NJ) following
incubation with NS- and 2-specific antisera and appropriate secondary anti-
bodies.
Infection with native and recombinant reovirus strains. Monolayers of L cells
were infected with various reovirus strains at a multiplicity of infection (MOI) of
2 PFU/cell. Following 1 h of adsorption, cells were washed with phosphate-
buffered saline (PBS) to remove the inoculum, and fresh medium was added.
Cultures were harvested at various intervals for virus titration, immunofluores-
cence assay, and immunoblotting.
LMB treatment. Monolayers of L cells were adsorbed with rsT1L at an MOI
of 10 (culture plates) or 20 (glass coverslips) PFU/cell. Following 1 h of adsorp-
tion, cells were washed with PBS to remove the inoculum, and fresh medium was
added. At 8 h postinfection, growth medium was replaced with fresh medium
containing 20 g/ml leptomycin B (LMB), and cultures were processed 4 h later
for plaque assay or confocal immunofluorescence microscopy.
Viability of uninfected and reovirus-infected cells in the presence of LMB was
determined using the CellTiter 96 AQueous assay (Promega, Madison, WI), which
is based on the capacity of viable cells to metabolically reduce 3-(4,5-dimethyl-
thiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS). L cells were distributed into 96-well plates at a density of 5.5  104
cells/well and infected with rsT1L at an MOI of 10 PFU/cell. Following 1 h of
adsorption, cells were washed with PBS to remove the inoculum, and fresh
medium was added. LMB was added 8 h postinfection at a final concentration of
20 g/ml, and the MTS assay was performed according to the manufacturer’s
instructions after 4 h of LMB exposure. Absorbance in reaction wells was re-
corded at 485  following 1 h of incubation.
The subcellular localization of shuttling reporter proteins was determined in
the presence and absence of LMB using the GFP-based vectors Rev68-90-
GFP2-M9 (24) and pXRGG (34). Rev68-90-GFP2-M9 contains sequences derived
from the human immunodeficiency virus type 1 (HIV-1) Rev protein nuclear
export signal (NES; amino acid residues 68 to 90) and heterogeneous nuclear
ribonucleoprotein A1 (hnRNPA1) nuclear localization signal (NLS; M9). The
pXRGG vector contains full-length HIV-1 Rev protein fused C-terminally to the
hormone-responsive region of the rat glucocorticoid receptor, followed by GFP.
Rev and the glucocorticoid receptor furnish pXRGG with one NLS and two
NLSs, respectively, while Rev supplies an NES. L cells were transfected with
plasmid vectors, and cultures were supplemented 20 h posttransfection with 20
g/ml LMB. Cells were imaged 4 h later by confocal microscopy.
Complementation of reovirus replication in cells expressing reovirus shRNAs.
trans-complementation of viral replication by transient expression of viral pro-
teins was performed as described previously (28). 293T cells (106) stably express-
ing M1 or M3 shRNA were seeded into six-well plates (Costar, Cambridge, MA)
approximately 24 h prior to transfection. Cells were transfected with expression
plasmids encoding 2 or NS protein, incubated for 4 or 6 h, respectively, and
adsorbed with T3D at an MOI of 10 PFU/cell. Following 1 h of adsorption, cells
were washed with PBS to remove the inoculum, and fresh medium was added.
Cultures were harvested 24 h after infection, and viral titers in cell lysates were
determined by plaque assay.
Rescue of reovirus mutants from cloned cDNAs. Viruses containing engi-
neered changes in NS and 2 proteins were generated from cloned cDNAs
using plasmid-based reverse genetics (27). Recombinant viruses were isolated
from cotransfection lysates at 5 days posttransfection by plaque assay using L cell
monolayers.
RESULTS
Complementation of reovirus replication in cells stably ex-
pressing T3D M3 shRNA by transient expression of NS.
Previous studies revealed that the N-terminal 40 residues of
NS are required for association with viral replication proteins
2 and NS and that C-terminal sequences in NS are re-
quired for inclusion formation (9, 12, 39). To determine
whether these NS domains are required for viral replication,
expression plasmids encoding wild-type (wt) and mutant forms
of NS were generated for use in RNAi-based replication-
complementation assays. We first assessed the intracellular
distribution of viral proteins in transiently transfected 293T
cells. At 24 h posttransfection, wt NS and an N-terminally
truncated NS isoform corresponding to NSC (amino acids
41 to 721) were present in globular inclusion-like structures,
similar morphologically to inclusions present in strain T3D-
infected cells (Fig. 1A). Likewise, truncation mutants lacking
amino acids 1 to 13 or 14 to 40, which are required for inter-
action of NS with NS and 2, respectively (12, 39), formed
distinctive globular structures. This finding contrasts with the
diffuse cytoplasmic distribution of NS protein lacking the
C-terminal 46 or 5 amino acid residues. Substitution of two
histidine residues (His570 to Gln and His572 to Ser) possessing
Zn2-binding potential and contained within a short sequence
motif conserved among NS proteins of orthoreoviruses and
aquareoviruses (9) also resulted in a diffuse cytoplasmic pat-
tern of protein localization. These results show that His570,
His572, and C-terminal sequences, but not 2- or NS-inter-
acting N-terminal sequences, of NS are required for autoas-
sembly into inclusion-like structures.
Cultures of 293T cells stably expressing M3 shRNA (28)
were transiently transfected with wt T3D NS expression plas-
mid pM3, which contains three silent point mutations within
the shRNA target sequence, followed by infection 4 h post-
transfection with T3D at an MOI of 10 PFU/cell. Viral titers in
culture lysates were determined 24 h postinfection by plaque
TABLE 1. Reovirus strains used for studies of viral
inclusion morphology
Virus strain M1 genederivation
Amino acid at
2 position:
208 302 383
T1L T1L Pro Phe Leu
T3D T3D Ser Phe Leu
rsT3D T3D Ser Phe Leu
rsT3D-2S208P T3D Pro Phe Leu
rsT3D-2S208PL383P T3D Pro Phe Pro
rsT3D-T1L2 T1L Pro Phe Leu
rsT3D-T1L2P208S T1L Ser Phe Leu
rsT3D-T1L2F302L T1L Pro Leu Leu
rsT3D-T1L2L383P T1L Pro Phe Pro
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FIG. 1. trans-complementation of reovirus replication in cells expressing M3 (NS-specific) shRNA. (A) Subcellular localization of mutant NS proteins.
293T cells were infected with T3D at an MOI of 2 PFU/cell or transfected with the indicated plasmid constructs, and NS expression was examined 24 h later
by confocal immunofluorescence microscopy usingNS-specific antiserum (green). Nuclei were stained with TO-PRO3 (blue). pcDNA, nonrecombinant vector
control; pM3, encodes full-length NS; pM3(41-721), encodes NS amino acids 41 to 721; pM3(14-721), encodes NS amino acids 14 to 721; pM3(14-40),
encodes NS amino acids 1 to 13 and 41 to 721; pM3(1-675), encodes NS amino acids 1 to 675; pM3(1-716), encodes NS amino acids 1 to 716; pH570Q,
H572S, encodes full-length NS containing His-to-Gln and His-to-Ser amino acid substitutions at positions 570 and 572, respectively. (B) Viral growth in cells
expressing vector-encoded NS proteins. Parental or M3 shRNA-expressing 293T cells were transfected with plasmids expressing wt or mutant NS proteins,
wt 2, or wt NS as indicated, followed by infection with T3D at an MOI of 10 PFU/cell. At 24 h postinfection, viral titers were determined by plaque assay.
Results are mean viral titers from three independent experiments. Error bars denote standard deviations.
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assay. Yields of T3D were diminished 5,000-fold in shRNA-
expressing cells transfected with nonrecombinant plasmid
compared to an 70-fold reduction in cells transfected with
pM3 (Fig. 1B). Thus, NS protein provided in trans restored
98% of viral growth suppressed by treatment with M3
shRNA. An additional 6-fold enhancement in yield was
achieved by coexpression of 2 and NS proteins with NS,
suggesting that the abundance or accessibility of NS-interact-
ing partners is an important factor in complementation effi-
ciency using this RNAi-based system.
We next assessed the capacity of mutant forms of ectopically
supplied NS protein to complement reovirus replication in
NS-silenced cells. Expression plasmids encoding mutant NS
proteins and wt 2 and NS proteins were cotransfected into
M3 shRNA-expressing cells, followed by infection with T3D.
Mutant NS proteins lacking amino acids 1 to 13, 1 to 40, 676
to 721, or 717 to 721, or containing the double-point mutations
His5703Gln and His5723Ser, were incapable of restoring re-
ovirus yields above control vector, although expression of a
deletion mutant lacking amino acids 14 to 40 resulted in a very
modest (5-fold) increase in viral titer (Fig. 1B). These results
indicate that viral replication depends on the capacity of NS
to form inclusions and interact with 2 and NS proteins.
Importance of NSC for viral replication in infected cells.
We demonstrated previously that heterologous expression of a
naturally occurring, internally initiated form of NS lacking
amino acids 1 to 40, known as NSC, is incapable of support-
ing reovirus replication in an RNAi-based complementation
system (28). However, the precise function of NSC in the
viral life cycle is unknown. To better understand the biologic
role of NSC, we used reverse genetics (27) to generate a virus
incapable of NSC expression, rsT3D-NSC-null, by altering
the in-frame NSC initiation codon (corresponding to nucle-
otides 139 to 141 of the NS open reading frame) to the
isoleucine-encoding sequence, ATC. All remaining genes were
derived from wt T3D. Immunoblot analysis of L cells infected
with plaque-purified rsT3D and rsT3D-NSC-null viruses re-
vealed that NS and NSC were expressed by rsT3D, but only
NS was expressed in rsT3D-NSC-null-infected cells (Fig.
2A). Inclusion formation (Fig. 2B) and growth kinetics (Fig.
2C) for the two viruses were virtually identical. These results
indicate that NSC is neither required for viral inclusion for-
mation nor viral replication in reovirus-infected cells.
Complementation of reovirus replication in cells stably ex-
pressing T3D M1 shRNA. To develop a complementation sys-
tem for studies of 2 functions in viral replication, we estab-
lished L cells constitutively expressing T3D M1-specific
shRNA. A T1L 2 expression plasmid containing a single
silent nucleotide substitution within the shRNA target se-
quence (pM1T1L) was transfected into M1 shRNA-expressing
cells, followed by infection 6 h posttransfection with T3D at an
MOI of 10 PFU/cell. At 20 h postinfection, infected cells were
subjected to immunofluorescence microscopy to detect outer
capsid protein 1/1C as a marker of viral replication. The
1/1C protein was detected in shRNA-expressing cells trans-
fected with pM1T1L but not in cells transfected with empty
vector (Fig. 3A). Concordantly, transfection of cells with
pM1T1L resulted in 150-fold-increased viral yields com-
pared to cells transfected with control vector (Fig. 3B), con-
firming that reovirus replication in 2-silenced cells is rescued
by ectopic 2 expression.
Importance of an intact 2 NTPase/RTPase domain for
reovirus replication. The 2 protein contains conserved re-
gions of primary sequence, A411VLPKGSFKS420 and D446
EVG449, with similarity to the nucleotide-binding A and B
motifs, respectively, of ATPases (26, 42). Previous studies
FIG. 2. Replication of a NSC-null virus. (A) Immunoblot detec-
tion of NS and NSC expression in virus-infected cells. L cells were
infected with rsT3D or rsT3D-NSC-null at an MOI of 2 PFU/cell. At
24 h postinfection, cells were lysed and lysates were immunoblotted
using NS-specific antiserum. (B) Immunofluorescence detection of
NS and NSC expression in virus-infected cells. L cells were infected
as described for panel A and processed for confocal microscopy at 24 h
postinfection using NS-specific antiserum (green). Nuclei were
stained with TO-PRO3 (blue). (C) Growth of rsT3D-NSC-null. L
cells were infected with rsT3D or rsT3D-NSC-null at an MOI of 2
PFU/cell, and viral titers in culture lysates were determined by plaque
assay at the intervals shown. Results are mean viral titers from three
independent experiments. Error bars denote standard deviations.
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showed that baculovirus-expressed 2 exhibits NTPase and
RTPase activities and that both functions are abolished by dual
Ala substitutions of conserved Lys residues at positions 415
and 419 (26). To ascertain the importance of 2 putative nu-
cleotide-binding motifs in virus replication, we replaced Lys415,
Gly416, Lys419, Asp446, and Gly449 individually with Ala (Fig.
4A). Mutant 2 proteins with Gly416 to Ala or Gly449 to Ala
mutations retained the capacity to restore viral growth in 2-
deficient cells, whereas mutants with Lys415 to Ala, Lys419 to
Ala, or Asp446 to Ala substitutions failed to support growth
FIG. 3. trans-complementation of reovirus replication in cells expressing M1 (2-specific) shRNA. Parental or M1 shRNA-expressing 293T
cells were transfected with empty vector (pcDNA) or T1L 2-expressing vector (pM1T1L), followed by infection with T3D at an MOI of 10
PFU/cell. (A) Immunofluorescence analysis of viral replication. At 20 h postinfection, cells were visualized by confocal immunofluorescence
microscopy using a monoclonal antibody specific for viral structural protein 1/1C (green). Nuclei were stained with TO-PRO3 (blue).
(B) Quantitation of viral growth. At 24 h postinfection, viral titers in culture lysates were determined by plaque assay. Results are mean viral titers
from two independent experiments. Error bars denote standard deviations.
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above background levels (Fig. 4B). Differing complementation
efficiencies among wt and mutant 2 proteins were not ex-
plained by variations in expression levels, based on results of
immunoblot assays (Fig. 4C). These findings indicate that both
putative nucleotide-binding motifs in 2 are vital to its func-
tion in viral replication, consistent with an essential role for 2
NTPase/RTPase activity.
Importance of a 2 N-terminal region basic cluster for
reovirus replication. Alignment of 2 sequences from reovirus
strains representing serotypes 1, 2, and 3 reveals a highly con-
served short stretch of predominantly basic amino acids that
occupies positions 100 to 110 in the primary sequence, R100R
LRKRLMLKK110 (67). Such motifs are associated with nu-
clear targeting activities (15, 21). Therefore, we investigated
the importance of R100RLRKRLMLKK110 in viral replication
by using complementation methods (Fig. 5A). Viral yields in
cells expressing a mutant 2 protein substituted at two apolar
positions, Leu106/Leu108 to Gln106/Gln108, were equivalent to
those expressing wt protein (Fig. 5B). In contrast, disruption of
basic positions via double or triple substitution mutants—
R100R101 to G100G101, R103 K104 R105 to G103Q104G105, and
K109K110 to Q109Q110—eliminated the capacity of vector-de-
rived 2 to restore viral growth in 2-silenced cells despite
equivalent expression levels of wt and mutant 2 proteins (Fig.
5C). These results indicate that a cluster of basic residues near
the N terminus of 2 is critical for viral replication and support
the idea that these conserved sequences are contained within a
discrete functional domain.
FIG. 4. trans-complementation of M1 (2-specific) RNAi with 2
proteins containing mutations in a domain required for NTPase and
RTPase activities. (A) Substitutions in predicted NTP-binding motifs
of T1L 2 protein. Changes are shown relative to the wt sequence
encoded by the parental vector, pM1T1L. (B) Viral growth in cells
expressing vector-encoded 2 proteins. Parental or M1 shRNA-ex-
pressing 293T cells were transfected with empty vector (pcDNA) or
T1L 2-expressing vectors, followed by infection with T3D at an MOI
of 10 PFU/cell. At 24 h postinfection, viral titers in culture lysates were
determined by plaque assay. Results are mean viral titers from three
independent experiments. Error bars denote standard deviations.
(C) Confirmation of 2 expression in transfected cells. Expression of
2 proteins from trans-complementation vectors was verified by im-
munoblotting of protein extracts from transiently transfected cells us-
ing 2-specific antiserum.
FIG. 5. trans-complementation of M1 (2-specific) RNAi with 2
proteins containing mutations in a conserved N-terminal polybasic
region. (A) Substitutions in a basic amino acid domain. Changes are
shown relative to the wt sequence encoded by the parental vector,
pM1T1L. (B) Viral growth in cells expressing vector-encoded 2 pro-
teins. Parental or M1 shRNA-expressing 293T cells were transfected
with empty vector (pcDNA) or T1L 2-expressing vectors, followed by
infection with T3D at an MOI of 10 PFU/cell. At 24 h postinfection,
viral titers in culture lysates were determined by plaque assay. Results
are mean viral titers from three independent experiments. Error bars
denote standard deviations. (C) Confirmation of 2 expression in
transfected cells. Expression of 2 proteins from trans-complementa-
tion vectors was verified by immunoblotting of protein extracts from
transiently transfected cells using 2-specific antiserum.
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Influence of 2 N-terminal region basic sequences on pro-
tein subcellular distribution. To determine whether perturba-
tions in protein nucleocytoplasmic compartmentalization con-
tribute to the lethal phenotype of mutations introduced at
positions occupied by basic residues between amino acids 100
and 110, we examined the distribution of 2 in transiently
transfected cells using confocal microscopy. Native 2 protein
was found in both the nucleus and cytoplasm of 293T cells with
similar staining intensities (Fig. 6A). As the molecular mass of
2 exceeds the exclusion limit for passive diffusion of mole-
cules into the nucleus (40 kDa) (7, 44), this finding is con-
sistent with the presence of a functional NLS. Amino acid
substitutions that abrogate the capacity of 2 to trans-comple-
ment viral replication—R100R101 to G100G101 and R103 K104
R105 to G103Q104G105—elicited a modest to moderate shift in
the distribution of 2 from the nucleus to cytoplasm. More-
over, an N-terminally truncated 2 protein lacking the first 106
amino acid residues displayed almost exclusive cytoplasmic
localization. These results provide evidence that N-terminal
region sequences in 2 harbor an NLS.
To directly determine whether the 2 polybasic region and
predicted NLS possess autonomous nuclear targeting activity,
we examined the intracellular distribution of GFP extended at
its C terminus with 2 sequences, D99RRLRKRLMLKK110
(Fig. 6B). In contrast to the homogeneous dispersion of un-
modified GFP in L cells, there was marked nuclear accumula-
tion of GFP fused to the 2 predicted NLS. Ala substitution of
basic residues in the appended 2 sequences nullified their
impact on GFP nuclear translocation, resulting in a uniform
distribution of the GFP-2 fusion protein indistinguishable
from wt GFP. These findings indicate that the N-terminal
polybasic region in 2 can independently function as an NLS.
Furthermore, because mutations in this same region pro-
foundly interfere with viral replication (Fig. 5B), results of the
2 localization experiments suggest that nuclear targeting of
2 is required for completion of the reovirus infectious cycle.
Effect of LMB on 2 localization and reovirus replication.
Because 2 protein distributes to both the nucleus and cyto-
plasm (Fig. 6) (10, 12, 37, 39, 45), it is possible that 2 shuttles
between these compartments. The best-characterized and most
commonly used nuclear export pathway is mediated by Crm1
(exportin 1), which facilitates translocation of cargos contain-
ing a Leu-rich NES, the Crm1 ligand (20, 30). LMB covalently
associates with Crm1 and blocks binding to this NES (29). To
determine whether Crm1-mediated nuclear export functions in
2 subcellular distribution and viral replication, we examined
the effect of LMB treatment on 2 nuclear accumulation and
viral replication in T1L-infected L-cell cultures. Addition of 20
g/ml LMB at 8 h postinfection did not appreciably alter the
nucleocytoplasmic distribution of 2 at 12 h postinfection (Fig.
7A). Furthermore, viral yields in LMB-treated and control
cells were virtually identical (Fig. 7C). The treatment condi-
tions employed were adequate to induce nuclear sequestration
of two GFP-based shuttling proteins, Rev68-90-GFP2-M9 and
pXRGG, containing the Crm1-dependent NES of HIV-1 Rev
(24, 34) (Fig. 7B). As an additional control, neither uninfected
nor reovirus-infected cells displayed evidence of substantial
LMB-induced cytotoxicity as judged by the capacity of treated
cells to reductively metabolize MTS (Fig. 7D). Thus, experi-
mental parameters commensurate with inhibition of Crm1-
mediated nuclear export did not reveal spatial or functional
evidence of Crm1-dependent 2 nucleocytoplasmic shuttling.
Sequence polymorphisms in 2 and viral inclusion mor-
phology. The 2-encoding M1 gene is a determinant of strain-
FIG. 6. Requirement for conserved N-terminal basic residues in 2 subcellular localization. (A) Intracellular distribution of wt and mutant 2
proteins. 293T cells were transfected with plasmid constructs encoding the indicated T1L-derived 2 proteins, which were detected by confocal
immunofluorescence microscopy using 2-specific antiserum (green). pM1T1L, wt T1L 2; pR100G,R101G, 2 containing Arg100-to-Gly and
Arg101-to-Gly substitutions; pRKR103-5GQG, 2 containing Arg103-to-Gly, Lys104-to-Gln, and Arg105-to-Gly substitutions; p1-106, truncated 2
protein lacking the N-terminal 106 amino acid residues. (B) Intracellular distribution of GFP fused to 2 protein sequences. L cells were
transfected with the indicated plasmid constructs. Expression of wt T1L 2 protein was detected by confocal immunofluorescence microscopy using
2-specific antiserum (green). Intrinsic GFP fluorescence was detected using confocal microscopy (green). pEGFP-C2, enhanced GFP; pGFP-
2(99-110), EGFP appended at the C terminus with the 2 putative nuclear localization sequence, D99RRLRKRLMLKK110; pGFP-2(99-110m),
pGFP-2(99-110) containing Ala substitutions for 2 basic residues.
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FIG. 7. Treatment of reovirus-infected cells with LMB. (A) Subcellular distribution of 2. L cells were infected with T1L at an MOI of 20
PFU/cell. At 8 h postinfection, the culture medium was supplemented to contain 20 g/ml LMB (LMB) or left unsupplemented (-LMB). Cells
were imaged 12 h postinfection using confocal immunofluorescence microscopy with NS (red)- and 2 (green)-specific antisera. Nuclei were
stained with TO-PRO3 (blue). (B) Subcellular distribution of nuclear shuttling proteins. Modified GFPs enabled for nucleocytoplasmic shuttling
were transfected into L cells. At 20 h posttransfection, the culture medium was supplemented to contain 20 g/ml LMB ( LMB) or left
unsupplemented (-LMB). GFP was visualized 24 h posttransfection using confocal microscopy. Nuclei were left unstained (- TO-PRO3) or stained
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specific differences in viral inclusion morphology (45), which
has been correlated with the efficiency of 2-microtubule in-
teractions and a single amino acid polymorphism in 2 at
position 208 (45, 67). To determine the significance of the
Pro208/Ser208 polymorphism in viral replication, L cells were
infected with wt and 2-mutant viruses recovered by reverse
genetics (Table 1) and subjected to immunofluorescence anal-
ysis at 24 h post infection. Consistent with patterns displayed
by native viruses, rsT3D, which contains a Ser residue at 2
position 208, produced exclusively globular inclusions, whereas
recombinant virus containing the T1L-derived 2 protein
(rsT3D-T1L2), in which Pro occurs at position 208, produced
only filamentous inclusions (Fig. 8A). Moreover, this pattern
was reversed upon reciprocal Ser208-to-Pro and Pro208-to-Ser
substitutions in T3D (rsT3D-2S208P) and T1L (rsT3D-
T1L2P208S) 2 proteins, respectively. These results confirm
that the Pro/Ser polymorphism at position 208 in 2 protein
serves as an independent determinant of viral inclusion mor-
phology in L cells.
Stocks of reovirus maintained in different laboratories ex-
hibit polymorphisms in the 2 protein (67). The T1L and T3D
stocks used in our laboratory were acquired from the labora-
tory of Bernard Fields and contain Phe and Leu residues at 2
positions 302 and 383, respectively. However, a cloned T1L 2
cDNA derived from a reovirus stock maintained in the labo-
ratory of Earl Brown contains Leu and Pro residues at posi-
tions 302 and 383, respectively (45). To determine whether
sequence variability at 2 positions 302 and 383 influences
inclusion morphology, we generated T1L and T3D 2-mutant
viruses with substitutions at both sites (Table 1). Immunoflu-
orescence analysis of L cells infected with rsT3D-T1L2- and
rsT3D-T1L2F302L displayed filamentous inclusion morphol-
ogy typical of T1L 2 (Fig. 9A). However, infection with
rsT3D-T1L2L383P revealed only globular viral inclusions,
whereas uniformly filamentous inclusions were observed in
rsT3D-2S208PL383P-infected cells (Fig. 9C). These find-
ings show that an amino acid position in 2 other than 208
modulates phenotypic effects of the Ser208/Pro208 polymor-
phism in a sequence context-dependent fashion. Furthermore,
the Phe302-to-Leu substitution in rsT3D-T1L2F302L serves
as a specificity control for the effects of engineered changes on
protein folding, which provides confidence that alterations in
inclusion morphology associated with substitutions at positions
208 and 383 are unlikely to result from gross conformational
changes in 2. Thus, amino acid residues 208 and 383 are part
of a functional, and possibly structural, domain involved in
2-microtubule interactions.
Inclusion morphology and viral growth. To ascertain the
relevance of inclusion morphology to viral replication, L cells
were infected with wt and 2-mutant rs viruses at an MOI of
2 PFU/cell, and viral growth was assessed by plaque assay at
various times postinfection (Fig. 8B and 9B). Kinetics of viral
growth and absolute titers of infectious particles did not differ
significantly among wt and mutant viruses, indicating that nei-
ther 2 sequence variability at positions 208, 302, or 383 nor
inclusion morphology is a critical modulator of reovirus repli-
cation efficiency in L cells infected with isogenic 2 mutant
viruses.
DISCUSSION
The NS protein forms distinct structures resembling viral
inclusions when expressed in the absence of other viral pro-
teins (12). Minimum sequences required for autoassembly of
NS protein into inclusion-like structures are contained within
the 161 to 251 C-terminal amino acids (9). The C-terminal two
to eight amino acid residues and a putative metal-chelating
motif (perhaps selective for Zn2) involving His570 and Cys572
appear to play critical roles in this process (2, 9). These se-
quences may contribute to a dimerization domain perhaps
involved in NS homotypic or heterotypic interactions re-
quired to nucleate inclusions (9). We found that preservation
of the NS extreme C terminus and conservation of His570 and
Cys572 are required for autoassembly of NS into structures
resembling viral inclusions. Furthermore, results of shRNA-
based trans-complementation assays indicate that mutant NS
proteins failing to form inclusion-like structures are incapable
of supporting viral growth in 293T cells, consistent with a
recent study using a different trans-complementation method-
ology (2). Therefore, concordant results obtained in indepen-
dent laboratories using different methods provide compelling
functional evidence that establishment of cytoplasmic inclu-
sions by NS is a prerequisite to reovirus replication.
Although formation of inclusions is necessary for viral rep-
lication, results reported here indicate that inclusion formation
is not sufficient. Our findings and those previously reported by
Arnold et al. (2) show that NSC, though capable of self-
assembly into inclusion-like structures, cannot support viral
replication. Such aspects of NS structure-function relation-
ships point to compulsory heterointeractions between NS and
2 and NS proteins at one or more steps in the viral RNA life
cycle, perhaps recruitment or retention of ()-strand RNAs at
sites of viral replication, dsRNA synthesis, or genome packag-
ing. In support of this model, we previously found that selective
RNAi-mediated elimination of NS, 2, or NS from reovi-
rus-infected cells inhibits viral dsRNA synthesis and produc-
tion of infectious particles (28). We show here that removal of
NS N-terminal sequences specifically required for interac-
(blue) with TO-PRO3 ( TO-PRO3). Rev68–90-GFP2-M9 contains sequences derived from the HIV-1 Rev protein nuclear export signal and the
heterogeneous nuclear ribonucleoprotein A1 nuclear localization signal. The nuclear export signal for pXRGG is supplied by full-length Rev, and
nuclear localization signals are furnished by both Rev and the rat glucocorticoid receptor hormone-responsive region. (C) Reovirus growth. L cells
were infected with T1L at an MOI of 10 PFU/cell, and the culture medium was supplemented 8 h postinfection to contain 20 g/ml LMB ( LMB)
or left unsupplemented (- LMB). Viral titers in culture lysates were determined at 0 and 12 h postinfection by plaque assay. Results are mean viral
yields (relative to time zero) from three independent experiments. Error bars denote standard deviations. (D) Cell viability. L cells were infected
with T1L at an MOI of 10 PFU/cell. At 8 h postinfection, culture medium was supplemented to contain 20 g/ml LMB ( LMB) or left
unsupplemented (- LMB). Cell viability was determined 12 h postinfection with an MTS assay. Results are mean absorbances from three
independent experiments. Error bars denote standard deviations. Reaction absorbance is directly proportional to cell viability.
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tions with either NS (1 to 13) or 2 (14 to 40) (10, 39) also
eliminates or drastically reduces the capacity of NS to sup-
port viral growth, yet without compromising its capacity for
inclusion formation.
Despite the failure of ectopically supplied NSC to restore
viral replication in NS-depleted cells, NSC might neverthe-
less contribute to viral inclusion formation or growth in in-
fected cells. Thus, to unequivocally define the importance of
NSC in the viral infectious cycle, we characterized the repli-
cation of a NSC-deficient mutant virus obtained using reverse
genetics. In these experiments, we found that NSC is neither
required for normal viral inclusion development nor viral
growth (Fig. 2). It is possible that NSC promotes viral growth
in certain cell or tissue types requisite to efficient spread within
or between hosts. Alternatively, NSC may modulate host
defenses to reovirus infection at the intracellular or organismal
level. We are currently investigating these possibilities.
RNAi-mediated reduction in 2 expression is associated
with marked retardation of viral inclusion development, inhi-
bition of dsRNA synthesis, and virtual absence of progeny
virion production (28). The exquisite responsiveness of reovi-
rus replication to diminished 2 levels permitted specific se-
quences in 2 important for viral growth to be defined by
complementation. We identified three short regions of se-
quence critical for viral replication: two predicted nucleotide-
binding units with similarity to Walker A (A411VLPKGS
FKS420) and B (D446EVG449) motifs of ATPases (26) and an
N-terminal basic amino acid cluster conforming to a possible
NLS (R100RLRKRLMLKKDLRK114) (15, 21). The Walker
A- and B-like motifs are invariant among 14 reported 2 se-
quences representing reovirus strains of all three serotypes,
including the prototype strains (67). Single Ala substitutions at
putative nucleotide-binding residues Lys415 and Lys419 in the
A-like motif prevented viral replication, whereas mutation of
the neutral position, Gly416, was replication compatible. These
results strongly suggest that 2 NTPase/RTPase activity is req-
uisite to viral replication and agree with recent findings by
Carvalho et al. (13), who reported that introduction of the
double mutation, Lys415/Lys419-to-Ala415/Ala419, into 2
caused an 10- to 100-fold viral titer reduction in CV-1 cells
when they used an siRNA-based replication complementation
system. Tolerance of a mutation at Gly449, but not Asp446, in
the Walker B-like domain provides further evidence that viral
replication is dependent on 2 NTPase/RTPase functionality.
Our findings do not address specific steps in the viral infec-
tious cycle disrupted by mutations in the Walker-like motifs.
Considering that 2 is a probable component of the core
particle transcriptional machinery (8, 26, 66) as well as inclu-
sion-associated protein (5, 10, 12, 37, 39, 40, 45) involved in
genomic RNA synthesis and particle assembly (16), diminished
NTPase/RTPase activities could interrupt progression of the
replication program at multiple points during or following
RNA ()-strand synthesis. Introduction of Lys415/Lys419-to-
Ala415/Ala419 mutations into T1L 2 does not interfere with its
capacity to form filamentous inclusion-like structures when
coexpressed with NS in CV-1 cells (26). Interestingly, the
NTPase function of rotavirus viroplasm-forming protein NSP2
is essential for productive rotavirus replication, but not viro-
plasm formation, in trans-complemented MA104 cells (59).
Taken together, these findings suggest that disruption of 2
FIG. 8. Modulation of viral inclusion morphology by engineered
changes at 2 amino acid position 208. (A) Inclusion morphology of
2 mutant viruses. L cells were infected at an MOI of 2 PFU/cell
with wt viruses or viral mutants with substitutions at amino acid
position 208 in the T1L and T3D 2 proteins. At 24 h postinfection,
cells were imaged using confocal immunofluorescence microscopy
after staining with NS-specific antiserum (green). Nuclei were
stained with TO-PRO3 (blue). T3D and T1L, native viruses; rsT3D,
wt strain; rsT3D-T1L2, rsT3D containing T1L-derived 2; rsT3D-
2S208P, rsT3D containing a Ser208-to-Pro substitution in 2;
rsT3D-T1L2P208S, rsT3D-T1L2 with a Pro208-to-Ser substitu-
tion in 2. (B) Growth of 2 mutant viruses. L cells were infected
with the indicated viruses at an MOI of 2 PFU/cell, and titers in
culture lysates were determined by plaque assay at the intervals
shown. Results are mean viral titers from three independent exper-
iments. Error bars denote standard deviations.
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NTPase/RTPase activity blocks reovirus replication at a point
subsequent to inclusion formation, for example, synthesis or
packaging of dsRNA.
We found that nonconservative substitutions at charged, but
not apolar, positions in the more N-terminal of two basic
clusters in 2 completely prevented transiently expressed 2
from restoring viral growth in 2-deficient cells. These changes
produced a mild nuclear-to-cytoplasmic shift in the subcellular
distribution of transiently expressed 2 protein, suggesting that
other sequences also regulate nuclear localization. One such
possibility is the slightly more C-terminal NLS-like sequence
element, K261RLR264, but additional nuclear-targeting activi-
ties may reside proximal to the N terminus of 2, as very little
mutant protein lacking the N-terminal 106 residues was
present in the nucleus. Nevertheless, we found that the oli-
gopeptide D99RRLRKRLMLKK110 is sufficient to direct a
heterologous protein (GFP) to the nucleus. Thus, this region
of 2 possesses intrinsic capacity for nuclear localization. Clas-
sical (i.e., basic) NLSs are recognized by importin-	, and NLS-
presenting proteins are translocated through the nuclear pore
in a complex containing importin-	 and importin-
 (57). These
findings are consistent with a physical interaction between 2
and components of the nuclear import apparatus.
A functional role for 2 nuclear entry is not apparent from
our studies. However, it is noteworthy that 2 protein has been
genetically linked to viral strain-specific differences in the in-
duction of alpha/beta interferon (IFN-	/
) expression in car-
diac myocytes and reovirus sensitivity to the antiviral effects of
IFN in these cells (55). A recent report by Zurney et al. (69)
provided evidence that the 2 protein of strain T1L, but not
T3D, antagonizes signal transduction from the IFN-	/
 recep-
tor by favoring the nuclear accumulation of a key signaling
molecule, IFN regulatory factor 9 (IRF9), which partners with
signal transducer and activator of transcription 1 (STAT1) and
STAT2 to form a heterotrimeric inducer of IFN-stimulated
gene (ISG) expression (49). The nuclear phase of 2 might
benefit viral replication by directly or indirectly perturbing the
normal cycle of IRF9 nucleocytoplasmic translocation, thereby
suppressing the expression of ISGs. Activities of 2 in the
nucleus might also involve cellular processes unrelated to in-
nate immunity, such as regulation of transcription or the cell
cycle, congruous with diverse functional interactions between
proteins encoded by cytoplasmically replicating RNA viruses
and nuclear structures and proteins (23).
The most commonly used and best-characterized pathway
for exporting nuclear cargo to the cytoplasm is dependent on
Crm1, which recognizes hydrophobic, typically Leu-rich, NESs
and translocates NES-containing proteins through the nuclear
pore as part of a heteromeric complex containing GTP-bound
Ran protein (57). A number of viral proteins are shuttled in a
Crm1-dependent fashion (20, 46, 48, 63, 65), and like 2, these
FIG. 9. Effect of altering 2 amino acids other than at position 208
on viral inclusion morphology and growth. (A) Inclusion morphology
of viruses with alterations in T1L 2. L cells were infected at an MOI
of 2 PFU/cell with wt viruses or viral mutants with substitutions at
amino acid positions 302 and 383 in the T1L 2 protein. At 24 h
postinfection, cells were imaged using confocal immunofluorescence
microscopy after staining with NS-specific antiserum (green). Nuclei
were stained with TO-PRO3 (blue). rsT3D, wt strain; rsT3D-T1L2,
rsT3D containing T1L-derived 2; rsT3D-T1L2F302L, rsT3D-
T1L2 with a Phe302-to-Leu substitution in 2; rsT3D-T1L2L383P,
rsT3D-T1L2 with a Leu383-to-Pro substitution in 2. (B) Growth of
virus with substitutions at amino acid position 383 of T1L 2. L cells
were infected with the indicated viruses at an MOI of 2 PFU/cell, and
titers in culture lysates were determined by plaque assay after 0, 12,
and 24 h of incubation. Results are mean viral yields (relative to time
zero) from three independent experiments. Error bars denote standard
deviations. (C) Inclusion morphology of viruses with alterations in
T3D 2. L cells were infected with the indicated viruses and imaged
24 h later as described for panel A. rsT3D-2S208P, rsT3D containing
a Ser208-to-Pro substitution in 2; rsT3D-2S208PL383P, rsT3D
with Ser208-to-Pro and Leu383-to-Pro substitutions in 2.
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proteins are frequently involved in viral RNA regulation or
subversion of the IFN response. A specific inhibitor of Crm1
nuclear export activity, LMB (29, 30), did not significantly
affect viral replication or the distribution of 2 protein in
T1L-infected L cells under treatment conditions adequate to
induce nuclear retention of two different GFP-based reporter
molecules containing the HIV-1 Rev NES. Nonetheless, our
results do not exclude the possibility of bidirectional move-
ment of 2 between the cytoplasm and nucleus. It is possible
that variation in the sequence of 2 (or other proteins) among
different viral strains (67) influences the extent or kinetics of
2 nucleocytoplasmic shuttling and, therefore, sensitivity to
LMB. Another possibility is that 2 export from the nucleus
occurs through a nonclassical pathway (43), reminiscent of
Crm1-indpendent nuclear export of morbillivirus N proteins
containing Leu-rich NESs (50). We note the presence of a
sequence element in 2, L328EMLGIEI335, which exhibits sim-
ilarity to a Leu-rich NES (31) and is highly conserved among
14 published 2 sequences except that belonging to strain T2J
(67).
The 2 protein binds and stabilizes microtubules and an-
chors inclusions of the majority of characterized reovirus
strains to the cytoskeleton, resulting in filamentous inclusion
morphology (12, 45, 67). However, a Pro208-to-Ser change
present in some viral strains is associated with the covariant
phenotypes of diminished microtubule binding by 2 (45) and
globular inclusion morphology (45, 67). We rescued isogenic
viruses containing single amino acid substitutions in 2 and
found that the Pro208/Ser208 polymorphism is indeed an inde-
pendent determinant of inclusion morphology. We further ob-
served that a Leu/Pro polymorphism at position 383, identified
in the cloned M1 cDNA sequence from a laboratory isolate of
T1L (45), also determines inclusion morphology of rescued
viruses expressing T1L 2 and that the simultaneous presence
of Pro and Leu at positions 208 and 383, respectively, is re-
quired to produce filamentous inclusions. Similar studies per-
formed using viruses expressing T3D 2 protein yielded the
somewhat surprising result that the polymorphism at position
383 in T3D 2 does not affect inclusion morphology dictated
by amino acid 208. There are nine amino acid differences
between the T1L- and T3D-derived 2 proteins used for our
studies (T1L/T3D amino acids: Val93/Ala93, Pro208/Ser208,
Val300/Met300, Gln342/Arg342, Phe347/Leu347, Val434/Ile434,
His458/Gln458, Met652/Ile652, and Asn726/Ser726), one or more
of which must control the differential effects of residue 383 on
inclusion morphology. Detailed structural models of the 2
protein are needed to fully explain these strain-specific effects,
but one logical hypothesis is that amino acid residues 208 and
383 are proximal in the 2 structure and contribute to the
microtubule-binding or microtubule-stabilizing region of 2.
Neighboring polymorphic positions may influence the interac-
tions of amino acid residues 208 and 383 with microtubules or
each other.
We were unable to correlate inclusion morphology with total
viral yields or replication kinetics by using rescued 2 mutant
viruses, which grew equivalently to wt regardless of the inclu-
sion morphotype or strain origin of 2. These findings contrast
with those reported by Carvalho et al. (13), which showed that
viral growth in an RNAi-based trans-complementation system
was significantly enhanced when complementation was per-
formed with 2 protein containing Pro rather than Ser at
position 208. The mechanistic basis for these differential effects
of Pro208 versus Ser208 on the capacity of transiently expressed
2 to restore viral replication was not evident in those studies,
but rescue of viral growth was sensitive to nocodazole, indicat-
ing dependence on intact microtubules. The requirements for
microtubule binding by 2 may be cell type dependent. In this
regard, previous experiments were performed with primate
kidney-derived (CV-1) cells, whereas we used murine fibro-
blast (L) cells. The 2-encoding M1 gene is a determinant of
differences between strains T1L and T3D with respect to viral
growth in MDCK cells (47), murine cardiac cells (36), and
bovine aortic endothelial cells (35); reovirus-induced myocar-
ditis in immunocompetent mice (54); and organ-specific viral
growth and injury in SCID mice (22). Thus, 2-mediated re-
cruitment of viral factories to microtubules might be necessary
for efficient reovirus growth in some types of cells. Although a
mechanistic explanation for such a requirement is not obvious,
concentration of viral proteins and RNA on the cytoskeleton
may facilitate genome replication and particle assembly or,
perhaps, shield viral components from recognition by the in-
tracellular pathogen surveillance system.
In this study, we combined RNAi-based and reverse genetics
strategies to define the role of functional domains in the viral
inclusion-forming proteins NS and 2 in reovirus replication.
Both proteins display modular architectures built from what
appear to be functionally and structurally unique sequence
domains involved in discrete steps of inclusion development
and viral replication. Recombinant reoviruses systematically
altered in the NS, 2, and other viral proteins will foster new
insights into the viral replication machinery and may reveal
posttranscriptional determinants of viral pathogenesis.
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ReassortmentMammalian orthoreoviruses (reoviruses) are highly useful models for studies of double-stranded RNA virus
replication and pathogenesis. We previously developed a strategy to recover prototype reovirus strain T3D
from cloned cDNAs transfected into murine L929 ﬁbroblast cells. Here, we report the development of a
second-generation reovirus reverse genetics system featuring several major improvements: (1) the capacity
to rescue prototype reovirus strain T1L, (2) reduction of required plasmids from 10 to 4, and (3) isolation of
recombinant viruses following transfection of baby hamster kidney cells engineered to express
bacteriophage T7 RNA polymerase. The efﬁciency of virus rescue using the 4-plasmid strategy was
substantially increased in comparison to the original 10-plasmid system. We observed full compatibility of
T1L and T3D rescue vectors when intermixed to produce a panel of T1L×T3D monoreassortant viruses.
Improvements to the reovirus reverse genetics system enhance its applicability for studies of reovirus
biology and clinical use.
© 2009 Elsevier Inc. All rights reserved.Introduction
One of the most transformative technologic advancements in
virology has been the development of reverse genetics systems for
nearly all major groups of RNA- and DNA-containing viruses.
Although the molecular design and methodologic details of these
systems vary, their common feature is the availability of cloned cDNAs
encoding viral genomes that can be manipulated and subsequently
used to isolate viruses containing engineered changes in genomic
nucleic acids. RNA virus rescue systems typically entail intracellular
transcription of full-length genomic or antigenomic RNAs from
plasmids transfected into permissive cells, frequently in conjunction
with transient expression of essential components of the viral
replicase (Bridgen and Elliott, 1996; Collins et al., 1995; Fodor et al.,
1999; Garcin et al., 1995; Lawson et al., 1995; Neumann et al., 1999;
Racaniello and Baltimore, 1981; Schneider et al., 2005; Schnell et al.,
1994; Whelan et al., 1995; Yoneda et al., 2006). Furthermore,
translational competence of (+)-strand RNA virus genomes hastric Research, D7235 MCN,
37232, USA. Fax: +1 615 343
Chappell),
t.
o University, Kyoto 606-8507,
ll rights reserved.enabled rescue of infectious virus from cells following introduction of
in vitro-generated genomic RNAs free of viral proteins (Almazan et al.,
2000; Coley et al., 2005; Gritsun and Gould, 1995; Kinney et al., 1997;
Racaniello and Baltimore, 1981; Rice et al., 1989; Yount et al., 2003;
Yun et al., 2003). Development of a fully plasmid-based reverse
genetics strategy for double-stranded (ds) RNA viruses of mammalian
species, which include coltiviruses, orbiviruses, reoviruses, and
rotaviruses, has trailed other major systems owing in part to the
technical complexities involved in manipulation of a multipartite
genome containing 10 or more segments. We have developed a
reverse genetics system for mammalian reovirus (Kobayashi et al.,
2007), a nonenveloped, double-layered particle containing 10 dsRNA
gene segments (Schiff et al., 2007), and used this system to engineer
changes in both structural and nonstructural proteins for studies of
reovirus replication and pathogenesis (Boehme et al., 2009; Danthi et
al., 2008a; Danthi et al., 2008b; Kirchner et al., 2008; Kobayashi et al.,
2007, 2009; Zurney et al., 2009).
The implications of targeted alterations of the reovirus genome are
highly signiﬁcant to current research focused on therapeutic use of
reovirus as an oncolytic agent (Kelly et al., 2009) and to conceptu-
alization of reovirus-vectored vaccines. Goals for our continuing work
with this technology include performance improvement in the form
of increased efﬁciency of virus recovery, broadened scope of
dissectible viral properties and phenotypes, expanded spectrum of
nonviral nucleic acids inserted into the viral genome, shortened time
to virus recovery, and reduced reagent preparation time and expense.
Fig. 1. Experimental strategy to generate reovirus type 1 Lang (T1L) from cloned cDNAs.
(A) Rescue plasmids containing T1L gene-segment cDNAs. Vectors contain cDNAs
representing each of the 10 full-length T1L gene segments. Reovirus cDNAs are ﬂanked
by the bacteriophage T7 RNA polymerase promoter (T7P) and the antigenomic
hepatitis delta virus (HDV) ribozyme (Rib). (B) Reverse genetics procedure. The 10 T1L
cDNA constructs are transfected into murine L cells that express T7 RNA polymerase
from recombinant vaccinia virus strain DIs-T7pol. Plasmid-derived transcripts
correspond to viral mRNAs with native 5′ termini. The 3′ termini of nascent transcripts
are fused to HDV ribozyme sequences, which generate authentic 3′ ends through
autocatalytic cleavage. After 5 days of incubation, transfected cells are lysed by freeze–
thaw, and recombinant strain (rs) viruses are isolated from lysates by plaque assay
using L cells.
195T. Kobayashi et al. / Virology 398 (2010) 194–200Progress in these key aspects of the rescue systemwill accelerate basic
studies of reovirus biology and development of reovirus for clinical
applications.
The reovirus reverse genetics system is based on the serotype 3
prototype strain, type 3 Dearing (T3D; Kobayashi et al., 2007), and
consists of 10 plasmids, each containing a full-length reovirus gene-
segment cDNA under transcriptional control of the bacteriophage T7
RNA polymerase promoter and fused at the 3′ terminus with hepatitis
delta virus (HDV) ribozyme sequences. These plasmids are presumed
to generate transcripts identical in sequence to reovirus-generated
(+)-strand RNAs that serve as templates for translation and dsRNA
synthesis in infected cells. The primary round of reovirus replication is
initiated by co-transfection of all 10 plasmids into murine L929 (L)
cells infected with a replication-defective vaccinia virus expressing T7
RNA polymerase. Following 5 days of incubation, recombinant strain
(rs) viruses are isolated from co-transfection lysates by plaque assay
using L cells. The global replication behavior and strain-speciﬁc
phenotypes of rs viruses studied to date are qualitatively and
quantitatively consistent with the natural parental isolates (Danthi
et al., 2008a; Kobayashi et al., 2007, 2009). These results demonstrate
that the reovirus reverse genetics system is a biologically plausible
approach to study viral replication and pathogenesis, optimize viral
oncotropism, and develop reovirus as a live, naturally attenuated
vaccine vector for diverse pathogenic microorganisms.
Reovirus strain type 1 Lang (T1L) serves as the prototype for
serotype 1 reoviruses. Like T3D, T1L infection has been extensively
studied using cultured cells and in vivo. T1L and T3D display
numerous phenotypic differences including receptor usage, activities
of viral replication proteins, regulation of the interferon response to
reovirus infection, apoptosis induction, growth in various types of
primary and transformed cells, virulence, dissemination pathways,
and cell and tissue tropism in newborn mice (Schiff et al., 2007).
Reassortant viruses derived from co-infections of T1L and T3D have
been used to deﬁne the genetic basis of several of these biologic
polymorphisms. Such analyses have provided key insights into viral
replication and disease mechanisms. A marker rescue system for T1L
does not exist. However, the availability of tools to derive infectious
T1L particles starting with plasmid templates would greatly expand
the potential utility of reovirus reverse genetics by permitting any
desired combinatorial exchange of T1L and T3D gene segments and
providing an alternative genetic background to optimize cell targeting
and vectoring capacity.
A reduction in the total number of plasmids necessary to initiate
the reovirus replication cycle would improve certain practical aspects
of the reverse genetics system including effort and costs associated
with reagent preparation. A decreased plasmid requirement also
theoretically carries the possibility of increased co-transfection
efﬁciency resulting in enhanced virus isolation, which is particularly
relevant to recovery of viruses that replicate poorly. Introduction of
changes that handicap reovirus replicative ﬁtness is a productive
approach to the elucidation of structure–function relationships in
viral proteins (Kirchner et al., 2008; Kobayashi et al., 2006, 2009).
Therefore, technical enhancements such as construct consolidation
that potentially lower the efﬁciency barrier to virus replication should
strengthen system performance and broaden its utility.
In this report, we describe the establishment of reverse genetics
for strain T1L and validate performance of this system by isolation of
viable rsT1L and rsT3D single-gene reassortant viruses using plasmid
vectors. We improved the reovirus reverse genetics system by
consolidating viral gene-segment cDNAs into four plasmids. Com-
pared to the 10-plasmid system, this strategy permits more efﬁcient
virus recovery than the 10-plasmid system from L cells using
recombinant vaccinia virus as a source of T7 RNA polymerase. Finally,
we show that both T1L and T3D can be recovered following plasmid
transfection of baby hamster kidney (BHK) cells in which the T7 RNA
polymerase is constitutively expressed. These enhancements toreverse genetics for reovirus represent a signiﬁcant advance for this
technology.
Results
Plasmid-based reverse genetics for reovirus T1L
To generate T1L from cloned cDNAs, plasmids encoding each gene
segment were engineered in similar fashion to T3D cDNAs used for
reverse genetics (Kobayashi et al., 2007; Fig. 1). Each plasmid contains
one full-length gene-segment cDNA placed under control of the
bacteriophage T7 RNA polymerase promoter and appended with the
HDV ribozyme at the 3′terminus. These plasmids are anticipated to
generate full-length (+)-sense RNAs containing native 5′ and 3′ ends
following transcription with T7 RNA polymerase. L cells were infected
with replication-defective T7 RNA polymerase-expressing vaccinia
virus strain rDIs-T7pol 1 h prior to co-transfection with the 10 T1L
cDNA plasmids. Recombinant viruses were recovered from cell-
culture supernatants by plaque assay using L cell monolayers. Thus,
rsT1L can be recovered from plasmid-transfected cells.
Characterization of T1L obtained using reverse genetics
Genomic dsRNA segments of different reovirus strains produce
characteristic electrophoretic patterns when resolved using SDS–
PAGE (Barton et al., 2001). To conﬁrm that rsT1L contains the correct
combination of gene segments, genomic dsRNA isolated from native
T1L and rsT1L virions was electrophoresed in an SDS–polyacrylamide
gel and visualized by ethidium bromide staining (Fig. 2A). The
electropherotype of rsT1L was indistinguishable from that of
native strain T1L. To exclude the possibility that rsT1L represents
Fig. 2. Characterization of T1L viruses derived using reverse genetics. (A) Electro-
pherotypes of native T1L and plasmid-derived rsT1L. Puriﬁed virions were electro-
phoresed in an SDS–polyacrylamide gel, followed by ethidium bromide staining to
visualize viral gene segments. Size classes of gene segments (L, M, S) are indicated.
(B)Novelmutations in the L3 gene of rs viruses. The C→T change at nucleotide 2059 and
G→C change at nucleotide 2062 eliminate a unique PmlI site. (C) Digestion of the L3
gene RT-PCR products of T1L and rsT1Lwith PmlI to conﬁrm the presence or absence of a
unique restriction site. Size markers are indicated. (D) Growth of T1L and rsT1L. L cells
were adsorbed with T1L or rsT1L at an MOI of 2 PFU/cell, and viral titers in cell lysates
were determined by plaque assay at the times shown. Results are presented as mean
viral titers for triplicate experiments. Error bars indicate S.D. (E) Immunoﬂuorescence
analysis of cells infected with T1L and rsT1L. L cells were adsorbed with either T1L or
rsT1L and stained at 24 h post-infection with μNS-speciﬁc antiserum followed by a
ﬂuorophore-conjugated, goat-anti-rabbit secondary antibody to visualize reovirus
inclusions. Representative images of T1L- and rsT1L-infected cells are shown.
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destroyed by the introduction of two silent point mutations into the
L3 rescue plasmid: C to T at nucleotide 2059 and G to C at nucleotide
2062 (Fig. 2B). A 1189-bp fragment of the L3 genewas ampliﬁed using
RT-PCR of viral dsRNA extracted from T1L and rsT1L virions. The L3
gene RT-PCR product derived from T1L was digested with PmlI to
produce 586- and 603-bp fragments, whereas the L3 product derived
from rsT1L was not (Fig. 2C), indicating that rsT1L originated from
plasmids. To ascertain whether rsT1L and native T1L have similar
replication kinetics, yields of rsT1L and T1L were quantiﬁed following
infection of L cells at an MOI of 2 PFU/cell (Fig. 2D). Titers of rsT1L and
T1L were virtually identical at all time points tested.Reoviruses form characteristic cytoplasmic inclusions in infected
cells (Becker et al., 2003; Kobayashi et al., 2009; Miller et al., 2004).
These inclusions are thought to represent sites of viral genome
replication and vary in morphology dependent on the infecting strain.
T1L forms ﬁlamentous inclusions, whereas the inclusions formed by
T3D are globular (Parker et al., 2002). To determine whether rsT1L
inclusions are similar to those produced by T1L, L cells were infected
with each virus, ﬁxed at 24 h post-infection, and imaged using
confocal microscopy (Fig. 2E). Inclusions formed by rsT1L and T1L
were indistinguishable and displayed ﬁlamentous morphology. Taken
together, these data demonstrate comparable replication character-
istics of rsT1L and native T1L.
Generation of an improved reverse genetics system using four
plasmid vectors
To reduce the number of plasmids required for reverse genetics,
two or four T1L gene transcription cassettes encoding reovirus cDNAs
ﬂanked by the T7 RNA polymerase promoter and HDV ribozyme were
combined in a single plasmid (Fig. 3A). Speciﬁcally, L1 and M2 (pT7-
L1-M2T1L), L2 and M3 (pT7-L2-M3T1L), L3 and S3 (pT7-L3-S3T1L),
and S1, S2, S4, and M1 (pT7-M1-S1-S2-S4T1L) transcription cassettes
were jointly introduced into the rescue backbone plasmid using PCR
to generate requisite restriction enzyme recognition sites compatible
with multiplex cloning (Fig. 3A).
To assess rescue efﬁciency of the 4-plasmid system, L cells were
infected with vaccinia virus strain rDIs-T7pol 1 h prior to transfection
with the 4- or 10-plasmid vector set, and viral titers in transfected cell
lysates were determined at 24 and 48 h post-transfection by plaque
assay using L cell monolayers. Viral titers following transfection with
10 plasmids encoding the T1L genomewere 10 and 1000 PFU/ml at 24
and 48 h, respectively. However, viral titers following transfection
with the 4-plasmid T1L cDNA vector set weremarkedly higher at both
24 h (1000 PFU/ml) and 48 h (10,000 PFU/ml) post-transfection
(Fig. 3B). Thus, transfection with four plasmids substantially enhances
rescue efﬁciency.
A 4-plasmid reverse genetics system was also developed for T3D.
Using this strategy, L1 and S1 (pT7-L1-S1T3D), L2 and M3 (pT7-L2-
M3T3D), L3 and M1 (pT7-L3-M1T3D), and M2, S2, S3, and S4 (pT7-
M2-S2-S3-S4T3D) gene cassettes were introduced into individual
plasmids (Fig. 3C). To compare the efﬁciency of the T3D rescue
systems, the T3D 4-plasmid and 10-plasmid vector sets were
independently transfected into rDIs-T7pol-infected L cells, and viral
titers in culture lysates were determined by plaque assay at 24 and 48
h. Viral titers in cultures transfected with 10 plasmids were below the
limit of detection at 24 h and ∼100 PFU/ml at 48 h. In contrast, L cell
cultures transfected with four plasmids produced ∼100 PFU/ml of
virus at 24 h and ∼1000 PFU/ml at 48 h (Fig. 3D). From these data, we
conclude that both T1L and T3D can be recovered using four plasmids
and that a reduction in plasmid number substantially improves rescue
efﬁciency.
Generation of rsT1L×rsT3D monoreassortant viruses
Using a combination of the 4-plasmid and 10-plasmid rescue
systems, we generated a panel of 20 rsT1L×rsT3D monoreassortant
viruses. These viruses contain nine genes from one parental strain and
one gene from the other. Genotypes of recovered viruses were
conﬁrmed using a combination of gene-segment electrophoretic
mobility and sequence analysis (data not shown). The electrophoretic
pattern of a representative monoreassortant, rsT1L-T3M1, which
contains the T3D M1 gene segment in an otherwise T1L background,
clearly shows co-migration of the M1 RNA with that of T3D (Fig. 4).
Conversely, the M1 RNA of the reciprocal reassortant virus, rsT3D-
T1M1, co-migrates with T1L M1. The generation of T1L×T3D
monoreassortant viruses demonstrates the versatility of the reverse
Fig. 3. Improved reverse genetics for reovirus strains T1L and T3D. (A, C) Two or four gene transcription cassettes encoding reovirus cDNAs ﬂanked by the T7 RNA polymerase
promoter and HDV ribozyme sequences were combined into single plasmids, creating four plasmids for the T1L and T3D reverse genetics systems. (B, D) L cells expressing T7
polymerase were co-transfected with either 4 or 10 rescue plasmids corresponding to the T1L (A,B) and T3D (C,D) genomes. Following 24 or 48 h incubation, transfected cells were
lysed by freeze–thaw, and viral titers in cell lysates were determined by plaque assay. Results are presented as mean viral titers for triplicate experiments. Error bars indicate S.D.
197T. Kobayashi et al. / Virology 398 (2010) 194–200genetics system to potentially rescue viruses with any desired genetic
combination, including monoreassortants, which have traditionally
been the most difﬁcult to obtain by co-infection of cells with T1L and
T3D.
Generation of rs viruses using BHK-T7 cells
BHK cells have been engineered to stably express T7 RNA
polymerase (BHK-T7) under control of a cytomegalovirus promoter
(Buchholz et al., 1999). To determine whether these cells allow
recovery of viable reovirus following plasmid transfection, thus
eliminating the requirement for rDIs-T7pol, we transfected BHK-T7
cells with the T1L or T3D 4-plasmid vector sets in the absence of rDIS-
T7pol and determined viral titers in transfected cell lysates by plaque
assay at 48 h post-transfection (Fig. 5). We found that transfection
with either T1L or T3D cDNAs led to substantial viral titers at 48
h post-transfection. From these results, we conclude that BHK-T7 cells
can be used as an alternative to rDIs-T7pol-infected L cells for the
recovery of reovirus using plasmid vectors.
Discussion
The prototype strain for type 1 reovirus, T1L, has been studied
extensively in replication and pathogenesis models. Therefore, a
primary goal of this studywas to generate a reverse genetics system for
T1L. As demonstrated for strain T3D (Boehme et al., 2009; Danthi et al.,
2008a, 2008b; Kirchner et al., 2008; Kobayashi et al., 2007, 2009;
Zurney et al., 2009), development of a reverse genetics system for T1L
affords an opportunity to leverage an extensive knowledge base of
virus structure and biology toward further acceleration of basic and
applied reovirus research. Here, we show production of T1L virions
from cloned cDNAs. Similar to rsT3D and native T3D, the replication
characteristics of rsT1L reﬂect native T1L. Growth kinetics, total yields,
inclusion morphology, and genomic electrophoretic signatures were
indistinguishable between T1L and rsT1L. These results further
validate retention of native viral properties by plasmid-derivedviruses. Moreover, development of the T1L rescue system will expand
the utility of reverse genetics for studies of reovirus biology.
Analysis of a large panel of T1L×T3D reassortant viruses has
shown that reovirus gene segments display nonrandom segregation
upon co-infection of L cells by the parental strains (Nibert et al.,
1996). This observation suggests that there may be interactions
among viral proteins, RNAs, or both that inﬂuence reovirus evolution.
Additionally, compensatory mutations that promote viral replication
efﬁciency may be necessary to stabilize certain genetic combinations
(Roner et al., 1995). Prior to this study, it was unclear whether
generation of all 20 single-gene T1L×T3D reassortant viruses would
be feasible due to uncertainties about the replicative ﬁtness of gene
constellations not previously isolated in T1L×T3D reassortant panels.
Development of a fully plasmid-based rescue system for T1L will
now allow systematic characterization of gene-segment co-evolution
and may facilitate isolation of viruses with replication impediments
or combinations of T1L and T3D genes normally disfavored in mixed
infections (Nibert et al., 1996).
Establishment of reverse genetics for reovirus has allowed
engineering of mutations into structural and nonstructural reovirus
proteins and provided an opportunity to observe the effects of these
mutations on viral replication and pathogenesis in the context of
infection. However, the current system is limited by the inefﬁciency of
transfection of 10 plasmids (Kobayashi et al., 2007). Therefore, a
second goal of this study was to improve viral yields by reducing the
number of plasmids required for virus recovery. This goal was
accomplished by combining two or four transcriptional cassettes in a
single plasmid, reducing the total number of plasmids from 10 to 4.
Compared to theﬁrst-generationmarker rescue system, the 4-plasmid
strategy enhanced efﬁciency of virus recovery by reducing time to
virus isolation and supporting increased total yields. The improved
reverse genetics system also offers the economic advantage of
requiring fewer reagents and less preparation time. Interestingly,
recovery of T1L appears to be more efﬁcient than T3D using either the
4- or 10-plasmid reverse genetics system. While the simplest
explanation is that T1L exhibits an intrinsic replication advantage
Fig. 5. Recombinant virus generated using BHK-T7 cells. (A) Schematic of reovirus
reverse genetics system using BHK-T7 cells. (B) BHK-T7 cells were co-transfected
with four rescue plasmids corresponding to the T1L and T3D genomes. Following
48-h incubation, transfected cells were lysed by freeze–thaw, and viral titers in cell
lysates were determined by plaque assay.
Fig. 4. Representative electropherotype of recombinant monoreassortant viruses.
Puriﬁed virions of rsT1L, rsT3D, and T1L×T3D monoreassortants containing reciprocal
exchanges of the M1 gene, rsT1L-T3M1 and rsT3D-T1M1, were electrophoresed in an
SDS–polyacrylamide gel, followed by ethidium bromide staining to visualize viral gene
segments. Size classes of gene segments (L, M, S) are shown. Positions of the T1L and
T3D M1 genes are indicated by round and diamond symbols, respectively.
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different gene arrangements between the T1L and T3D 4-plasmid
systems contribute to higher yields of T1L. Whether genetic linkage
within the rescue constructs affects virus production is unknown.
The 4-plasmid reverse genetics system reported here could
conceivably enhance efﬁciency of virus recovery by three nonmu-
tually exclusive mechanisms. First, since fewer plasmids are required
to simultaneously enter a cell, the probability is increased that a full
set of viral RNAs will accumulate to a critical threshold for replication
initiation. While plasmids are provided in vast excess, there may be a
limit to the amount of plasmid that can enter a single cell. Second, it is
possible that only a small fraction of transfected plasmids avoid
degradation and remain competent for transcription. By decreasing
the number of plasmids from 10 to 4, the likelihood that a single cell
will contain a sufﬁcient number of intact transcription cassettes is
enhanced. Third, it is possible that constraining transcription and
translation of individual viral RNAs to the same intracellular
microenvironment, as might be anticipated for multicistronic vectors,
facilitates essential protein–protein or protein–RNA interactions
required for virus recovery.
Technical complexities associated with manipulation of multi-
cistronic vectors may limit their use for certain applications.
Therefore, the 10-plasmid system remains a useful alterative for
demanding cloning tasks. Tetracistronic vectors can be reduced to
tricistronic constructs by simple endonucleolytic excision of a gene-
segment cDNA and then complemented by co-transfection with the
corresponding single-gene vector containing the desired mutations.We have found that the 4- and 10-plasmid vector systems are fully
compatible for virus rescue. Hence, the monocistronic vectors remain
important adjuncts to the 4-plasmid strategy by combining enhanced
ﬂexibility with gains in efﬁciency.
In our effort to improve reovirus reverse genetics, we found that
BHK-T7 cells, which constitutively express T7 RNA polymerase
(Buchholz et al., 1999), allow recovery of both rsT1L and rsT3D. The
capacity of BHK-T7 cells to support virus rescue obviates the
requirement for rDIs-T7pol and thereby greatly simpliﬁes the rescue
protocol. BHK-T7 cells are easier to maintain and propagate than rDIs-
T7pol and thus provide an additional improvement to the reovirus
rescue system.
Our progress with reovirus reverse genetics in many respects
parallels the evolution of reverse genetics technology for inﬂuenza
virus, which has also been modiﬁed to improve efﬁciency. Early
reverse genetics systems for inﬂuenza virus required co-transfection
of 12–16 plasmids encoding viral mRNAs or proteins (Neumann et al.,
1999). Subsequently, the number of required plasmids was reduced
to 8; each containing a viral gene ﬂanked by both pol I and pol II
promoters that drive viral genomic and messenger RNA expression,
from the same cDNA (Hoffmann et al., 2000). As these systems were
practical only in cell types supporting high transfection efﬁciencies,
further improvements were achieved by combining eight RNA pol I
transcription cassettes for viral RNA synthesis into a single plasmid
and condensing three of the four protein expression cassettes onto
one plasmid. The resulting 3-plasmid system increases efﬁciency of
virus production in Vero cells, which are amenable to propagation of
inﬂuenza vaccines for use in humans (Neumann et al., 2005). Hence,
reverse genetics of viruses containing segmented genomes appears to
be inherently inefﬁcient, but this problem is surmountable through
plasmid reduction.
We have established an improved reverse genetics system of
reovirus that allows recovery of prototype strain T1L from plasmid
vectors and reduces the number of plasmids for both the T1L and T3D
systems. These enhancements have increased the ﬂexibility and
efﬁciency of reverse genetics for basic studies of reovirus biology and
will accelerate development of reovirus for clinical and technological
purposes.
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Cells and viruses
L cells were grown in Joklik's modiﬁed Eagle's minimal essential
medium (Irvine Scientiﬁc) supplemented to contain 5% fetal calf
serum (Gibco), 2 mM L-glutamine, 100 U of penicillin G/ml, 100 μg of
streptomycin/ml, and 0.25 μg amphotericin B/ml (Gibco). BHK-T7
cells were grown in Dulbecco's modiﬁed Eagle's minimal essential
medium (Invitrogen) supplemented to contain 5% fetal calf serum, 2
mM L-glutamine, 2% MEM amino acid solution (Invitrogen), and 1
mg/ml geneticin (Invitrogen). Reovirus strains T1L and T3D are
laboratory stocks originally obtained from the laboratory of Dr.
Bernard Fields. Strain rsT3D was produced by reverse genetics
(Kobayashi et al., 2007). Virus was puriﬁed from L cells by CsCl-
gradient centrifugation (Furlong et al., 1988). Viral titers were
determined by plaque assay using L cell monolayers as described
(Virgin et al., 1988). Attenuated vaccinia virus strain rDIs-T7pol
expressing T7 RNA polymerase (Ishii et al., 2002) was propagated in
chicken embryo ﬁbroblasts.
Plasmid construction
T1L plasmid cDNAs for rescue of recombinant infectious reovirus
were constructed using RT-PCR, viral genomic RNA, and gene-speciﬁc
primer sets (Table 1). RT-PCR products were cloned into the SmaI–
RsrII (L1, L2, and S3), SmaI–BseRI (S2), EcoRV–RsrII (M3), or EcoRV–
BseRI (S4) sites of p3E5EGFP (Watanabe et al., 2004), resulting in pT7-
L1T1L, pT7-L2T1L, pT7-M3T1L, pT7-S2T1L, pT7-S3T1L, and pT7-S4T1L.
The T1L L3 gene cDNA, ampliﬁed from viral genomic RNAwith speciﬁc
primers (Table 1), was inserted into the EcoRI–RsrII site of pT7-L3T3D
(Kobayashi et al., 2007), thereby replacing the T3D L3 cDNA and
generating pT7-L3T1L. pT7-M2T1L was constructed by insertion into
the p3E5EGFP RsrII site of RT-PCR ampliﬁcation products generated
with viral genomic RNA and speciﬁc primers (Table 1). The resulting
construct containing the cloned T1L M2 gene was digested with SmaI
and AvrII, followed by self-ligation to remove GFP-encoding
sequences and the Ebola virus leader and trailer sequences. pT7-
M1T1L and pBacT7-S1T1L, encoding T1L M1 and S1 genes, respec-
tively, were described previously (Kobayashi et al., 2007, 2009).
Recombinant reovirus generation from four plasmids was facili-
tated by combining two or four viral gene transcription cassettes
encoding T1L and T3D reovirus cDNAs ﬂanked by the T7 RNA
polymerase promoter (5′) and HDV ribozyme (3′) onto one plasmid.
Bicistronic reovirus cDNA constructs pT7-L1-M2T1L (T1L L1 and M2),
pT7-L2-M3T1L (T1L L2 and M3), pT7-L3-S3T1L (T1L L3 and S3), pT7-
L1-S1T3D (T3D L1 and S1), pT7-L2-M3T3D (T3D L2 andM3), and pT7-Table 1
Oligodeoxynucleotide primers used for plasmid construction.
Plasmid DNA Nucleotide sequencea
pT7-L1T1L Forward 5'-TAACCC
Reverse 5'-GGTCG
pT7-L2T1L Forward 5'-TAACCC
Reverse 5'-GGTCG
pT7-L3T1L Forward 5'-TAAGA
Reverse 5'-GGTCG
pT7-M2T1L Forward 5'-CCTCGC
Reverse 5'-GGTCG
pT7-M3T1L Forward 5'-TAAGA
Reverse 5'-GGTCG
pT7-S2T1L Forward 5'-TAACCC
Reverse 5'-ACCGC
pT7-S3T1L Forward 5'-TAACCC
Reverse 5'-GGTCG
pT7-S4T1L Forward 5'-TAAGA
Reverse 5'-CGCGA
a The T7 RNA polymerase promoter sequence is underlined.L3-M1 (T3D L3 and M1) were generated by cloning PCR-ampliﬁed
T1L M2, T1L M3, T1L S3, T3D S1, T3D M3, and T3D M1 gene
transcription cassettes into the SphI site of pT7-L1T1L, NheI site of
pT7-L2T1L, HindIII site of pT7-L3T1L, HindIII site of pT7-L1T3D, NheI
site of pT7-L2T3D, and HindIII site of pT7-L3T3D, respectively.
Tetracistronic reovirus cDNA constructs, pT7-M1-S1-S2-S4T1L (T1L
S1, S2, S4, and M1) and pT7-M2-S2-S3-S4T3D (T3D S2, S3, S4, and
M2), were generated by cloning PCR-ampliﬁed T1L S3, T1L S4, T1L
M1, T3D S3, T3D S4, and T3D M2 gene transcription cassettes into
the XbaI (T1L S1), SalI (T1L S4), or NheI (T1L M1) sites of pT7-S2T1L
or SalI–HindIII (T3D S3), HindIII–NheI (T3D S4), or NheI (T3D M2)
sites of pT7-S2T3D.
Plasmid transfection and recovery of recombinant virus using L cells
Monolayers of L cells at 90% conﬂuency (approximately 3×106
cells) seeded in 60-mm dishes (Costar) were infected with rDIs-T7pol
at an MOI of approximately 0.5 TCID50. At 1 h post-infection, cells
were co-transfected with plasmids representing the cloned reovirus
genome using 3 μl of TransIT-LT1 transfection reagent (Mirus) per
microgram of plasmid DNA. The amount of each plasmid used for
transfection was given as follows: pT7-L1T1L, 2 μg; pT7-L2T1L, 2 μg;
pT7-L3T1L, 2 μg; pT7-M1T1L, 1.75 μg; pT7-M2T1L, 1.75 μg; pT7-
M3T1L, 1.75 μg; pBacT7-S1T1L, 2 μg; pT7-S2T1L, 1.5 μg; pT7-S3T1L, 1.5
μg; pT7-S4T1L, 1.5 μg; pT7-L1-M2T1L, 4.5 μg; pT7-L2-M3T1L, 4.5 μg;
pT7-L3-M3T1L, 4.5 μg; pT7-M1-S1-S2-S4T1L, 4.5 μg; pT7-L1-S1T3D,
4.5 μg; pT7-L2-M3T3D, 4.5 μg; pT7-L3-M1T3D, 4.5 μg; and pT7-M2-
S2-S3-S4T3D, 4.5 μg. Quantities of T3D monocistronic plasmid were
used as previously described (Kobayashi et al., 2007). Following 1–5
days of incubation, recombinant virus was isolated from transfected
cells by plaque puriﬁcation using L cells (Virgin et al., 1988).
SDS–PAGE analysis of viral gene segments
Puriﬁed virions (5×1010 particles) were loaded into wells of 10%
SDS–polyacrylamide gels. Gels were electrophoresed for approxi-
mately 600 m Amp-h. Gene segments were visualized by ethidium
bromide staining.
Quantiﬁcation of virus infectivity
Monolayers of L cells (5×105 cells) seeded in 24-well plates
(Costar) were adsorbed with virus at an MOI of 2 PFU/cell. After 1
h adsorption at room temperature, the inoculum was removed, cells
were washed with PBS, and fresh medium was added. Cells were
incubated at 37 °C for various intervals, and viral titers in cell lysates
were determined by plaque assay using L cells (Virgin et al., 1988).GGGTAATACGACTCACTATAGCTACACGTTCCACGACAATGTCATCCA-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAGTTGACGCACCACGACCCAT-3'
GGGTAATACGACTCACTATAGCTATTGGCGCAATGGCGAACGTTTGGG-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAATTAGGCACGCTCACGAGGG-3'
ATTCTAATACGACTCACTATAGCTAATCGTCAGGATGAAGCGGATTCCA-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAATCGGCCCAACTAGCATCGA-3'
GGTCCGACCTGGGGTTAATACGACTCACTATAGCTAATCTGCTGACCGTCACTCT-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGATGTGCCTGCACCCTTAACC-3'
TATCTAATACGACTCACTATAGCTAAAGTGACCGTGGTCATGGCTTCAT-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAATAGGGGTCGGGAAGGCTTA-3'
GGGTAATACGACTCACTATAGCTATTCGCTGGTCAGTTATGGCT-3'
GAGGAGGTGGAGATGCCATGCCGACCCGATGAATGTGTGGTCAGTCGTGAGGGGTGTG-3'
GGGTAATACGACTCACTATAGCTAAAGTCACGCCTGTTGTCGTCAC-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGATTAGGCGCCACCCACCACC-3'
TATCTAATACGACTCACTATAGCTATTTTTGCCTCTTCCCAAACG-3'
GGAGGTGGAGATGCCATGCCGACCCGATGAATGGAGCCTGTCCCACGTC-3'
200 T. Kobayashi et al. / Virology 398 (2010) 194–200Immunoﬂuorescence detection of reovirus infection
L cells were plated on glass coverslips in 24-well plates (Costar)
and adsorbed at an MOI of 2 PFU/cell. Following incubation at 37 °C
for 24 h, cells were ﬁxed and stained with rabbit μNS antiserum
followed by ﬂuorophore-conjugated, goat anti-rabbit secondary
antibody (Invitrogen). Images were acquired using a Zeiss LSM 510
META inverted confocal system (Carl Zeiss) with a Zeiss inverted
Axiovert 200M microscope.
Plasmid transfection and recovery of recombinant virus using BHK-T7
cells
Monolayers of BHK-T7 cells at 90% conﬂuency (approximately
3×106 cells) seeded in 60-mm dishes were co-transfected with
plasmids representing the cloned reovirus genome using 3 μl of
TransIT-LT1 transfection reagent (Mirus) per microgram of plasmid
DNA. The amount of each plasmid used for transfection was identical
to that described for L cell transfection. Following 1–5 days of
incubation, recombinant virus was isolated from transfected cells by
plaque puriﬁcation using monolayers of L cells (Virgin et al., 1988).
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Mammalian reoviruses replicate in a broad range of hosts,
cells, and tissues. These viruses display strain-dependent vari-
ation in tropism for different types of cells in vivo and ex vivo.
Early steps in the reovirus life cycle, attachment, entry, and
disassembly, have been identified as pivotal points of virus-cell
interaction that determine the fate of infection, either produc-
tive or abortive. However, in studies of the differential capacity
of reovirus strains type 1 Lang and type 3 Dearing to replicate
in Madin-Darby canine kidney (MDCK) cells, we found that
replication efficiency is regulated at a late point in the viral life
cycle following primary transcription and translation. Results
of genetic studies using recombinant virus strains show that
reovirus tropism for MDCK cells is primarily regulated by rep-
lication protein 2 and further influenced by the viral RNA-
dependent RNA polymerase protein, 3, depending on the
viral genetic background. Furthermore, 2 residue 347 is a
critical determinant of replication efficiency in MDCK cells.
These findings indicate that components of the reovirus repli-
cation complex are mediators of cell-selective viral replication
capacity at a post-entry step. Thus, reovirus cell tropism may
be determined at early and late points in the viral replication
program.
Viral tropism, defined by the range of hosts and tissues pro-
ductively infected, creates natural biologic groupings among
viruses that correlate with infection pathology, clinical disease
expression, and epidemiology. Delineating the molecular basis
of viral cell tropism is fundamental to the elucidation of dis-
ease mechanisms and the identification of viral and cellular
targets for treatment and prevention of infection. Growing
threats posed by zoonotic viral diseases with global pandemic
potential (1) underscore the necessity for an enhanced under-
standing of unifying principles that influence viral tropism
and host range. We are conducting studies using mammalian
reoviruses to better understand the nature of virus-cell inter-
actions that dictate unique tropism properties.
Mammalian orthoreoviruses (hereafter referred to as reovi-
ruses) are an established model for studies of viral replication
and pathogenesis (2–6). Reoviruses have contributed to the
development of paradigms of viral disease based on discrete
patterns of viral tropism for particular host cells and tissues.
The reovirus virion is a nonenveloped, double layered, icosa-
hedral particle consisting of an outer shell surrounding an
inner core that contains 10 double-stranded (ds) RNA gene
segments. The viral genome encodes eight structural and
three nonstructural proteins. Viral RNA gene segments can
be resolved into small, medium, and large size classes by SDS-
PAGE, corresponding to , , and  proteins, respectively.
Four reovirus serotypes have been identified based on neu-
tralization and hemagglutination studies (7–9). Strains type 1
Lang (T1) 3 and type 3 Dearing (T3) serve as prototypes for
serotype 1 and 3 reoviruses, respectively. T1 and T3 display
numerous phenotypic differences, and the genetic basis of
several biologic polymorphisms has been defined using reas-
sortant viruses derived from co-infections of T1 and T3 (6).
Such analyses have provided key insights into the mechanisms
of viral replication and disease.
The reovirus replication program (reviewed in Ref. 6) be-
gins with attachment using proteinaceous or carbohydrate
receptors followed by entry into host cells by receptor-medi-
ated endocytosis. Proteolytic disassembly of the outer capsid
within endosomes facilitates membrane penetration, leading
to release of transcriptionally active cores into the cytoplasm.
Full-length, positive-strand, capped, and nonpolyadenylated
RNAs synthesized by core particles serve as templates for
translation and synthesis of new genomic dsRNA. Secondary
viral mRNAs transcribed from new dsRNA templates fuel
subsequent rounds of protein synthesis. The source of these
late transcripts is presumed to be subviral particles. Virion
assembly is completed by the addition of outer capsid pro-
teins to core particles. Reovirus replication and assembly are
thought to occur within viral intracytoplasmic inclusions (10),
which strictly depend on nonstructural proteins NS and
NS and structural protein 2 for proper formation and
function in reovirus-infected cells (11, 12). Inclusions are de-
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tectable within 4 h post-infection, lack a delimiting mem-
brane, contain viral proteins, dsRNA and virion particles at
various stages of morphogenesis, and are composed of highly
ordered arrays of mature virions at late times of infection
(13–19).
The 83-kDa 2 protein, encoded by the M1 gene segment,
is essential for viral replication (20). The 2 protein functions
in viral transcription (21, 22) and virion particle assembly
(22). As an integral component of viral inclusions, 2 deter-
mines kinetics of inclusion formation (23) and inclusion mor-
phology (24). Fluorescence microscopy performed on a vari-
ety of cell types has shown that T1 and T3 form filamentous
and globular inclusions, respectively (11, 20, 23, 24), which is
explained by a differential capacity of T1 and T3 2 proteins
to bind microtubules and anchor inclusions to the cytoskele-
ton (24).
The 2 protein is a component of the reovirus core, which
contains20 molecules of 2 per virion particle (6, 25, 26).
Although the precise position of 2 is unknown, several lines
of evidence from biochemical, structural, and genetic studies
indicate that 2 resides at the vertex base in close approxima-
tion to 3, the viral RNA-dependent RNA polymerase (RdRp)
(22, 27–31). Single-stranded RNA and dsRNA (32) are bound
by 2, which possesses nucleotide triphosphatase and RNA
triphosphatase activities enhanced by the presence of 3 (27,
28). Two regions of 2 sequence bare similarity to the nucle-
otide-binding motifs of ATPases and are essential for triphos-
phatase action (27). Strain-specific differences in transcrip-
tional efficiency of core particles are determined by 2 (21),
and reovirus strains containing temperature-sensitive lesions
in 2 protein display defects in replication and particle as-
sembly at restrictive temperatures (22). Thus, 2 is a probable
subunit of the functional reovirus polymerase complex.
In addition to its central place in viral replication, 2 also
regulates reovirus cell tropism and virulence. Strain-depen-
dent viral replication efficiency has been genetically linked to
2 in studies using primary and transformed cells, including
murine cardiac cells (33–36), bovine aortic endothelial cells
(37), and Madin-Darby canine kidney (MDCK) cells (38). The
capacity of reovirus to cause myocarditis in neonatal mice is
regulated by 2 and tied to the innate antiviral response. Reo-
virus induction of and sensitivity to type 1 interferon (IFN) in
cardiac myocytes is coupled through 2 to viral replication
efficiency, organ pathology, and survival (34–36). The 2
protein of myocarditic strains such as T1 antagonizes the IFN
response by mediating nuclear sequestration of interferon
regulatory factor-9 (39).
A previous study using T1  T3 reassortant viruses
showed that the M1 and 3-encoding L1 genes segregate
with differences in the replication efficiency of T1 and T3
in MDCK cells (38). This dichotomy presents a useful ex-
perimental platform to rigorously address the individual
and cooperative roles of 2 and 3 in reovirus cell tropism
and identify 2-sensitive steps in the viral life cycle. There-
fore, we conducted studies to genetically and biochemically
characterize strain-specific differences in reovirus replication
efficiency in MDCK cells. Our findings indicate the 2 pro-
tein is the primary determinant of viral replication efficiency
in these cells and that 3 is a conditional co-regulator of 2
function depending on the viral genetic background. Further-
more, the critical 2-dependent step in MDCK cells occurs at
a later point in the reovirus replication program subsequent
to primary rounds of viral transcription and translation.
These results enhance our understanding of the viral replica-
tion apparatus and the viral and cellular requirements crucial
for its activity.
EXPERIMENTAL PROCEDURES
Cells and Viruses—L cells were grown in Joklik’s modified
Eagle’s minimal essential medium (Lonza, Walkersville, MD)
supplemented to contain 5% fetal calf serum (Cellgro, Manas-
sas, VA), 2 mM L-glutamine (Invitrogen), 100 units of penicil-
lin G/ml (Invitrogen), 100 g of streptomycin/ml (Invitro-
gen), and 0.25 g of amphotericin B/ml (Sigma). MDCK cells
were grown in DMEM supplemented to contain 4.5 g/liter
sodium pyruvate (Cellgro), 10% fetal calf serum, 2 mM L-gluta-
mine, 100 units of penicillin G/ml, 100 g of streptomycin/
ml, and 0.25 g of amphotericin B/ml. BHK-T7 cells were
grown in DMEM (Invitrogen) supplemented to contain 5%
fetal calf serum, 2 mM L-glutamine, 2% minimal essential me-
dium amino acid solution (Invitrogen), and 1 mg/ml geneticin
(Invitrogen). Strains T1, T3, T1-T3M1, T3-T1M1, and all
other reassortant strains used in this study were recovered by
reverse genetics as described previously (40, 41). Virus was
purified from L cells by CsCl gradient centrifugation (42). Vi-
ral titers were determined by plaque assay using L cell mono-
layers as described previously (43). Attenuated vaccinia virus
strain rDIs-T7pol expressing T7 RNA polymerase (44) was
propagated in chicken embryo fibroblasts (40).
Construction of Mutant Viruses—T1 T3 M1 chimeric
cDNAs were generated by inserting the EcoRV-RsrII (Ch1),
MfeI-RsrII (Ch2), PsiI-RsrII (Ch3), and NdeI-RsrII (Ch4) frag-
ments of pT7-M1T1L (41) into the pT7-M1T3D vector (40).
M1 point mutants were generated using PCR with mutagenic
primers and the pT7-M1T1L and pT7-M1T3D plasmids.
Vectors containing mutant M1 genes were substituted for
WTM1 to recover recombinant viruses using reverse genet-
ics. Plasmid sequences were determined to confirm fidelity of
mutagenesis and cloning.
Quantification of Virus Infectivity—Monolayers of L cells or
MDCK cells (5 105 cells) seeded in 24-well plates (Costar,
Corning, NY) were adsorbed with virus at an m.o.i. of 2 pfu/
cell. After 1 h of adsorption at room temperature, the viral
inoculum was removed, cells were washed with PBS, and fresh
medium was added. Cells were incubated at 37 °C for various
intervals and removed to80 °C. Viral titers in cell lysates
were determined by plaque assay using L cells (43). Viral yield
was calculated as the difference between log10 titer at 24 h
and log10 titer at 0 h. Negative differences were assigned a
value of zero. For the purpose of calculating fold differences
in viral yields, non-log transformed data were used, and a
yield of less than 1 was considered to be 1.
Immunofluorescence Detection of Reovirus Infection—L cells
plated on untreated glass coverslips and MDCK cells plated
on poly-L-lysine (Sigma)-treated glass coverslips in 24-well
plates were adsorbed with virus at an m.o.i. of 20 pfu/cell. Fol-
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lowing incubation at 37 °C for various intervals, cells were
fixed and stained with rabbit 2-specific (45) and guinea pig
NS-specific (46) antisera followed by Alexa 546-conjugated
goat anti-rabbit secondary antibody (Invitrogen), Alexa 488-
conjugated goat anti-guinea pig secondary antibody (Invitro-
gen), and ToPro3 (Invitrogen). Images were acquired using a
Zeiss LSM 510 META inverted confocal microscope.
Analysis of Viral RNA Production Using Reverse Tran-
scription-Quantitative PCR—Monolayers of L cells or
MDCK cells (5  105 cells) seeded in 24-well plates were
adsorbed with virus at an m.o.i. of 10 pfu/cell. After 1 h of
adsorption at room temperature, the viral inoculum was
removed; cells were washed with PBS, and fresh medium
was added. Following incubation at 37 °C for various inter-
vals, cultures were frozen at 80 °C, and total RNA was
extracted from 140 l of thawed lysate using the RNeasy mini
kit (Qiagen, Valencia, CA). RNA was incubated at 95 °C for 3
min and immediately placed on ice. Reovirus S4 RNA in 10 l
of RNA extract was quantified using the SuperScript III Plati-
num One-Step qRT-PCR system (Invitrogen). PCRs were pre-
pared according to the manufacturer’s specifications with
minor modifications. The S4-specific fluorogenic probe used
was 5-dFAM-AGCGCGCAAGAGGGATGGGA-BHQ-1–3
(Biosearch Technologies, Novato, CA). Either forward (S4
83F, 5-CGCTTTTGAAGGTCGTGTATCA-3) or reverse
(S4 153R, 5-CTGGCTGTGCTGAGATTGTTTT-3) primer
corresponding to the viral S4 gene was used for reverse tran-
scription performed at 50 °C for 15 min. Following 3 min of
incubation at 95 °C, the second primer was added, and 40
cycles of quantitative PCR were performed at 95 °C for 15 s
followed by 60 °C for 30 s. Total S4 RNA (combined dsRNA
and mRNA) was quantified using the S4-specific reverse
primer (complementary to the positive strand) in the reverse
transcription step, and double-stranded S4 RNA was quanti-
fied using the S4-specific forward primer (complementary to
the negative strand) in the reverse transcription step. Inclu-
sion of only the reverse or forward primer in the reverse tran-
scription step resulted in specific detection of the positive or
negative strand of S4 RNA, respectively. Total S4 RNA is rep-
resented by the amount of positive-sense template, whereas
dsRNA is equivalent to the amount of negative-sense tem-
plate. S4 mRNA was calculated by subtracting the amount of
dsRNA from total RNA. Standard curves relating Ct values to
copies of positive- or negative-sense RNA template were gen-
erated using 10-fold dilutions of viral RNA extracted from
purified virion particles (QIAamp viral RNA purification kit,
Qiagen) and quantified by spectrophotometry. The amount of
total and dsRNA in each sample was then extrapolated from
standard curves generated with the reverse and forward prim-
ers, respectively. Standard curves generated using forward
and reverse primers in the reverse transcription step were
consistently similar, reflecting comparable amplification effi-
ciencies of S4 RNA positive- and negative-sense strands.
Analysis of Viral Protein Synthesis—Monolayers of L cells
or MDCK cells (5 105 cells) seeded in 24-well plates were
adsorbed with virus at an m.o.i. of 100 pfu/cell. After 1 h at
room temperature, the inoculum was removed; fresh medium
was added, and cells were incubated at 37 °C for various inter-
vals. Cells were incubated with 50 mCi of [35S]methionine-
cysteine (PerkinElmer Life Sciences) in methionine-free me-
dium (MP Biomedicals, Solon, OH) for 1 h prior to harvest;
the medium was removed, and 50 l of lysis buffer (0.1 M
NaCl, 1 mM EDTA, 10 mM Tris (pH 7.4), and 0.5% IGEPAL)
was added. Cell lysates were centrifuged at 14,000 g at 4 °C
for 15 min, and 20 l of the resultant supernatant was mixed
with an equal volume of Laemmli sample buffer (Bio-Rad).
Samples were incubated at 95 °C for 5 min and electrophore-
sed in a 10% SDS-polyacrylamide gel, which was dried onto
filter paper and exposed to film (BioMaz MR film, Eastman
Kodak Co.).
RESULTS
Reovirus Strain-specific Replication in MDCK Cells—Previ-
ous studies revealed a strain-specific capacity of reovirus T1
and T3 to replicate in MDCK cells (38). Using classic reassor-
tant analysis, this phenotype was genetically mapped to the
3-encoding L1 and 2-encoding M1 gene segments. To con-
firm that recombinant viruses recovered using reverse genet-
ics (40, 41) recapitulate growth characteristics of native T1
and T3 in MDCK cells, recombinant strain T1 and recombi-
nant strain T3 were used to infect MDCK cells at an m.o.i. of
2 pfu/cell, and viral titers in cell lysates were monitored over
the course of infection. Consistent with previous findings,
strain T1 achieved an100-fold increase in viral titer over
48 h of growth (Fig. 1A). Conversely, strain T3 exhibited a
minimal increase in titer during the course of infection. In
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FIGURE 1. Growth of reovirus in cultured cells.MDCK cells (A) or L cells (B) were infected at an m.o.i. of 2 pfu/cell, and viral titers in cell lysates were deter-
mined at the time points shown by plaque assay using L cell monolayers. Results represent the mean of triplicate experiments. Error bars indicate S.D.
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contrast to growth in MDCK cells, both strains replicated
with similar kinetics and produced equivalently high titers in
L cells (Fig. 1B). These results demonstrate that differences in
tropism for MDCK cells displayed by the native viruses are
recapitulated by the recombinant strains.
Genetic Analysis of Reovirus Replication in MDCK Cells—
To more fully understand the contributions of individual reo-
virus genes to viral replication efficiency in MDCK cells, we
generated monoreassortant viruses (containing nine gene seg-
ments from one strain, denoted first in the virus name, and
one gene derived from a different strain, indicated second in
the virus name) and assessed production of infectious prog-
eny virions. L1, M1, and S1 monoreassortant viruses were
generated in both T1 and T3 genetic backgrounds. L1 and M1
were reassorted because these genes were previously identi-
fied as determinants of reovirus tropism for MDCK cells (38).
Monoreassortant viruses encoding reciprocal exchanges of
the S1 gene, encoding viral attachment protein 1 and non-
structural protein 1s, were tested for growth in MDCK cells
because receptor engagement is responsible for differences in
the infectivity of type 1 and type 3 reoviruses for a variety of
cells and tissues (6, 47–50). Parental and monoreassortant
viruses were used to infect MDCK cells at an m.o.i. of 2 pfu/
cell, followed by quantification of viral yields after 24 h of
growth. Consistent with the earlier mapping study (38), the
T1 M1 gene was sufficient to support growth of T3 to the
level of T1, whereas the S1 gene was not associated with
strain-specific differences in viral yield (Fig. 2). However, con-
trary to previous findings (38), an independent association of
the L1 gene with viral replication was not observed using L1
monoreassortant viruses; T1-T3L1 and T3-T1L1 displayed
high and low yields, respectively, mimicking their parental
strains. Furthermore, the effect of M1 on viral replication was
unidirectional; the T3 M1 gene segment alone did not dimin-
ish T1 yield. These results indicate that the 2 protein regu-
lates reovirus replication efficiency in MDCK cells, but the
effects of 2 on replication are subject to modulation by other
viral determinants. We assessed potential cooperativity be-
tween the L1 and M1 genes in viral yield experiments using
L1/M1 double reassortant viruses in the T1 (T1-T3L1M1)
and T3 (T3-T1L1M1) backgrounds. Pairing T3 L1 and T3 M1
genes in the T1 background significantly reduced T1 viral
yield in MDCK cells at 24 h post-infection (Fig. 3A). In con-
trast, growth of T3-T1M1 was unaffected by the strain origin
of the L1 gene.
Yields of M1 monoreassortant and L1/M1 double-reassor-
tant viruses were also determined using L cells to control for
potential constitutive effects of the T1 and T3 L1 and M1
genes on viral replication. In these experiments, all strains
produced high yields in L cells (Fig. 3B). Reassortant strain
T1-T3L1M1 grew less efficiently in L cells compared with the
T1 parental strain. However, the reduction in viral yield was
10-fold compared with a 100-fold difference in MDCK cells.
The yield of T3-T1L1M1 exceeded that of T3 by3-fold, but
this difference was modest compared with the 70-fold in-
crease in MDCK cells. Taken together, results of experiments
using M1 and L1 reassortant viruses indicate that 2 is a key
determinant of reovirus tropism for MDCK cells and, addi-
tionally, provide evidence for co-regulation of viral replication
by polymerase protein 3, conditioned on the viral genetic
background.
Identification of Sequences in 2 That Mediate Reovirus
Tropism for MDCK Cells—To identify 2 sequence features
of reovirus replication efficiency in MDCK cells, we generated
a panel of T1 T3 2-chimeric viruses in the T3 genetic
FIGURE 2. Growth of monoreassortant viruses in MDCK cells. Cells were
infected with L1, M1, or S1 monoreassortant viruses at an m.o.i. of 2 pfu/cell,
and viral yields (relative to 0 h) at 24 h post-infection were determined by
plaque assay using L cell monolayers. Results represent the mean of tripli-
cate experiments. Error bars indicate S.D. *, p 0.05 in comparison with
strain T1 (Student’s t test).
FIGURE 3. Yields of L1/M1 reassortant viruses in cultured cells.MDCK
cells (A) or L cells (B) were infected at an m.o.i. of 2 pfu/cell, and viral yields
(relative to 0 h) were determined at 24 h post-infection by plaque assay us-
ing L cell monolayers. Results represent the mean of triplicate experiments.
Error bars indicate S.D. *, p 0.05 in comparison with strain T1 (Student’s t
test).
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background (Fig. 4A). Chimera 1 and chimera 2, containing
T3 2-derived sequences 1–126 and 1–208, respectively, pro-
duced high viral yields similar to T1, whereas chimera 3 and
chimera 4, containing T3 2-derived sequences 1–389 and
1–600, respectively, produced low yields similar to T3 (Fig.
4B). Relative replication efficiencies of the four chimeric vi-
ruses suggest that 2 sequences regulating reovirus replica-
tion in MDCK cells are bounded by amino acid residues 209
and 389.
Three sequence polymorphisms with respect to T1 and T3
(300, 342, and 347) are present within the 2 region that con-
trols viral growth efficiency in MDCK cells (Fig. 4C). The rela-
tive contribution of these amino acids to viral growth was
assessed by reciprocal exchanges between the 2 proteins of
T1 and T3 using reverse genetics. Moderately increased yields
(4-fold) resulted from replacement of T3 2 amino acids
with the corresponding T1 2 residues at positions 300 and
342. In contrast, substitution of Leu-347 in T3 2 with Phe
(T3-M1L347F), which is found at this position in T1 2, en-
abled T3 to grow equivalently to T1 (100-fold yield). The
yield of T1-M1F347L, isogenic to T1 except for Leu at 2
amino acid position 347, approximated that of T1 (Fig. 5A).
Yields of 2 point-mutant viruses T1-M1Q342R and T1-
M1F347L, which contain T3 residues at 2 amino acid posi-
tions 342 and 347, were modestly reduced in L cells, relative
to parental strain T1 (Fig. 5C). However, the other 2 point-
mutant strains and the parental viruses all exhibited equiva-
lently high yields in L cells, and no influence of the L1 gene
was detected (Fig. 5, C and D). Therefore, constitutive replica-
tion defects are unlikely to account for disparities in yields of
2-mutant viruses when propagated in MDCK cells.
Consistent with the cooperative relationship of WT 3 and
2 proteins in viral growth (Fig. 3), we observed a functional
interaction between 3 and mutant 2 governed by the spe-
cific viral genetic environment; yield of T1-M1F347L in
MDCK cells was reduced relative to WT parental strain T1
when the mutant 2 protein was accompanied by the T3
(strain T1-T3L1-M1F347L), but not T1 (strain T1-M1F347L),
3 protein (Fig. 5, A and B).
Interestingly, the T1 3 protein acted synergistically with
the 2 L347F mutation to moderately suppress (13-fold
reduction in yield) the growth of T3 (T3-T1L1-M1L347F) in
MDCK cells (Fig. 5B), which further substantiates the func-
tional linkage of 3 and 2 in reovirus tropism for these cells.
These results indicate that a sequence polymorphism at
amino acid position 347 is the primary determinant of 2-
mediated reovirus replication efficiency in MDCK cells. Fur-
thermore, the 3 protein acts as a modifier of tropic pheno-
types manifested by sequence variation at this position in 2.
Viral Inclusion Formation in Reovirus-infected Cells—As an
initial approach to delineating the 2-sensitive step in viral
replication in MDCK cells, we imaged viral inclusions over a
time course of infection using confocal immunofluorescence
microscopy. Cells were infected with T1 or T3, fixed at vari-
ous intervals, and stained with anti-2 and anti-NS antisera.
In both T1- and T3-infected MDCK cells, inclusions initially
appeared as small, punctate structures that gradually enlarged
and assumed strain-dependent filamentous and globular fea-
tures characteristic of T1 and T3, respectively, in L cells (Fig.
6) (23, 24). However, T1 inclusions in MDCK cells also dis-
played globular structures intermingled with filamentous
forms, resulting in a more intermediate phenotype. Although
the progress of inclusion formation for both T1 and T3 was
slightly delayed in MDCK cells in comparison with L cells,
inclusion development was comparable between MDCK cells
and L cells by 12 h post-infection. Thus, kinetics of T3 inclu-
sion maturation in MDCK cells was not overtly impaired.
Typical inclusion maturation and abundant expression of
NS, a nonstructural protein, in T3-infected MDCK cells in-
dicate that viral attachment, entry, and early rounds of tran-
scription and translation proceed normally.
Quantification of Reovirus RNA in Infected Cells—Although
the presence of viral inclusions in T3-infected MDCK cells
confirms the occurrence of viral transcription and translation,
these findings cannot distinguish possible temporal defects
occurring during primary and secondary rounds of gene ex-
pression. To monitor production of viral RNA over the course
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FIGURE 4. Identification of a2 domain that mediates reovirus tropism
for MDCK cells. A, schematic of T1 T3 chimeric (Ch) M1 gene segments.
Chimeric junctions were introduced at the nucleotide position correspond-
ing to the amino acid numbers shown. Viruses containing M1 chimeric gene
segments were generated in a T3 strain background. B,MDCK cells were
infected with M1 chimeric viruses at an m.o.i. of 2 pfu/cell, and viral yields
(relative to 0 h) were determined at 24 h post-infection by plaque assay us-
ing L cell monolayers. Results represent the mean of triplicate experiments.
Error bars indicate S.D. *, p 0.05 in comparison with strain T1 (Student’s t
test). C, T1 and T3 2 proteins differ at nine amino acid positions.
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of infection, we used an RT-qPCR approach to specifically
quantify positive and negative sense S4 gene RNA, which en-
codes viral structural protein 3. Standard curves relating
total viral genomic RNA to Ct were used for calculations of S4
total, double-stranded, and mRNA in RNA extracts from vi-
rus-infected cells. MDCK cells and L cells were infected at an
m.o.i. of 10 pfu/cell with either T3-T1M1 or T3. Strain T3-
T1M1 was used in place of T1 because the T3 and T3-T1M1
S4 alleles are identical. Growth of T3-T1M1 in MDCK cells
recapitulated that of T1 (Fig. 2). At 12 h post-infection and
the following time points, high levels of total S4 RNA were
detected in T3-T1M1-infected MDCK cells compared with
the minimal amount of RNA produced in T3-infected cells
(Fig. 7A). Conversely, in L cells, significant levels of total RNA
were present in both T3-T1M1- and T3-infected cells at 12 h
post-infection and beyond (Fig. 7B). Similar patterns of S4
dsRNA production by T3-T1M1 and T3 were observed (Fig.
7, C and D). Significant levels of S4 mRNA were detected in
MDCK cells at 12, 18, and 24 h post-infection with strain T3-
T1M1 (Fig. 7E), whereas little S4 mRNA was detected in T3-
infected cells at 12 and 18 h post-infection (Fig. 7E). The
amount of S4 mRNA in T3-infected cells at 24 h post-infec-
tion was below the limit of detection (10 copies of S4 RNA
(data not shown)). These results indicate roughly equivalent
efficiencies of early viral RNA synthesis in T3-T1M1- and
T3-infected MDCK cells. However, late RNA synthesis is
markedly diminished in T3-infected cells in comparison with
that in T3-T1M1-infected cells, consistent with attenuated
dsRNA production by T3 in MDCK cells.
Protein Synthesis in Reovirus-infected Cells—We next as-
sessed viral protein synthesis in infected MDCK cells and L
cells. Strains T1 and T3 differ in the capacity to inhibit host
cell protein synthesis, a phenotype unrelated to the M1 gene
segment (51, 52). Therefore, T3-T1M1 was used instead of T1
to remove this variable. MDCK cells and L cells were infected
at an m.o.i. of 100 pfu/cell with either T3-T1M1 or T3. One
hour prior to harvest, cells were incubated with 50 mCi
[35S]methionine-cysteine, and solubilized whole-cell proteins
were resolved using SDS-PAGE, followed by autoradiography.
New viral protein synthesis was observed at 12, 18, and 24 h
post-infection in T3-T1M1-infected MDCK cells, yet only at
12 h post-infection in T3-infected cells (Fig. 8A). These data
generally mirror T3-T1M1 and T3 RNA production in
MDCK cells. In contrast, the kinetics and magnitude of new
viral protein synthesis by T3-T1M1 and T3 did not signifi-
cantly differ in infected L cells (Fig. 8B). Thus, early viral pro-
tein synthesis was roughly equivalent between T3-T1M1 and
T3 in MDCK cells, but late protein synthesis by T3 was unde-
tectable, consistent with diminished mRNA production at
later time points.
DISCUSSION
The purpose of this study was to define post-receptor con-
trol mechanisms of reovirus cell tropism. Our primary find-
ings emerging from this study are the following: 1) 2 con-
trols efficiency of reovirus growth in MDCK cells; 2) residue
347 is the primary determinant of 2-mediated viral replica-
tion potential in these cells; 3) polymerase protein 3 is a co-
regulator of viral replication in a strain-dependent manner;
and 4) 2 protein appears to regulate a later step in the reovi-
rus replication program subsequent to primary rounds of viral
transcription and translation. These findings suggest a unique
structural or functional interaction between 2 and 3 that
FIGURE 5. Identification of residues in2 that mediate reovirus tropism for MDCK cells.MDCK cells (A) or L cells (C) were infected with 2 point-mu-
tant viruses at an m.o.i. of 2 pfu/cell, and viral yields (relative to 0 h) were determined at 24 h post-infection by plaque assay using L cell monolayers. MDCK
cells (B) or L cells (D) were infected at an m.o.i. of 2 pfu/cell with L1 monoreassortant viruses containing point mutations at residue 347 of 2, and viral
yields (relative to 0 h) were determined at 24 h post-infection by plaque assay using L cell monolayers. Results represent the mean of triplicate experiments.
Error bars indicate S.D. *, p 0.05 in comparison with strain T1 (Student’s t test).
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facilitates productive viral replication in a manner responsive
to specific viral and host-cell environments.
Initial studies of reovirus replication in MDCK cells re-
vealed a genetic association of the 3 and 2 proteins with
viral replication efficiency using classical reassortant analysis
(38). A reverse genetics system for reovirus has permitted us
to generate viruses containing specific combinations of T1
and T3 gene segments and clearly define the relative contri-
butions of 2 and 3 to this phenotype (Figs. 2 and 3). T1 2
is associated with efficient reovirus replication in MDCK cells
irrespective of the viral genetic background. The influence of
T3 2 on viral replication is more complex; its quantitative
effect on production of infectious progeny requires the co-
association of T3 3. The 2 protein is thought to be a cofac-
tor of the viral RdRp (6). However, there is limited insight into
interactions between 2 and 3. Biochemical data show that
the nucleotide triphosphatase and RNA triphosphatase activi-
ties of 2 are enhanced in the presence of 3, and the two
proteins interact in immunoprecipitation assays (27). Further-
more, the L1 and M1 genes display nonrandom segregation in
T1 T3 reassortant viruses (53), suggesting co-evolution of
3 and 2 to optimize concerted roles in viral replication.
Data presented in this study showing the unidirectional 2-
mediated regulation of replication efficiency in MDCK cells
and viral background-dependent co-regulation by 3 suggest
a unique structural or functional interaction between 2 and
3 in specific viral and cellular contexts. Our findings provide
additional genetic evidence linking the function of these two
proteins and implicate the role of the polymerase complex in
determining viral cell tropism.
Using recombinant viruses containing chimeric and point-
mutant 2 proteins, we were able to systematically define se-
quence determinants of reovirus replication efficiency in
MDCK cells. Our results indicate that residue 347 is primarily
responsible (Fig. 5A). The influence of this polymorphic posi-
tion on viral replication potential is modulated by 3 in a
manner consistent with the effect of 3 on full-length 2 (Fig.
5B). A crystal structure of 2 has not been reported; however,
a number of functional sequence determinants have been de-
fined (20, 22, 24, 27, 28). It is possible that critical residues
identified in this study are part of a larger domain of 2 that
controls reovirus tropism for different types of cells. For ex-
ample, a temperature-sensitive strain of reovirus (tsH11.2)
containing mutations at residues 399 and 414 of 2 displays
defective dsRNA synthesis and particle assembly at restrictive
temperatures. The proximity of these residues to amino acid
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FIGURE 6. Reovirus inclusion formation.MDCK or L cells were infected with T1 or T3 at an m.o.i. of 20 pfu/cell, fixed at the time points shown, stained with
anti-2 (green) and anti-NS (red) antibodies and ToPro3 (blue, nuclear), and imaged using confocal microscopy. Scale bars, 20 m.
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position 347 in primary sequence raises the possibility that
all three are part of a functional unit responsive to the host
cell environment. Residue 347 is also near a predicted
leucine-rich nuclear export signal spanning residues 328–
335 (NetNES 1.1 (54)). Because 2 distributes to both the
cytoplasm and nucleus (Fig. 6) (20, 24) and contains two
predicted nuclear localization signals, one of which has
been shown to be important for viral replication (20), it is
plausible that a polymorphism at position 347 could deleteri-
ously shift the nucleocytoplasmic balance of 2.
The three-dimensional structure of the 2 protein is un-
known; therefore, it is not possible to rule out an interac-
tion of residue 347 with other structural or functional do-
mains distantly located in the primary sequence, such as
the nucleotide-binding motifs located at residues 414–420
and 445–450 (27). These sequences are required for nucle-
otide triphosphatase and RNA triphosphatase activities of 2
(27), and we found them necessary for viral replication using
an RNAi trans-complementation system (20). Therefore,
changes at 2 residue 347 plausibly could alter the function of
these domains, with a resultant impact on viral replication
efficiency in MDCK cells.
Although negative-stand RNA synthesis and particle as-
sembly have been ascribed to viral inclusions, the discrete
series of steps that occur between entry of transcriptionally
active core particles into the cytoplasm and the appearance
of mature progeny particles within viral inclusions remain
poorly defined. The absence of detectable viral RNA and pro-
tein synthesis at late times of infection in T3-infected MDCK
cells (Figs. 7 and 8) despite normal-appearing inclusions (Fig.
6) indicates that the impasse occurs at one or more of these
undefined steps. Several potential but nonmutually exclusive
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FIGURE 7. Analysis of viral RNA synthesis. Cells were infected with T3-T1M1 or T3 at an m.o.i. of 10 pfu/cell, and total RNA was extracted from cell lysates
at the indicated time points. RT-qPCR of total S4 RNA in MDCK cells (A) and L cells (B) was performed using an S4-specific reverse primer (complementary to
the ()-strand) in the reverse transcription step, followed by qPCR. A standard curve relating Ct to the amount of S4 RNA isolated from purified virion parti-
cles was used to determine S4 ()-strand RNA copy number. RT-PCR of dsRNA in infected MDCK cells (C) and L cells (D) was performed using an S4-specific
forward primer (complementary to the ()-strand) in the reverse transcription step, followed by qPCR. A standard curve relating Ct to the amount of S4
RNA isolated from purified virion particles was used to determine S4 ()-strand RNA copy number. Amounts of viral mRNA in MDCK cells (E) and L cells (F)
are expressed as the difference between total RNA and dsRNA at each time point shown. Results represent the mean of triplicate experiments. Error bars
indicate S.D.
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mechanisms can be proposed to explain the replication block
in T3-infected MDCK cells, including the following: 1) mislo-
calization of RNA; 2) decreased RNA stability; 3) malfunction
of the viral replicase during positive- or negative-strand syn-
thesis; and 4) defective genome packaging or particle assem-
bly. Each of these possibilities is currently under investigation.
Notably, by confocal immunofluorescence microscopy, core
protein 2 (which serves as the viral RNA-capping enzyme)
exhibits the expected pattern of localization to inclusions in
T3- and T3-T1M1-infected MDCK cells, using infected L
cells as a reference for 2 distribution in permissive cells (data
not shown). These results suggest that recruitment of virion
core proteins occurs normally in T3-infected MDCK cells and
the defect in viral replication is not ascribable to mislocaliza-
tion of replicase components.
The capacity of MDCK cells to discriminate reovirus
strains T1 and T3 in a 2- and 3-dependent manner at a
later point in the viral life cycle indicates the existence of a
tightly controlled post-entry replication checkpoint respon-
sive to structural or functional features of the viral polymerase
complex. Conceivably, the regulatory mechanism could be
positive or negative, i.e. active stimulation of T1 replication or
suppression of T3 replication. A passive mechanism also is
possible in which MDCK cells fail to provide a function essen-
tial for T3, but not T1, replication. The mediator of replica-
tion permissivity might be as simple as a single protein or as
intricate as a biochemical pathway.
RdRp complexes of diverse RNA viruses may function in
viral adaptation to different intracellular environments (55–
57). In the influenza A paradigm, host-range restriction in-
volves an active inhibitory process that protects against cross-
species transmission of nonadapted viruses. It is provocative
that reovirus strains T1 and T3 sharply contrast in their ca-
pacities to grow in canine cells, whereas both strains produc-
tively infect cells derived from several other species, including
mouse (L (Fig. 1)), human (HeLa and 293T (11, 58)), and pri-
mate (Vero and CV-1 (59, 60)), raising the possibility that 2
is a host-range determinant of reovirus infection. However,
this hypothesis awaits formal testing.
The reovirus 2 protein is a pleiotropic mediator of reovi-
rus replication operating at the intersection of virus multipli-
cation, cellular regulation of infection, and host disease. Based
on this study, the capacity of 2 to mediate viral tropism at
the post-entry level can be added to the list of 2 functions in
the reovirus replication program. Further investigation of 2
interactions with the viral and cellular metabolic machineries
will provide sharper insights into mechanisms of cellular per-
missivity to reovirus infection and create a framework for
conceptualizing and testing general models of viral pathogen-
esis, epidemiology, and adaptation.
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A Single-Amino-Acid Polymorphism in Reovirus Protein 2
Determines Repression of Interferon Signaling and
Modulates Myocarditis
Susan C. Irvin,a Jennifer Zurney,a* Laura S. Ooms,b,d James D. Chappell,b,c,d Terence S. Dermody,b,c,d and Barbara Sherrya
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Myocarditis is indicated as the second leading cause of sudden death in young adults. Reovirus induces myocarditis in neonatal
mice, providing a tractable model system for investigation of this important disease. Alpha/beta-interferon (IFN-/) treatment
improves cardiac function and inhibits viral replication in patients with chronic myocarditis, and the host IFN-/ response is a
determinant of reovirus strain-specific differences in induction of myocarditis. Virus-induced IFN- stimulates a signaling cas-
cade that establishes an antiviral state and further induces IFN-/ through an amplification loop. Reovirus strain-specific dif-
ferences in induction of and sensitivity to IFN-/ are associated with the viral M1, L2, and S2 genes. The reovirus M1 gene-
encoded2 protein is a strain-specific repressor of IFN- signaling, providing one possible mechanism for the variation in
resistance to IFN and induction of myocarditis between different reovirus strains. We report here that2 amino acid 208 deter-
mines repression of IFN- signaling andmodulates reovirus induction of IFN- in cardiac myocytes. Moreover,2 amino acid
208 determines reovirus replication, both in initially infected cardiac myocytes and after viral spread, by regulating the IFN-
response. Amino acid 208 of2 also influences the cytopathic effect in cardiac myocytes after spread. Finally,2 amino acid 208
modulates myocarditis in neonatal mice. Thus, repression of IFN- signaling mediated by reovirus2 amino acid 208 is a deter-
minant of the IFN- response, viral replication and damage in cardiac myocytes, andmyocarditis. These results demonstrate
that a single amino acid difference between viruses can dictate virus strain-specific differences in suppression of the host IFN-
response and, consequently, damage to the heart.
Viral infection is the leading cause of myocarditis in NorthAmerica and Europe (12). This disease can be fatal in infants
and, although usually resolved in adults, can lead to dilated car-
diomyopathy and cardiac failure. Importantly, myocarditis is in-
dicated as the second leading cause of sudden death in young
adults (10). Most virus families are implicated in myocarditis in
humans (12), with enteroviruses, such as coxsackievirus B (8, 12),
adenoviruses (8, 12), andmore recently parvovirus B19 (8, 22, 24)
as the most frequently identified. While enterovirus-induced
myocarditis in mice is predominantly immune mediated, cardiac
damage is also due to direct viral cytopathic effect (CPE). Indeed,
immunosuppressive therapy is only minimally beneficial in af-
fected humans (30, 40). Furthermore, adenovirus-positive cardiac
sections from patients with myocarditis often lack inflammatory
cell infiltrates (29). Therefore, the importance of immune-
mediated damage inmyocarditis is unclear. Reovirus induction of
cardiac lesions in newbornmice reflects direct viral CPE in cardiac
myocytes (2, 47) and is virus strain specific (46). Thus, reovirus
infection in mice provides a useful experimental system to study
the direct effects of viral infection on the heart.
The type I interferon (IFN) response is critical for protection of
cardiac cells against reovirus infection in vitro (48). Accordingly,
nonmyocarditic reoviruses induce myocarditis in mice depleted
of alpha/beta IFN (IFN-/) (48) or lacking a transcription factor
critical for the induction of IFN (15). Reoviruses that are either
strong inducers of IFN or are most sensitive to IFN-mediated
antiviral effects, such as strain type 3 Dearing (T3D), do not in-
duce myocarditis (48). Conversely, reoviruses that are weak in-
ducers of IFN or are highly resistant to its effects, such as strain
type 1 Lang (T1L), induce myocarditis (48). Given that cardiac
myocytes are essentially nonreplenishable (4) and thus vulnerable
to systemic viral infections, the IFN response provides a critical
first-line of protection for these cells. Indeed, cardiacmyocytes are
pre-armed with higher basal expression of IFN- than neighbor-
ing cardiac fibroblasts (55). Moreover, IFN- (9, 32) and IFN-
(23) treatment has improved cardiac function and inhibited viral
replication in patients with chronic myocarditis.
Viral nucleic acids can be recognized by pattern recognition
receptors (PRRs), including RIG-I-like receptors, to stimulate in-
tracellular signaling cascades that result in the induction and se-
cretion of IFN-/ (52). Through autocrine and paracrine signal-
ing, IFN-/ induces expression of IFN-stimulated genes (ISGs),
including those with antiviral activity (37), and the transcription
factor, IRF7, which further amplifies IFN expression (17, 42). Vi-
ruses have evolved mechanisms to inhibit the induction of IFN,
IFN signaling, and ISG protein function (5, 13, 41, 51). Reovirus
subverts IFN signaling by a novel mechanism associated with nu-
clear accumulation of IRF9 (56). Reovirus strain-specific differ-
ences in this subversion are determined by the M1 gene-encoded
protein 2 (56). While strain-specific differences in reovirus re-
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pression of IFN signaling correlate with induction of myocarditis
(56), the role of this repression in disease is not known.
The M1 gene is the primary determinant of reovirus strain-
specific differences in murine myocarditis (45, 46). Reovirus
strain-specific differences in induction of and sensitivity to IFN
are also determined by the M1 gene in concert with the L2 and S2
genes (44). In the present study, we investigated 2 determinants
of IFN induction, repression of IFN signaling, viral replication
and CPE in cardiac myocytes, and reovirus-induced myocarditis
inmice.We found that2 amino acid 208 is a determinant of IFN
responses, viral spread, and damage in cardiac cells and that this
amino acid modulates myocarditis.
MATERIALS AND METHODS
Cells and mice. Mouse L929 cells were maintained in minimal essential
medium (SAFCBiosciences) supplemented to contain 5% fetal calf serum
(FCS) (Atlanta Biologicals) and 2 mM L-glutamine (Mediatech, Inc.).
L929 cells were plated at 5  105 cells per well in 24-well clusters and
allowed to adhere 2 h prior to infection.
Timed-pregnant Cr:NIH(S) mice from the National Cancer Institute
were maintained as a colony in a facility that is accredited by the Associ-
ation for Assessment and Accreditation of Laboratory Animal Care. All
animal procedures were approved by the North Carolina State University
Institutional Animal Care and Use Committee.
Primary cardiac myocyte and fibroblast cultures were generated from
1-day-old neonatal or term fetal Cr:NIH(S) mice resulting from timed
pregnancies. Neonatal or term fetal mice were euthanized, and the apical
two-thirds of hearts were excised and treated with trypsin (2). Cardiac
myocytes were separated from cardiac fibroblasts by differential adher-
ence to culture wells and resuspended in Dulbecco modified Eagle me-
dium (Gibco) supplemented to contain 7% FCS (Atlanta Biologicals) and
10g of gentamicin (Sigma-Aldrich Corp.)/ml.Myocyte culturemedium
also contained 0.06% thymidine (Sigma-Aldrich Corp.). Myocyte cul-
tures contain5%fibroblasts, and fibroblast cultures contain1%myo-
cytes (55). Myocyte cultures were plated at 1.5  105 cells per well in
96-well clusters or at 5 105 cells per well in 48-well clusters. Fibroblast
cultures were plated at one-half those densities in 96-well or 48-well clus-
ters, were confluent by the day of infection, and were assumed to double
from the initial plating density. Cells were incubated for 2 days prior to
infection. Myocyte and fibroblast cultures were not passaged before use.
Two-day-old mice from timed litters were injected in the left hind
limb with 20 l of gel saline (46) containing 106 PFU of various virus
strains or gel saline as amock infection. At 7 days postinjection,mice were
euthanized, and hearts were removed, fixed in 10% buffered formalin,
and sectioned for hematoxylin and eosin (H&E) staining. Sections were
photographed with a Nikon AZ100 zoom microscope at75 magnifica-
tion. A minimum of eight hearts (with a minimum of 15 sections per
heart) were scored as blinded cardiac sections for each virus. Mice were
considered “positive” if more than a single lesion was detected in the15
sections examined. Lesions in adjacent sections were not scored as inde-
pendent lesions.
Viruses. All viruses were generated from plasmids by reverse genetics
as described previously (20, 38). The recombinant viruses were plaque
purified, amplified using L929 cells, purified using CsCl gradients (49),
and stored as diluted aliquots at80°C.
Virus replication. Primary cardiac myocyte and cardiac fibroblast
cultures were plated in 96-well clusters. Cells were infected at a multiplic-
ity of infection (MOI) of 3 PFUper cell for single-cycle assays and 0.1 PFU
per cell for multicycle assays. After 1 h of incubation at 37°C, additional
supplemented medium was added to each well. For some experiments,
this overlay also contained 640 neutralizing units per ml (final concentra-
tion) of anti-IFN- antibody (catalog no. 32400-1; PBL, Inc., Piscataway,
NJ) and, at 2 days postinfection, these cells were again treated with anti-
IFN- antibody (320 neutralizing units per ml). Cells were incubated for
various times before freezing at 80°C. Plates of cells were frozen and
thawed twicemore, and cells were lysed in 0.5%Nonidet P-40. For plaque
assays, serial dilutions of the lysates were used to infect monolayers of
L929 cells, which were subsequently overlaid with agar and stained with
neutral red as described previously (44). In each experiment, duplicate or
triplicate wells of cardiac cells were each assessed for viral replication by
duplicate plaque assay wells.
SDS-PAGE and immunoblotting. Primary cardiac myocyte cultures
were plated in 24-well clusters, infected at an MOI of 10 PFU per cell,
incubated for 24 h, and lysed to generate total cellular protein extracts
using radioimmunoprecipitation assay lysis buffer (50mMTris-HCl [pH
7.4], 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM
EDTA) supplemented to contain 1% SDS and a cocktail of protease and
phosphatase inhibitors (Sigma-Aldrich, catalog numbers P8340 and
P2850, respectively). Cells were rocked on ice for 25 min and centrifuged
at 10,000 g for 10min at 4°C to remove cellular debris. Protein concen-
trations were determined by using a bicinchoninic acid protein assay
(Thermo Fisher Scientific, catalog no. 23227), and 10 g of protein from
each lysate was boiled for 5 min in 1 Laemmli sample buffer and re-
solved using 10% SDS-polyacrylamide gel electrophoresis (PAGE). After
protein transfer onto nitrocellulose, membranes were blocked for 1 h in
phosphate-buffered saline (PBS) containing 5% bovine serum albumin.
Membranes were incubated overnight at 4°C with a rabbit anti-2 poly-
clonal antibody (1:500; generated against two 2 peptides by Open Bio-
systems, Huntsville, AL). Membranes were washed three times for 5 min
each in PBS containing 0.05% Tween 20 (PBS-T) and then incubated for
1 h at room temperature with a goat anti-rabbit horseradish peroxidase-
conjugated polyclonal (secondary) antibody (1:2,000; Millipore, catalog
no. AP132P). The membranes were washed, and proteins were visualized
using enhanced chemiluminescence (GE Healthcare, catalog no.
RPN2108) according to the manufacturer’s instructions. Membranes
were exposed to film and converted to digital format using an HP Scanjet
G4050.
CPE. Primary cardiac myocyte and cardiac fibroblast cultures were
plated in 96-well clusters. Cells were infected at anMOI of 10 PFU per cell
(single-cycle assays) or 0.1 PFUper cell (multicycle assays) in five replicate
wells. After 1 h of incubation at 37°C, additional supplemented medium
was added to each well. At 7 days (multicycle assay), the cultures were
photographed using a Nikon TE-200 inverted microscope (phase con-
trast). At 2 days (single-cycle assays) or 5 or 7 days (multicycle assays)
postinfection, anMTT assay was performed to quantify cell viability (48).
An automated microplate reader (TECAN Sunrise Microplate Reader)
was used to determine the optical density at 570 (OD570) and the OD650.
The absorbance was determined by subtracting OD650 from OD570.
Quantitative (real-time) reverse transcription-PCR (qRT-PCR).
Duplicate wells were plated in 24-well (L929 cells) or 48-well (primary
cardiac cell cultures) clusters. Cells were infected at anMOI of 25 PFU per
cell (L929 cells) or 10 PFU per cell (primary cardiac cell cultures). After 1
h of incubation at 37°C, additional supplemented medium was added to
each well. L929 cells were incubated for 20 h, treated with 100 or 1,000 U
of IFN- (catalog no. 12400-1; PBL, Inc.)/ml, and incubated for an addi-
tional 5 h. Primary cardiac myocyte and cardiac fibroblast cultures were
incubated for 8 and 24 h postinfection. All cells were lysed with an RNeasy
kit (Qiagen, Inc.), and total RNA was harvested and treated with RNase-
free DNase  (Qiagen, Inc.). From each harvested well, one-third of the
total RNAwas used to generate cDNA by reverse transcription in a 100-l
reaction containing 5 M oligo(dT) (Invitrogen Corp.), 1 Taq buffer
(Promega Corp.), 7.5 mMMgCl2 (Promega Corp.), 1 mM dithiothreitol
(Promega Corp.), 1mM concentrations of each deoxynucleoside triphos-
phate (Roche), 0.67U of RNasin (Promega Corp.)/l, and 0.20U of avian
myeloblastosis virus reverse transcriptase (Promega Corp.)/l. Then, 5%
of the reverse transcription product was amplified on an iCycler iQ fluo-
rescence thermocycler (Bio-Rad Laboratories) in 96-well plates. Each du-
plicate 25-l reaction contained 1 Quantitech SYBR green master mix
(Qiagen, Inc.), 10 mM fluorescein, and 0.3 M concentrations of each
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forward and reverse primer. Primer sequences were as previously pub-
lished (50). The relative abundance of IRF7, IFN-, and GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) mRNA was determined by
comparison to a standard curve generated from serial dilutions of a DNA
standard; IRF7 and IFN- expression and IRF7 fold repressions were
normalized to GAPDH expression.
Statistical analysis. A Student two-sample t test (pooled variance;
Systat 9.0) was applied to all data except those for Fig. 6, where a chi-
square test was applied. The results were considered significant if the P
value was0.05.
RESULTS
Amino acid (aa) 208 in reovirus protein2 determines reovirus
repression of IFN signaling. The M1 gene product, 2, of reovi-
rus strain T1L but not that of strain T3D represses IFN signaling in
L929 cells (56). To identify the 2 amino acids responsible for
repression of IFN signaling, viruses containing T1L-T3D chimeric
M1 genes or viruses containing mutations in the M1 gene (Fig.
1A) were tested for the capacity to repress IFN signaling in L929
cells (Fig. 1B). A recombinant virus containing nine genes from
T3D and a chimeric M1 gene expressing the N-terminal 126 2
amino acids from T3D and remaining amino acids from T1L
(Ch1) was as effective as T1L at repressing IFN induction of IRF7.
In contrast, viruses containing a chimeric M1 gene expressing the
N-terminal 208 2 amino acids (Ch2) or more (Ch3 and Ch4)
from T3D failed to repress IFN signaling. Strains T1L and T3D
differ at only aa 208 in the 2 region spanning aa 127 through aa
208. Remarkably, a T3D virus mutated at only 2 residue 208
(T3D-S208P), changing it from the T3D serine (S) to a T1L pro-
line (P), repressed IFN signaling as effectively as T1L. Conversely,
a virus containing nine T3D genes and the T1L M1 gene mutated
to T3D serine at 2 residue 208 (T3D-T1LM1-P208S) failed to
repress IFN signaling. Together, these data demonstrate that T1L
2 aa 208 is both required and sufficient for reovirus repression of
IFN signaling.
2 aa 208 modulates reovirus induction of IFN- in cardiac
cells. As anticipated from previous reports (48, 55), in cardiac
myocytes, T3D induced IFN- well and T1L induced IFN-
poorly (Fig. 2A, P 0.001 at 8 and 24 h). Differences in T3D and
T1L induction of IFN in cardiac myocytes segregate with the M1,
L2, and S2 genes (48). Reovirus infection stimulates PRRs to in-
duce IFN- (16, 18, 26). While strain-specific differences in in-
duction of IFN could reflect differences in this stimulation, they
also could reflect differences in repression of IFN signaling since
reovirus-mediated induction of IFN involves the positive feed-
back loop in cardiac myocytes (50, 56). T3D-T1LM1 induced
markedly less IFN- than did T3D (Fig. 2A, P 0.001 at 8 and 24
h), a finding consistent with the association of the T1L M1 gene
with poor induction of IFN (48). T1L-T3DM1 also induced min-
imal IFN- (P  0.001 relative to T3D at 8 and 24 h), which is
consistent with the association of the T1L L2 and S2 genes with
poor induction of this cytokine (48). Thus, theT3DM1gene is not
sufficient for strong induction of IFN. Instead, a full response
requires the T3D L2 and S2 genes in addition to the T3DM1 gene.
To determine the effect of 2 aa 208 on reovirus induction of
IFN, viruses with single aa substitutions at that site were tested. At
8 h postinfection in cardiac myocytes (Fig. 2A), viral induction of
IFN-was decreased almost 3-fold by changing T3D2 aa 208 to
that of T1L (T3D-S208P; P  0.001), indicating that 2 aa 208
modulates reovirus induction of IFN- at this early time. How-
ever, by 24 h postinfection, T3D and T3D-S208P induction of
IFN- (Fig. 2A, P  0.05) and IRF7 (Fig. 2B, P  0.05) were
similar, indicating that repression of IFN signaling is not the pri-
mary determinant of strain-specific differences in reovirus induc-
tion of IFN-. The similar induction of IRF7 by T3D and T3D-
S208P (Fig. 2B) contrasts with T3D-S208P repression of
exogenous IFN induction of IRF7 (Fig. 1B), likely reflecting the
difference between induction of IRF7 concomitant with (Fig. 2B)
or after (Fig. 1B) the majority of 2 expression. Interestingly,
other sequences in the T1L M1 gene also affected induction of
IFN-. Specifically, in contrast to the minimal effect of changing
T3D 2 aa 208 to that of T1L (T3D-S208P), induction of IFN-
and IRF7was significantly increased by changing T1L2 aa 208 of
T3D-T1LM1 to that of T3D (T3D-T1LM1-P208S, Fig. 2A and B,
P 0.01 at 8 and 24 h for both IFN- and IRF7). In addition, the
substantial increase in the induction of IFN- at 24 h by T3D-
T1LM1-P208S relative to T3D (Fig. 2A, P  0.001) suggests that
FIG 1 2 aa 208 determines reovirus repression of IFN signaling. (A) Viruses
with a chimeric M1 gene or viruses with a mutated amino acid at position 208
of 2 were generated by reverse genetics (21, 38). (B) L929 cells were infected
with the indicated viruses, cells were treated with IFN, and mRNA was har-
vested for qRT-PCR. The fold repression was calculated as ([copies IRF7/
GAPDH in IFN-treated mock-infected cells]/[copies IRF7/GAPDH in IFN-
treated virus-infected cells]). Viruses that induce high levels of IFN resulted in
values1, but the relative repression between viruses was the same (56). The
results are means  the standard deviation (SD) (average of replicate wells;
representative of four experiments). , Different from T3D (P  0.05); ‡,
different from T1L (P 0.05).
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T1L M1 sequences other than aa 208 influence induction of this
cytokine. The results for cardiac fibroblasts (Fig. 2C and D) were
similar to those for cardiac myocytes, with the notable and ex-
pected difference (50, 55) that reovirus induction of IFN- is
much higher in cardiacmyocytes than in cardiac fibroblasts (com-
pare scales between Fig. 2A and C), but the opposite is true for
reovirus induction of ISGs (Fig. 2B and D). Thus, reovirus 2
proline 208 (the T1L residue) represses the induction of IFN- in
both cardiacmyocytes and cardiac fibroblasts, but predominantly
when expressed in the context of the entire T1L M1 gene.
2 aa 208 determines reovirus single-cycle and multicycle
replication in cardiac myocytes. As expected (48, 50), T1L
achieved higher titers in cardiac myocytes than did T3D after sin-
gle or multiple cycles of replication (Fig. 3A and 3B; P 0.005 for
both cases). Differences between T1L and T3D could reflect IFN-
dependent, IFN-independent, or both mechanisms. After single
or multiple cycles of replication, T1L-T3DM1 titers were as low
(P  0.05) or lower than those for T3D, whereas T3D-T1LM1
titers were as high (P 0.05) as those for T1L, demonstrating that
the T1L M1 gene is both required and sufficient for reovirus to
replicate maximally in cardiac myocytes. After single (Fig. 3A) or
multiple (Fig. 3B) cycles of replication, the titers for T3D-T1LM1-
P208S were as low (P 0.05) or lower than those for T3D, dem-
onstrating that T1L 2 aa 208 is required for production of high
titers in cardiac myocytes. Conversely, after a single round of rep-
lication, titers for T3D-S208P were even higher (P  0.05) than
those for T1L, demonstrating that T1L 2 aa 208 is sufficient for
high titers in cardiac myocytes. As expected, levels of 2 protein
paralleled levels of infectious virus (Fig. 3A).
To determine whether T1L 2 aa 208 regulates replication in
cardiacmyocytes solely by regulating the IFN response, titers were
compared after multiple cycles of replication in the absence or
FIG 2 2 aa 208modulates reovirus induction of IFN in cardiac cells. Primary cardiacmyocyte (A and B) or fibroblast (C andD) cultures were infected with the
indicated viruses, and mRNA was harvested for qRT-PCR using primers specific for IFN- (A and C) or IRF7 (B and D) and GAPDH. The fold induction was
calculated as copies IFN- or IRF7/GAPDH in infected cultures relative to uninfected cultures. (A and C) Results are means the standard errors of the mean
(SEM) (average of two experiments); (B and D) results are means  the SD (average of replicate wells; representative of two experiments). See the statistical
analyses in the text.
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presence of anti-IFN- antibody (Fig. 3C). As anticipated (48),
elimination of the IFN response in cardiac myocytes increased
T3D replication 11.5-fold (P  0.001), which is consistent with
evidence that the IFN response dictates the replication efficiency
of this strain in these cells. Furthermore, elimination of the IFN
response increased replication of all viruses tested to the level of
T1L (P 0.05) or higher, demonstrating that 2 aa 208 regulates
reovirus multicycle replication in cardiac myocytes by regulating
the IFN response.
2 aa 208 influences reovirus single-cycle and multicycle
replication in cardiac fibroblasts. In contrast to results obtained
in experiments using cardiac myocytes, differences in yields of
T1L and T3D were apparent in cardiac fibroblasts only after mul-
tiple cycles of replication, suggesting that the IFN response has
little effect on initial infection in cardiac fibroblasts (Fig. 4A and
B). This finding is consistent with the dramatically lower induc-
tion of IFN by reovirus in cardiac fibroblasts (Fig. 2C) than in
cardiac myocytes (Fig. 2A). Indeed, in contrast to cardiac myo-
cytes, the T1L M1 gene did not result in a higher yield of T3D
(T3D-T1LM1) after a single cycle of replication in cardiac fibro-
blasts (Fig. 4A, P 0.05). Replication of T3D-T1LM1-P208S was
markedly reduced relative to the parent T3D-T1LM1 virus, most
likely reflecting the effect of the single aa 208 substitution on in-
duction of IFN (Fig. 2C. P  0.002) and suggesting that the IFN
response can modulate reovirus replication in cardiac fibroblasts
if the IFN response is sufficiently strong. Replication of T1L-
T3DM1 was reduced relative to both T1L and T3D after a single
cycle of replication (Fig. 4A, P 0.001), but intermediate between
these two viruses after multiple cycles (Fig. 4B, P 0.001). While
reproducible, the underlying mechanism is unclear but may re-
flect heterologous gene combinations that are detrimental only in
certain cell types (33). After multiple cycles of replication in car-
diac fibroblasts, T3D replicated less well than T1L (P 0.001), a
property determined by the M1 gene (Fig. 4B). T3D-T1LM1-
P208S produced the lowest titers of the viruses tested, a finding
consistent with its dramatically higher induction of IFN (Fig. 2C).
To test the role of IFN in 2 aa 208 effects on reovirus replica-
tion in cardiac fibroblasts, virus titers in the presence or absence of
anti-IFN- antibody were compared (Fig. 4C). In comparison to
results using cardiac myocytes, all viruses achieved only slightly
higher titers when IFN was eliminated, consistent with the low
level of IFN induced in cardiac fibroblasts relative to cardiacmyo-
cytes (Fig. 2).
2 aa 208 determines reovirus CPE in cardiacmyocytes only
after spread. Results thus far suggested that T1L 2 aa 208 influ-
ences the IFN response to reovirus in both cardiac myocytes and
cardiac fibroblasts but that the effect on viral replication is greater
in cardiac myocytes than in cardiac fibroblasts. To determine the
FIG 3 2 aa 208 determines reovirus single-cycle and multicycle replication
in cardiac myocytes. (A) Primary cardiac myocyte cultures were infected with
the indicated viruses at anMOIof 3 PFUper cell and harvested for plaque assay
after 24 h or infected at 10 PFUper cell and harvested for immunoblotting after
24 h. The leftmost lane contains mock-infected sample. (B) Primary cardiac
myocyte cultures were infected at anMOI of 0.1 PFU per cell and harvested for
plaque assay after 5 days. (C) Primary cardiac myocyte cultures were infected
as in panel B, treatedwith anti-IFN- antibodywhere indicated, and harvested
for plaque assay. All results are means  the SD (average of replicate wells;
representative of two to four experiments). See the statistical analyses in the
text.
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contribution of 2 aa 208 to viral CPE, cardiac cells were infected
at a high MOI (10 PFU per cell) and cell viability was quantified
after a single cycle of replication (2 days) or the cells were infected
at a low MOI (0.1 PFU per cell) and cell viability was quantified
after multiple cycles of replication (5 days and 7 days). PFU are
quantified using L929 cells, and virus is less infectious in cardiac
cells than in L929 cells (data not shown). Therefore, even at an
MOI of 10 PFU per cell, not all cardiac cells are infected (44). In
cardiac fibroblasts, none of the viruses were cytopathic after a
single cycle of replication, andCPE increased onlyminimally after
multiple cycles (data not shown). As expected (48), T1L and T3D
were similarly cytopathic in cardiacmyocytes after a single cycle of
replication (Fig. 5). However, after multiple cycles of replication,
T1L and T3D clearly differed in the induction of CPE (P 0.001
at 5 and 7 days), as did the entire panel of viruses. The overall trend
inversely correlated with viral replication in cardiac myocytes
(Fig. 3A and B): viruses that replicated to the highest titers left the
fewest cells viable.More specifically, after 5 or 7 days, T3D-T1LM1
was even more cytopathic than T1L (P  0.001), while T1L-
T3DM1was as noncytopathic as T3Dat 5 days (P 0.05) andonly
slightly more cytopathic at 7 days. Moreover, changing only T3D
2 aa 208 to that of T1L (T3D-S208P) increased cytopathicity to
even greater than that of T1L (P 0.002). Finally, T3D-T1LM1-
P208S cytopathicity was markedly reduced relative to the parent
T3D-T1LM1 virus (P 0.001). Gross CPE paralleledMTT results
(Fig. 5B). Together, these results demonstrate that T1L 2 aa 208
determines CPE after viral spread, likely through repression of the
IFN signaling that is required for the positive feedback loop of
induction of IFN-.
2 aa 208 modulates myocarditis. To determine the effect of
2 aa 208 on viral myocarditis, mice were inoculated with the
panel of recombinant viruses, and cardiac lesions were quantified.
As expected (45), T1L induced cardiac lesions in all mice, while
T3D induced few lesions (Fig. 6). Reovirus strain-specific differ-
ences in the capacity to inducemyocarditis segregate with theM1,
L1, and L2 genes (45, 46), but the role of theM1 gene alone has not
been previously determined. A virus containing the T1L M1 gene
in the T3D genetic background (T3D-T1LM1) induced a higher
frequency ofmyocarditis than did T3D (P 0.05), demonstrating
that the T1L M1 gene when introduced into the genetic back-
ground of T3D is sufficient to cause myocarditis. The T3D M1
gene in the T1L genetic background (T1L-T3DM1) induced a
lower frequency ofmyocarditis than did T1L (P 0.05), confirm-
ing the importance of the T1L M1 gene in this phenotype. Fur-
thermore, although not statistically significant, T1L-T3DM1 ap-
peared to induce myocarditis more efficiently than did T3D,
providing evidence to support previous conclusions that genes in
T1L in addition toM1 contribute to myocarditis (45, 46). Finally,
changing T3D2 aa 208 to that of T1L (T3D-S208P) dramatically
increased the frequency of myocarditis (P  0.05) compared to
that caused by T3D (P 0.05), suggesting that repression of IFN
signaling alone canmodulate this disease. T3D-T1LM1-P208S ap-
peared to be less myocarditic than the parental T3D-T1LM1 virus
butmoremyocarditic thanT3D (not statistically significant), sup-
porting the importance of repression of IFN signaling but indicat-
FIG 4 2 aa 208 influences reovirus single-cycle andmulticycle replication in
cardiac fibroblasts. Primary cardiac fibroblast cultures were infected with the
indicated viruses at an MOI of 3 PFU per cell and incubated for 24 h (A) or at
an MOI of 0.1 PFU per cell and incubated for 5 days (B) and harvested for
plaque assay. (C) Primary cardiac fibroblast cultures were infected as in panel
B, treatedwith anti-IFN-where indicated, and harvested for plaque assay. All
results are means the SD (average of replicate wells; representative of two to
four experiments). See the statistical analyses in the text.
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ing that other T1LM1 functions are also determinants of myocar-
ditis. Collectively, these results demonstrate that 2 aa 208
modulates myocarditis, suggesting that repression of IFN signal-
ing is a determinant of reovirus-induced cardiac disease.
DISCUSSION
The IFN-/ response is essential for protection against reovirus
infection of cardiac cells in vitro and reovirus-induced myocardi-
tis in mice (48). We demonstrated here that sequence polymor-
phisms at reovirus protein 2 aa 208 are both required and suffi-
cient for strain-specific differences in reovirus repression of IFN-
signaling. Furthermore, 2 aa 208 modulation of IFN expression
and signaling determines viral replication and spread in cardiac
myocytes and modulates myocarditis in mice.
Virus-induced IFN- stimulates the expression of antiviral
ISGs, as well as transcription factor IRF7, which results in further
induction of IFN- in a positive amplification loop. Viral repres-
sion of IFN signaling could: (i) limit IFN expression to that initi-
ated by PRRs and (ii) suppress IFN-induced expression of antivi-
ral genes. Viruses have evolved many mechanisms to antagonize
IFN signaling, including inactivation of JAKs, degradation or se-
questration of STATs, and inhibition of karyopherins required for
ISGF3 nuclear translocation (41). Only two viruses are known to
repress IFN signaling through IRF9: human papillomavirus type
16 sequesters IRF9 to inhibit its nuclear translocation (1), and
adenovirus infection leads to a decrease in IRF9 levels (25). The2
protein from reovirus strain T1L but not strain T3D represses
IFN- signaling, and this repression is associated with nuclear
accumulation of IRF9 (56). However, it is not known whether
alterations in IRF9 mediate repression or are merely a conse-
quence of that event. In the present study, we found that sequence
variation in 2 aa 208 determines these reovirus strain-specific
differences in repression of IFN- signaling (Fig. 1).
TheM1 gene sequences of nine field isolate reovirus strains are
available, and while all nine contain a proline or serine at 2
residue 208, eight contain a proline-like T1L, suggesting a selective
advantage (53). Interestingly, 2 aa 208 governs several differ-
ences displayed by strains T1L and T3D. Reovirus replicates and
assembles in viral inclusion bodies (VIBs). While T3D induces
formation of globular VIBs, T1L induces formation of filamen-
tous VIBs, reflecting T1L2-stimulated hyperacetylation and sta-
bilization of microtubules (39). While these T1L 2-stimulated
events are disrupted when the T1L proline at aa 208 is substituted
with the T3D serine (39), substitutions at 2 aa 383 also prevent
T1L formation of filamentous VIBs (21). Importantly, aa 208me-
diates greater ubiquitylation and aggregation of T3D2 than T1L
2, suggesting that the capacity of T1L 2 to stabilize microtu-
bules and induce filamentous VIBs may be a consequence of virus
strain-specific posttranslational 2 modifications (31). The re-
sults presented here identify T1L 2 aa 208 as both required and
sufficient for reovirus repression of IFN signaling and suggest two
possible models: (i) repression of IFN signaling requires the cyto-
skeletal changes that accompany formation of filamentous VIBs
or (ii) ubiquitylated and aggregated2 cannot function to repress
IFN signaling. Future studies are planned to discriminate between
these possibilities.
Strain-specific differences in reovirus induction of IFN-/
genetically segregate with the reovirus M1, L2, and S2 genes (48).
While T3D induces IFN well and T1L induces IFN poorly (48), it
is unclear whether this polymorphism reflects differences in PRR-
FIG 5 2 aa 208 determines reovirus CPE in cardiac myocytes only after
spread. (A) Primary cardiac myocyte cultures were infected with the indicated
viruses at an MOI of 10 PFU per cell and incubated for 2 days (single cycle) or
at an MOI 0.1 PFU per cell and incubated for 5 or 7 days (multicycle) and
harvested for MTT assay. The percent viable cells was calculated relative to
mock-infected cells. The results at 2 and 5 days are means the SEM (average
of at least two experiments); results at 7 days are means the SD (average of
replicate wells for a single experiment). See the statistical analyses in the text.
(B) Primary cardiac myocyte cultures were infected at an MOI of 0.1 PFU per
cell, incubated for 7 days, and photographed at a final magnification of100
(representative fields shown).
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stimulated induction, IRF7-mediated amplification, or both ef-
fects. The roles of the L2-encoded 2 and S2-encoded 2 proteins
in these processes have not been reported, but one possible role for
theM1-encoded2 protein could be to suppress IFN induction of
IRF7, thereby inhibiting further induction of IFN. Indeed, substi-
tution of only 2 aa 208 in T3D to provide a repressor of IFN
signaling (T3D-S208P), significantly reduced reovirus induction
of IFN in both cardiac myocytes and cardiac fibroblasts at 8 h
postinfection (Fig. 2). Interestingly, the converse substitution, in
which only 2 aa 208 in T3D-T1LM1 is replaced to remove the
repressor of IFN signaling (T3D-T1LM1-P208S), had a much
more substantial effect on reovirus induction of IFN in both cell
types (Fig. 2). Specifically, T3D-T1LM1-P208S induced 10-fold
more IFN- than did T3D-T1LM1 at 8 h and a remarkable 150-
fold more at 24 h (Fig. 2A) with a concomitant increase in induc-
tion of IRF7 (Fig. 2B). Therefore, in the context of the T1L M1
gene, T1L 2 aa 208 repression of IFN signaling dramatically af-
fected reovirus induction of IRF7 and consequently IFN-. Im-
portantly, viruses with a T1LM1 gene display enhanced kinetics of
viral RNA synthesis in cardiac myocytes in comparison to those
with a T3D M1 gene (44). Thus, T1L 2 should be synthesized
earlier than T3D 2, offering T3D-T1LM1 greater opportunity
than T3D-S208P to repress induction of IRF7. The substantial
increase in the induction of IFN- at 24 h by T3D-T1LM1-P208S
relative to T3D (Fig. 2A) is consistent with both the absence of the
T1L 2 aa 208 repressor of IFN signaling and the T1L M1-
associated rapid RNA synthesis phenotype facilitating RNA-
stimulated activation of IRF7 (44). Together, these data indicate
that reovirus induction of IFN in cardiac cells involves a positive
amplification loop and that repression of IFN signaling reduces
reovirus induction of IFN-.
The reovirus M1-, L2-, and S2-encoded proteins also could
modulate reovirus activation of PRRs. Depending on the cell type
or perhaps infection stage (14), reovirus activates the PRRs RIG-I,
MDA5, or bothmolecules to induce IFN (16, 18, 26), although the
specific nucleic acid stimulus remains unclear. While reovirus
particles contain genomic double-stranded RNA (dsRNA), viri-
ons are not thought to fully uncoat during viral replication (43),
and thus genomic dsRNA should be protected from PRRs. In-
stead, reovirus cores synthesize single-stranded RNA, which is ex-
truded and then complexed into new subviral particles for RNA
second-strand synthesis (43). The 2 protein is found at the ico-
sahedral vertices of viral cores as part of a probable RNA-
synthesizing complex (19, 54), has both NTPase (19, 35) and
RNA-binding activity (6, 19, 35), and determines the rate of viral
RNA synthesis in cardiacmyocytes (44).However, reoviruseswith
a T1L M1 gene synthesize RNA more rapidly than those with a
T3D M1 gene (44), the opposite of what would be predicted if
2-stimulated viral RNA synthesis solely determined the level of
IFN induction. It is possible that the location of both2 and 2 at
the icosahedral vertices (7, 11) influences particle stability. Virions
contain not only genomic dsRNA, a potential RIG-I and MDA5
ligand, but also short oligonucleotides with free 5= triphosphates
(3, 34, 43), an additional potential RIG-I ligand, although shorter
than other RIG-I agonists (27, 28). Therefore, T3D particles may
aberrantly disassemble more readily than T1L particles, resulting
in commensurately greater PRR activation and induction of IFN.
We found that T3D induction of IFN in cardiac cells was reduced
when itsM1 genewas replacedwith that of T1L (T3D-T1LM1, Fig.
2A and C). However, the striking increase in induction of IFN
when the T1LM1 repressor of IFN signaling was removed (T3D-
T1LM1-P208S), particularly later during infection, suggests that
the main function of 2 in the IFN response is to repress IFN
signaling (as in T1L) rather than to shield PRR ligands from the
innate immune surveillance machinery.
The protective effects of secreted IFN should be greater in cells
that have not been infected, i.e., as a paracrine signal, than in cells
already infected, i.e., as an autocrine signal, since the former have
FIG 6 2 aa 208 modulates myocarditis. Neonatal mice were inoculated with the indicated viruses and euthanized 7 days postinjection. Hematoxylin-eosin-
stained cardiac sections were scored for lesions. (A) Representative sections. (B) Aminimum of eight hearts (minimum of 15 sections per heart) were scored for
each virus. Lesions in adjacent sections were not scored as independent lesions. Hearts were considered “positive” if more than a single lesion was detected in the
 15 sections examined. , Different from T3D; ‡, different from T1L (chi square, P 0.05). The results are representative of two independent experiments.
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more time to induce antiviral proteins. In addition, IFN-mediated
reductions in viral yield should result in fewer secondary infec-
tions. Therefore, the effect of the IFN response on viral yield
should be amplified following viral spread. The IFN response de-
termines reovirus yields in primary cardiac myocyte cultures and,
as expected, the effect is increased following viral spread (48). We
found that2 aa 208 determines strain-specific differences in viral
replication in cardiac myocytes even after a single cycle of replica-
tion (Fig. 3A), suggesting that IFN can reduce viral replication in
these cells even after infection is initiated. As expected, the effect
was enhanced after multiple cycles (Fig. 3B), and all viruses
achieved equivalent titers when IFN was removed (Fig. 3C). To-
gether, the data demonstrate that 2 aa 208 regulation of the IFN
response determines reovirus replication and spread between car-
diac myocytes.
Virus strain-specific differences in the induction of myocardi-
tis correlate with differences in CPE in primary cardiac myocyte
cultures only after viral spread (2, 48), which is consistent with the
IFN response regulating viral spread in vitro and in vivo (15, 36,
48). Many investigations have used IFN-deficient mice or viruses
that are defective in repressing the IFN response to demonstrate
the importance of the IFN response in protection against virus-
induced disease, but few have pinpointed the populations of dif-
ferentiated cells in which IFN critically acts to limit progression of
viral infection. Here, we found that a serine-proline polymor-
phism at aa 208 in the reovirus 2 protein influences CPE after
multiple cycles of replication in cardiac myocytes (Fig. 5) and
modulates myocarditis (Fig. 6), providing evidence that viral re-
pression of IFN signaling in a target differentiated cell can deter-
mine disease outcome.
ACKNOWLEDGMENTS
We thank Lianna Li and Ray Pickles for insightful discussions and Lance
Johnson for excellent technical assistance.
This research was supported by Public Health Service awards R01
AI32539 (T.S.D.), R37 AI38296 (T.S.D.), and R01 A1083333 (B.S.) and
the Elizabeth B. Lamb Center for Pediatric Research. Additional support
was provided by Public Health Service awards CA68485 for the
Vanderbilt-Ingram Cancer Center and DK20593 for the Vanderbilt Dia-
betes Research and Training Center.
REFERENCES
1. Barnard P, McMillan NA. 1999. The human papillomavirus E7 onco-
protein abrogates signaling mediated by interferon-alpha. Virology
259:305–313.
2. Baty CJ, Sherry B. 1993. Cytopathogenic effect in cardiac myocytes but
not in cardiac fibroblasts is correlated with reovirus-induced acute myo-
carditis. J. Virol. 67:6295–6298.
3. Bellamy AR, Joklik WK. 1967. Studies on the A-rich RNA of reovirus.
Proc. Natl. Acad. Sci. U. S. A. 58:1389–1395.
4. BergmannO, et al. 2009. Evidence for cardiomyocyte renewal in humans.
Science 324:98–102.
5. Bowie AG, Unterholzner L. 2008. Viral evasion and subversion of
pattern-recognition receptor signalling. Nat. Rev. Immunol. 8:911–922.
6. Brentano L, Noah D, Brown EG, Sherry B. 1998. The reovirus protein
mu 2, encoded by the M1 gene, is an RNA-binding protein. J. Virol. 72:
8354–8357.
7. Coombs KM. 1998. Stoichiometry of reovirus structural proteins in virus,
ISVP, and core particles. Virology 243:218–228.
8. Cooper LT, Jr. 2009. Myocarditis. N. Engl. J. Med. 360:1526–1538.
9. Daliento L, et al. 2003. Successful treatment of enterovirus-inducedmyo-
carditis with interferon-alpha. J. Heart Lung Transplant. 22:214–217.
10. Drory Y, et al. 1991. Sudden unexpected death in persons less than 40
years of age. Am. J. Cardiol. 68:1388–1392.
11. Dryden KA, et al. 1998. Internal structures containing transcriptase-
related proteins in top component particles of mammalian orthoreovirus.
Virology 245:33–46.
12. Feldman AM, McNamara D. 2000. Myocarditis. N. Engl. J. Med. 343:
1388–1398.
13. Fensterl V, Sen GC. 2009. Interferons and viral infections. Biofactors
35:14–20.
14. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M, Jr. 2008.
Establishment and maintenance of the innate antiviral response to West
Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J.
Virol. 82:609–616.
15. Holm GH, et al. 2010. Interferon regulatory factor 3 attenuates reovirus
myocarditis and contributes to viral clearance. J. Virol. 84:6900–6908.
16. Holm GH, et al. 2007. Retinoic acid-inducible gene-I and interferon-beta
promoter stimulator-1 augment proapoptotic responses following mam-
malian reovirus infection via interferon regulatory factor-3. J. Biol. Chem.
282:21953–21961.
17. Honda K, et al. 2005. IRF-7 is the master regulator of type-I interferon-
dependent immune responses. Nature 434:772–777.
18. Kato H, et al. 2008. Length-dependent recognition of double-stranded
ribonucleic acids by retinoic acid-inducible gene-I and melanoma
differentiation-associated gene 5. J. Exp. Med. 205:1601–1610.
19. Kim J, Parker JS, Murray KE, Nibert ML. 2004. Nucleoside and RNA
triphosphatase activities of orthoreovirus transcriptase cofactor mu2. J.
Biol. Chem. 279:4394–4403.
20. Kobayashi T, et al. 2007. A plasmid-based reverse genetics system for
animal double-stranded RNA viruses. Cell Host Microbe 1:147–157.
21. Kobayashi T, Ooms LS, Chappell JD, Dermody TS. 2009. Identification
of functional domains in reovirus replication proteins muNS and mu2. J.
Virol. 83:2892–2906.
22. Kuhl U, et al. 2005. High prevalence of viral genomes and multiple viral
infections in the myocardium of adults with “idiopathic” left ventricular
dysfunction. Circulation 111:887–893.
23. Kuhl U, et al. 2003. Interferon-beta treatment eliminates cardiotropic
viruses and improves left ventricular function in patients with myocardial
persistence of viral genomes and left ventricular dysfunction. Circulation
107:2793–2798.
24. Kuhl U, et al. 2005. Viral persistence in themyocardium is associated with
progressive cardiac dysfunction. Circulation 112:1965–1970.
25. Leonard GT, Sen GC. 1996. Effects of adenovirus E1A protein on
interferon-signaling. Virology 224:25–33.
26. Loo YM, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses
in innate immunity. J. Virol. 82:335–345.
27. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors.
Immunity 34:680–692.
28. Marques JT, et al. 2006. A structural basis for discriminating between self
and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol.
24:559–565.
29. Martin A, et al. 1994. Acute myocarditis: rapid diagnosis by PCR in
children. Circulation 90:330–339.
30. Mason JW, et al. 1995. A clinical trial of immunosuppressive therapy for
myocarditis. N. Engl. J. Med. 333:269–275.
31. Miller CL, et al. 2004. Increased ubiquitination and other covariant
phenotypes attributed to a strain- and temperature-dependent defect of
reovirus core protein mu2. J. Virol. 78:10291–10302.
32. Miric M, et al. 1996. Long-term follow-up of patients with dilated heart
muscle disease treated with human leukocytic interferon alpha or thymic
hormones: initial results. Heart 75:596–601.
33. Nibert ML, Margraf RL, Coombs KM. 1996. Nonrandom segregation of
parental alleles in reovirus reassortants. J. Virol. 70:7295–7300.
34. Nichols JL, Bellamy AR, Joklik WK. 1972. Identification of the nucleo-
tide sequences of the oligonucleotides present in reovirions. Virology 49:
562–572.
35. Noble S, Nibert ML. 1997. Core protein mu 2 is a second determinant of
nucleoside triphosphatase activities in the reovirus core. J. Virol. 71:7728–
7735.
36. O’Donnell SM, et al. 2005. Organ-specific roles for transcription factor
NF-B in reovirus-induced apoptosis and disease. J. Clin. Invest. 115:
2341–2350.
37. O’Neill LA, Bowie AG. 2010. Sensing and signaling in antiviral innate
immunity. Curr. Biol. 20:R328–R333.
38. Ooms LS, Kobayashi T, Dermody TS, Chappell JD. 2010. A post-entry
Irvin et al.
2310 jvi.asm.org Journal of Virology
step in themammalian orthoreovirus replication cycle is a determinant of
cell tropism. J. Biol. Chem. 285:41604–41613.
39. Parker JSL, Broering TJ, Kim J, Higgins DE, Nibert ML. 2002. Reovirus
core protein mu2 determines the filamentous morphology of viral inclu-
sion bodies by interacting with and stabilizing microtubules. J. Virol. 76:
4483–4496.
40. Parrillo JE, et al. 1989. A prospective, randomized, controlled trial of
prednisone for dilated cardiomyopathy. N. Engl. J. Med. 321:1061–1068.
41. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay
between induction, signaling, antiviral responses and virus countermea-
sures. J. Gen. Virol. 89:1–47.
42. SatoM, et al. 1998. Postive feedback regulation of type 1 IFN genes by the
IFN-inducible transcription factor IRF-7. FEBS Lett. 441:106–110.
43. Schiff LA, Nibert ML, Tyler KL. 2007. Orthoreoviruses and their repli-
cation, p 1853–1915. In Knipe DM, Howley PM (ed), Fields virology, 5th
ed, vol 2. Lippincott/The Williams & Wilkins Co, Philadelphia, PA.
44. Sherry B, Baty CJ, Blum MA. 1996. Reovirus-induced acute myocarditis
in mice correlates with viral RNA synthesis rather than generation of in-
fectious virus in cardiac myocytes. J. Virol. 70:6709–6715.
45. Sherry B, Blum MA. 1994. Multiple viral core proteins are determinants
of reovirus-induced acute myocarditis. J. Virol. 68:8461–8465.
46. Sherry B, Fields BN. 1989. The reovirus M1 gene, encoding a viral core
protein, is associatedwith themyocarditic phenotype of a reovirus variant.
J. Virol. 63:4850–4856.
47. Sherry B, Li X, Tyler KL, Cullen JM, Virgin HW. 1993. Lymphocytes
protect against and are not required for reovirus-induced myocarditis. J.
Virol. 67:6119–6124.
48. Sherry B, Torres J, BlumMA. 1998. Reovirus induction of and sensitivity
to beta-interferon in cardiac myocyte cultures correlate with induction of
myocarditis and are determined by viral core proteins. J. Virol. 72:1314–
1323.
49. Smith RE, Zweerink HJ, Joklik WK. 1969. Polypeptide components of
virions, top component and cores of reovirus type 3. Virology 39:791–
810.
50. Stewart MJ, Smoak K, Blum MA, Sherry B. 2005. Basal and reovirus-
induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expres-
sion are cell type specific in the cardiac protective response. J. Virol. 79:
2979–2987.
51. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol.
Rev. 227:75–86.
52. Wilkins C, Gale M, Jr. 2010. Recognition of viruses by cytoplasmic
sensors. Curr. Opin. Immunol. 22:41–47.
53. Yin P, et al. 2004. Comparisons of theM1 genome segments and encoded
mu2 proteins of different reovirus isolates. Virol. J. 1:6.
54. Zhang X, Walker SB, Chipman PR, Nibert ML, Baker TS. 2003. Reo-
virus polymerase lambda 3 localized by cryo-electron microscopy of viri-
ons at a resolution of 7.6 Å. Nat. Struct. Biol. 10:1011–1018.
55. Zurney J, Howard KE, Sherry B. 2007. Basal expression levels of IFNAR
and Jak-STAT components are determinants of cell-type-specific differ-
ences in cardiac antiviral responses. J. Virol. 81:13668–13680.
56. Zurney J, Kobayashi T, Holm GH, Dermody TS, Sherry B. 2009.
Reovirusmu2 protein inhibits interferon signaling through a novelmech-
anism involving nuclear accumulation of interferon regulatory factor 9. J.
Virol. 83:2178–2187.
Reovirus Amino Acid Modulates IFN and Myocarditis
February 2012 Volume 86 Number 4 jvi.asm.org 2311
 
APPENDIX F  
 
MOLECULAR DETERMINANTS OF PROTEOLYTIC DISASSEMBLY OF THE 
REOVIRUS OUTER CAPSID 
 
Joshua D. Doyle, Pranav Danthi, Emily A. Kendall, Laura S. Ooms, J. Denise Wetzel, 
and Terence S. Dermody 
 
Journal of Biological Chemistry. 287(11) 8029-38; 2012 
  144
Molecular Determinants of Proteolytic Disassembly of the
Reovirus Outer Capsid*
Received for publication,December 16, 2011, and in revised form, January 16, 2012 Published, JBC Papers in Press, January 17, 2012, DOI 10.1074/jbc.M111.334854
Joshua D. Doyle‡§, Pranav Danthi§¶1, Emily A. Kendall§¶2, Laura S. Ooms‡§, J. Denise Wetzel§¶,
and Terence S. Dermody‡§¶3
From the Departments of ‡Pathology, Microbiology, and Immunology and ¶Pediatrics and the §Elizabeth B. Lamb Center for
Pediatric Research, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
Background: The reovirus outer capsid protein 3 acts as a substrate for intracellular proteases.
Results: Two polymorphic amino acids in 3 act in opposition to determine protease sensitivity, disassembly kinetics, and
biochemical stability.
Conclusion: A regulatory network of residues maintains optimal reovirus outer capsid function.
Significance:Thebalancebetweenstability and instabilityof capsid structures is likely tobean importantdeterminantof viral fitness.
Following attachment and internalization,mammalian reovi-
ruses undergo intracellular proteolytic disassembly followed by
viral penetration into the cytoplasm. The initiating event in reo-
virus disassembly is the cathepsin-mediated proteolytic degra-
dation of viral outer capsid protein 3. A single tyrosine-to-
histidine mutation at amino acid 354 (Y354H) of strain type 3
Dearing (T3D) 3 enhances reovirus disassembly and confers
resistance to protease inhibitors such as E64. The3 amino acid
sequence of strain type 3 Abney (T3A) differs from that of T3D
at eight positions including Y354H. However, T3A displays dis-
assembly kinetics and protease sensitivity comparable with
T3D.We hypothesize that one or more additional 3 polymor-
phisms suppress the Y354H phenotype and restore T3D disas-
sembly characteristics. To test this hypothesis, we engineered a
panel of reovirus variants with T3A 3 polymorphisms intro-
duced individually into T3D-3Y354H. We evaluated E64
resistance and in vitro cathepsin L susceptibility of these viruses
and found that one containing a glycine-to-glutamate substitu-
tion at position 198 (G198E) displayed disassembly kinetics and
E64 sensitivity similar to those properties of T3A and T3D.
Additionally, viruses containing changes at positions 233 and
347 (S233L and I347T) developed de novo compensatory muta-
tions at position 198, strengthening the conclusion that residue
198 is a key determinant of 3 proteolytic susceptibility. Vari-
ants with Y354H in3 lost infectivity more rapidly than T3A or
T3D following heat treatment, an effect abrogated by G198E.
These results identify a regulatory network of residues that
control 3 cleavage and capsid stability, thus providing insight
into the regulation of nonenveloped virus disassembly.
All virusesmust transit host cellmembranes, either at the cell
surface or following particle internalization, to productively
infect cells. Enveloped viruses, such as orthomyxoviruses (1, 2),
paramyxoviruses (3), and retroviruses (4, 5), encode proteins
that mediate fusion of the viral envelope with target cell mem-
branes, thus facilitating viral cell entry. Nonenveloped viruses,
such as adenovirus (6) and reovirus (7), traverse cellular mem-
branes despite the absence of a viral envelope. The capsid pro-
teins of nonenveloped viruses often contain hydrophobic
motifs that are exposed in response to receptor binding or
endosomal cues. These motifs in turn disrupt host cell mem-
branes and mediate viral access to the cytosol. The viral
machinery that guides the virus into the cell interior must be
tightly regulated to ensure its activation only at the appropriate
time and in the correct compartment to ensure productive
infection.
Mammalian orthoreoviruses (reoviruses) are nonenveloped,
icosahedral viruses that contain a double-stranded RNA
genome housed within two concentric protein shells, an outer
capsid, composed primarily of viral proteins 3 and 1, and an
inner core (8, 9). Following binding to cell-surface receptors,
including sialylated glycans and junctional adhesional mole-
cule-A (JAM-A), reovirus particles are internalized via 1
integrin-dependent, clathrin-mediated endocytosis (10–13).
Internalized viral particles undergo a stepwise disassembly
process. The initial event in reovirus disassembly is the proteo-
lytic cleavage of 3 protein, which is catalyzed by endosomal
cathepsin proteases (14–16). Ablation of cathepsin activity by
either pharmacological (7, 14) or genetic (16) means abolishes
reovirus infectivity, suggesting that 3 cleavage is essential for
reovirus disassembly and productive infection. Proteolytic
removal of 3 facilitates cleavage of 1 to generate the frag-
ments  and , resulting in formation of infectious subvirion
particles (7, 17, 18). Infectious subvirion particles feature
exposedmembrane interactionmotifs and transit across mem-
branes, leading to the delivery of viral core particles into the
cytosol (19). Infectious subvirion particles can be generated in
vitro using several proteases, including cathepsins B and L (7,
16, 20).
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Structural determinants of 3 cathepsin-cleavage suscepti-
bility are not well defined. Putative cathepsin L cleavage sites
between residues 243–244 and 250–251 have been identified in
reovirus strain type 1 Lang (T1L)4 3 (16), and this region is
conserved between T1L and strain type 3 Dearing (T3D). How-
ever, structural models of 3 (21) indicate that these cleavage
sites are masked by the 3 carboxyl-terminal domain (C termi-
nus). Additional evidence suggests that the C terminus deter-
mines 3 protease susceptibility (22). Mutant viruses isolated
frompersistently infected cultures have increased protease sus-
ceptibility (23), a phenotype that genetically segregates with a
tyrosine-to-histidine mutation at amino acid position 354
(Y354H) in 3 (22), which is located in the C terminus of the
protein. The Y354H mutation increases the rate at which 3 is
cleaved by proteases in vitro and confers resistance to protease
inhibitors, such as the pan-cysteine protease inhibitor E64 and
ammonium chloride, which inhibits vacuolar acidification (14,
22, 24). ThemechanismbywhichY354Henhances the protease
sensitivity of 3 is unclear, but it is possible that His-354 alters
the intramolecular localization of the C terminus and exposes
the normally occluded protease cleavage sites (22).
The relationship between the stability of nonenveloped virus
capsid structures and viral fitness is poorly defined. Mutations
that enhance outer capsid proteolysis, such as Y354H, acceler-
ate the kinetics of viral entry into tissue culture cells and enable
viral replication in settings of diminished protease availability.
However, this mutation is absent from most primary reovirus
isolates (25), suggesting that it imposes a fitness penalty on the
virus. Interestingly, the deduced 3 amino acid sequence of
strain type 3 Abney (T3A) (26) contains a native histidine at
residue 354 (25). Determining how His-354 in T3A 3 affects
cell entry, viral disassembly, and viral replication should pro-
vide information about hownonenveloped virusesmaintain the
optimum balance between capsid stability and instability and
further an understanding of the fitness implications of perturb-
ing that balance.
In this study, we compared disassembly kinetics and sensitiv-
ity to protease inhibitors of T3A and T3D. The deduced 3
amino acid sequence of T3D contains a tyrosine at residue 354,
and there are seven additional amino acid polymorphisms
between T3A and T3D 3 sequence. We engineered a panel of
reovirus variants containing each of these native 3 polymor-
phisms in the context of 3-Y354H to identify residues in 3
that modulate protease sensitivity. The panel of variants was
tested for growth inhibition by E64 and disassembly mediated
by cathepsin L in vitro. We identified a glycine-to-aspartate
polymorphism at position 198 in 3 that is capable of inde-
pendently suppressing the Y354H phenotype.We propose that
residues 198 and 354 act in concert to maintain optimum sta-
bility of the reovirus capsid.
EXPERIMENTAL PROCEDURES
Cells and Viruses—Spinner-adapted murine L929 cells were
grown in either suspension or monolayer cultures in Joklik’s
spinner-modified Eagle’s minimal essential medium (SMEM;
Lonza, Walkersville, MD) supplemented to contain 5% fetal
bovine serum (Invitrogen), 2 mM L-glutamine (Invitrogen), 100
units of penicillin/ml, 100 units of streptomycin/ml (Invitro-
gen), and 0.25 g of amphotericin/ml (Sigma-Aldrich).
BHK-T7 (baby hamster kidney-T7) cells were grown inDulbec-
co’s modified Eagle’s minimal essential medium (Invitrogen)
supplemented to contain 5% fetal calf serum, 2mM L-glutamine,
2%minimal essentialmediumamino acid solution (Invitrogen),
and 1 mg of Geneticin/ml (Invitrogen).
Reovirus strain T3A is maintained as a laboratory stock.
Recombinant strain (rs) T3D is a stock generated by plasmid-
based reverse genetics from cloned T3D cDNAs (27). The engi-
neered reovirus mutant rsT3D-3Y354H was generated as
described (28).
Generation of Reovirus Variants—Viruses containing engi-
neered changes in3 protein were generated using reverse genet-
ics (27). The S4 genewas excised from the pT7-M2-S2-S3-S4T3D
plasmid (27) using HindIII and NheI to generate the tricistronic
plasmid pT7-M2-S2-S3T3D. The pT7-S4T3D plasmid was
used as template to generate pT7-S4T3DA28TY354H,
pT7-S4T3DE108AY354H, pT7-S4T3DI180V Y354H, pT7-
S4T3DG198EY354H, pT7-S4T3DS215DY354H, pT7-
S4T3DS233L Y354H, and pT7-S4T3DI347TY354H using
QuikChange mutagenesis (Stratagene, La Jolla, CA). Monolayers
of BHK-T7 cells (27) at 90% confluency (3 106 cells) seeded in
60-mmdishes (Costar; Corning Inc., Corning,NY)were co-trans-
fected with 3.5 g each of five plasmids representing the cloned
reovirusT3Dgenomeusing 3l of TransIT-LT1 transfection rea-
gent (Mirus Bio LLC;Madison,WI) perg of plasmid DNA. Fol-
lowing 72 h of incubation, recombinant virus was isolated from
transfected cells by plaque purification using monolayers of L929
cells (29). Virus stocks were passaged, and titers were determined
as described (30).
Growth of Virus inCells Treatedwith E64—Confluentmono-
layers of L929 cells (2  105 cells/well) in 24-well plates
(Costar) were preincubated in SMEM supplemented to contain
0–200 M E64 (Sigma-Aldrich) at 37 °C for 4 h. The medium
was removed, and cells were adsorbed with second- or third-
passage virus stocks at anm.o.i. of 2 pfu/cell. After incubation at
4 °C for 1 h, the inoculumwas removed, cells were washed with
PBS, and 1 ml of fresh SMEM supplemented to contain 0–200
M E64 was added. Cells were incubated at 37 °C for 24 h and
frozen and thawed twice. Viral titer in cell lysates was deter-
mined by plaque assay (29).
Treatment of Reovirus Virions with Cathepsin L—Purified
reovirus virions at a concentration of 2  1012 particles/ml in
reaction buffer L (100 mM NaCl, 15 mM MgCl2, 50 mM sodium
acetate (pH 5.0)) were treated with 50 g of purified, recombi-
nant human cathepsin L (7) per ml in the presence of 5 mM
dithiothreitol at 37 °C for 0–4 h. Aliquots were removed at
various intervals, mixed with SDS sample buffer supplemented
to contain 500 M E64, and incubated on ice for 5 min to ter-
minate protease activity. Reaction mixtures were analyzed by
SDS-PAGE.
SDS-PAGE of Reovirus Structural Proteins—Discontinuous
SDS-PAGE was performed as described (31). Samples were
incubated at 98 °C for 5min, loaded intowells of precast 4–20%
4 The abbreviations used are: T1L, type 1 Lang; T3A, type 3 Abney; T3D, type 3
Dearing; SMEM, spinner-modified Eagle’s minimal essential medium; Tri-
cine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; m.o.i., multiplic-
ity of infection; rs, recombinant strain.
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gradient Tris-Tricine polyacrylamide gels (Bio-Rad Laborato-
ries), and electrophoresed at a constant voltage of 180 V for 1 h.
Following electrophoresis, gels were stained using a Novex col-
loidal blue staining kit (Invitrogen) according to the manufac-
turer’s instructions.
Densitometric Analysis of Reovirus Structural Proteins—
Stained gels were visualized using an infrared imaging system
(LI-COR Biosciences, Lincoln, NE). Band intensities in the
scanned images were quantified using Odyssey Application
software version 3.0.16 (LI-COR). The relative amount of 3
protein was determined by comparing the intensity of bands
corresponding to 3, which has an apparent molecular mass of
41 kDa, with bands corresponding to viral core protein 2,
which has an apparent molecular mass of 47 kDa and is not
affected by protease treatment under these conditions (14).
Heat Resistance of Reovirus Virions—Purified reovirus viri-
ons at a concentration of 2 108 particles/ml in virion storage
buffer (150mMNaCl, 15 mMMgCl2, 10 mMTris (pH 7.4)) were
treated at 55 °C for 60 min. At 15-min intervals, samples were
removed and placed on ice. Viral titers were determined by
plaque assay (28).
Specific Infectivity of Reovirus Virions—Fresh preparations of
reovirus virions were generated in triplicate from second-pas-
sage lysate stocks as described (27). Particle density of each viral
preparation was determined by quantifying absorbance at 260
nm and calculated using the equivalence of 1A260 2.1 1012
particles/ml (32). Titer of each preparation was determined by
plaque assay (28).
Kinetic Ammonium Chloride Protection Assay—Confluent
monolayers of L929 cells (2 105 cells/well) in 24-well plates
were adsorbed with second- or third-passage virus stocks at an
m.o.i. of 25 pfu/cell. After incubation at 4 °C for 1 h, the inocu-
lum was removed, cells were washed with PBS at 4 °C, and 1 ml
of prewarmed SMEMwas added. At various times after adsorp-
tion, 25l of 1 MNH4Clwas added to themedium to give a final
concentration of 25 mM. At 20 h after adsorption, the medium
was removed, and cellmonolayerswere fixedwith 1ml ofmeth-
anol at 20 °C for a minimum of 30 min. Fixed monolayers
were washed twice with PBS, blocked with 5% immunoglobu-
lin-free BSA (Sigma-Aldrich) in PBS, and incubated at 37 °C for
30 min with rabbit polyclonal anti-reovirus serum at a 1:1000
dilution in PBS plus 0.5% Triton X-100. Monolayers were
washed twice with PBS and incubated at 37 °C for 30minwith a
1:1000 dilution of anti-rabbit goat immunoglobulin conjugated
with Alexa Fluor 488 (Molecular Probes, Inc., Eugene, OR).
Monolayers were washed twice and visualized by indirect
immunofluorescence. Reovirus antigen-positive cells were
quantitated by enumerating fluorescent cells in three random
fields of view per well at 100–400 magnification. Total cell
number was quantified by enumerating 4,6-diamidino-2-phe-
nylindole (DAPI)-stained nuclei.
RESULTS
T3A and T3D Are Sensitive to Protease Inhibitor E64—The
deduced amino acid sequences of T3A and T3D 3 proteins
contain eight polymorphic residues (Table 1). Several of the
T3A-T3D polymorphic residues including 354 are found in the
virion-distal region of 3, which is predicted to be accessible to
protease (Fig. 1). To determine whether the Y354H polymor-
phism inT3A3 confers resistance to protease inhibitors, T3A,
T3D, and T3D-3Y354H were tested for the capacity to repli-
cate in the presence of protease inhibitor E64. L929 cells were
incubated in medium supplemented to contain 100 or 200 M
E64, adsorbed with T3A, T3D, and T3D-3Y354H, and incu-
bated in the presence or absence of E64 for 24 h. Cells were
lysed, and viral titers in cell lysates were determined by plaque
assay (Fig. 2). Despite the presence of histidine at position 354
inT3A3, yields of T3Awere reduced 259-fold, approximating
the reduction observed for T3D, 195-fold, in the presence of
100 M E64, whereas yields of T3D-3Y354H were diminished
less than 10-fold at this E64 concentration. Replication of T3A
andT3Dwas completely ablated in the presence of 200ME64,
but yields of T3D-3Y354H were not further diminished.
These findings suggest that one or more of the additional poly-
morphisms displayed by T3A 3 suppresses the Y354H pheno-
type and restores optimal 3 stability.
G198EConfers Susceptibility to E64 inContext of Y354H—To
identify residues in T3A 3 that suppress the capacity of the
Y354H polymorphism to confer viral growth in the presence of
protease inhibitors, we engineered a panel of reovirus variants
that incorporate single T3A-T3D polymorphisms in the con-
text of T3D-3Y354H but are otherwise isogenic with T3D
(Table 2). Despite several attempts, we could not recover T3D-
3A28T,Y354H. In addition, T3D-3 S233L,Y354Hwas recov-
ered only with a concomitant glycine-to-tryptophan mutation
at position 198 of3. Each of the other variantswas rescued and
propagated to high titer working stocks.
We tested each of the variant viruses for replication in the
presence of E64 (Fig. 3). As before, yields of T3A and T3Dwere
diminished substantially by this inhibitor, whereas yields of
T3D-3Y354H were only modestly impaired. Similarly, yields
of T3D-3E108A, T3D-3I180V, T3D-3S215N, and T3D-
3I347T were only slightly diminished by E64. In sharp con-
trast, yields of T3D-3G198E,Y354Hwere markedly decreased
in the presence of E64, approximating those of T3A and T3D.
These findings suggest that a glycine-to-glutamic acid muta-
tion at position 198 independently suppresses the Y354H phe-
notype in T3A and enhances its sensitivity to the protease
inhibitor E64.
Cathepsin L Sensitivity of T3A-T3D Variant Viruses—Ca-
thepsin proteases catalyze reovirus disassembly within cellular
endosomes (16, 33). To determinewhetherT3A-T3Dpolymor-
phisms alter capsid disassembly when treated with endosomal
proteases, virions of T3A, T3D, T3D-3Y354H, and the T3A-
T3D variants were digested in vitro with purified human
cathepsin L (34). At 30-min intervals, aliquots were removed
from the digestionmixtures, and viral proteinswere resolved by
SDS-PAGE and visualized using colloidal blue staining (Fig.
TABLE 1
Polymorphic residues between T3A and T3D3
T3A and T3D differ at the eight indicated positions in the 3 open reading frame.
Virus strain
Amino acid position
28 108 180 198 215 233 347 354
T3A Thr Ala Val Glu Asn Leu Thr His
T3D Ala Glu Ile Gly Ser Ser Ile Tyr
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4A). Intensity of the band corresponding to 3 remained rela-
tively constant for T3A and T3D over the 240-min time course,
as did the band corresponding to1C.However, in these exper-
iments, T3D-3Y354H displayed almost complete loss of 3
protein within 60 min. In addition, the band corresponding to
1C in T3D-3Y354H diminished in intensity over the course
of protease treatment, and the appearance of a band corre-
sponding to the  fragment of 1C was noted for this virus.
Each of the variant viruses was observed to undergo disassem-
bly with kinetics similar to those of T3D-3Y354H (Fig. 4A)
with the exception of T3D-3G198E,Y354H, which displayed a
digestion profile similar to that of T3A and T3D.
We quantified the intensity of protein bands corresponding
to 3 using an Odyssey infrared imaging system (Fig. 4B). To
control for differences in gel loading, the band intensity of 3
protein was normalized to that of reovirus core protein 2,
which is resistant to protease cleavage under these conditions.
The 3/2 ratio of T3A and T3D slightly decreased over the
time course tested. The 3/2 ratio of T3D-3Y354H and the
variant viruses rapidly approached zero (Fig. 4B), with the nota-
FIGURE 1. Location of polymorphic residues in strains T3A and T3D 3 proteins. A crystal structure of T3D 3 (21) is shown highlighting polymorphic
residues in T3A and T3D3proteins, including Tyr-354 (dark green), which is altered in reovirus variants selected for enhanceddisassembly kinetics (23, 24, 39).
The virion-distal domain of3 including the C terminus (depicted in red) is at the top of the figure. The virion-proximal region including theN terminus is at the
bottom. Putative cathepsin L cleavage sites (determined for strain type 1 Lang) between amino acids 243 and 244 and between 250 and 251 are depicted in
black (16).
FIGURE 2. Replication of T3A, T3D, and rsT3D-3Y354H in L929 cells
treated with E64. Monolayers of L929 cells were preincubated for 4 h in
medium supplemented with or without E64 at the concentrations shown.
The mediumwas removed, and cells were adsorbed with virus at an m.o.i. of
2 pfu/cell. After adsorption for 1 h, the inoculum was removed, and fresh
medium with or without E64 was added. After incubation at 37 °C for 24 h,
cells were frozen and thawed twice, and viral titers were determined by
plaque assay. The results are presented as themean viral yields, calculated by
dividing titer at 24 h by titer at 0 h for each concentration of E64, for triplicate
experiments. Yields of less than zero are not shown. Error bars indicate S.D.
TABLE 2
Reovirus variants in which polymorphic residues in T3D 3 are
exchanged with those in T3A3
Reovirus variants were engineered using plasmid-based reverse genetics. Each reo-
virus variant is isogenic with T3D with the exception of His-354 and a single addi-
tional T3A residue as shown. Bold and italics indicate viruses that were not success-
fully recovered.
Virus strain
Amino acid position
28 108 180 198 215 233 347 354
T3D A E I G S S I Y
T3A T A V E N L T H
T3D-3Y354H A E I G S S I H
T3D-3A28T,Y354H T E I G S S I H
T3D-3E108A,Y354H A A I G S S I H
T3D-3I180V,Y354H A E V G S S I H
T3D-3G198E,Y354H A E I E S S I H
T3D-3S215N,Y354H A E I G N S I H
T3D-3S233L,Y354H A E I G S L I H
T3D-3I347T,Y354H A E I G S S T H
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ble exception of T3D-3G198E,Y354H. For this virus, the
3/2 ratio approximated the T3D 3/2 ratio throughout the
digestion time course.We conclude that G198E stabilizes 3 in
the context of Y354H.
Specific Infectivity of Reovirus Variants—Wenext considered
the possibility that one ormore of the3 polymorphisms in our
panel of variant reovirus strains might affect assembly of 3
onto nascent virions and thus compromise infectivity. To test
this hypothesis, we examined the specific infectivity of our var-
iant panel by calculating particle/pfu ratios for several inde-
pendent preparations of each virus (Fig. 5). We observed that
most of the virion stocks tested displayed particle/pfu ratios
between 300 and 1000, consistent with reported values for type
3 reovirus strains (35) and our previous observations (data not
shown). Although we observed some prep-to-prep variation,
there were no significant differences between the variant and
parental viruses (analysis of variance, p 0.05). Therefore, the
3 mutations introduced in our variant panel do not substan-
tially affect reovirus replicative efficiency and thus are not likely
to alter capsid assembly.
OuterCapsidMutationsAffect ReovirusHeat Sensitivity—To
assess whether the differences in protease sensitivity of our var-
iant viruses correlate with biochemical measures of capsid sta-
bility, we determined the relative loss of titer of our variant
panel following heat treatment. Samples of each virus were
diluted to a titer of 2 108 and placed at 55 °C for 1 h. Aliquots
were removed at 15-min intervals, and titers were deter-
mined by plaque assay (Fig. 6). We observed that T3D-
3Y354H lost titer significantly more rapidly (Student’s t
test, p 0.05) at elevated temperature than did either T3A or
T3D. Additionally, each of the variant viruses tested lost titer
at rates similar to T3D-3Y354H, again with the exception
FIGURE 3. E64 susceptibility of T3A-T3D variant viruses. Monolayers of
L929 cells were preincubated for 4 h in medium supplemented with or with-
out E64 at the concentrations shown. The medium was removed, and cells
were adsorbedwith virus at anm.o.i. of 2 pfu/cell. After adsorption for 1 h, the
inoculum was removed, and fresh medium with or without E64 was added.
After incubation at 37 °C for 24 h, cells were frozen and thawed twice, and
viral titers were determined by plaque assay. The results are presented as the
mean viral yields, calculated by dividing titer at 24 h by titer at 0 h for each
concentration of E64, for triplicate experiments. Yields of less than zero are
not shown. Error bars indicate S.D.
FIGURE4.Digestionof reovirus strainswith cathepsin L.A, purified virionswere treatedwithhuman cathepsin L (34) for the intervals shownand loaded into
wells of 4–20% gradient polyacrylamide gels. After electrophoresis, the gels were stainedwith colloidal blue (Invitrogen). Viral proteins1C, , 2, and 3 are
labeled at the left. The experiments shown are representative of two performed for each virus. B, intensities of bands corresponding to reovirus proteins were
quantified using the Odyssey software package (LI-COR). Results are expressed as the ratio of 3 band intensity to 2 band intensity to control for differences
in loading for two independent experiments. Error bars indicate S.D.
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of T3D-3G198E,Y354H. The rate of titer loss for that virus
did not significantly differ from T3D. The fact that enhanced
protease sensitivity and altered sensitivity to heat are corre-
lated in the context of Y354H suggests that this residue
controls both properties through a common structural
mechanism.
EnhancedOuter Capsid Protease Sensitivity Facilitates Endo-
somal Escape—Following binding to cell-surface receptors,
reovirus particles are thought to be internalized via clathrin-de-
pendent endocytosis (10–12, 36). Cleavage of 3 by endo-
somal cathepsins is required for particle disassembly and
subsequent escape from the endosome into the cytoplasm
(14–19, 37). To determine whether the enhanced suscepti-
bility to proteolytic cleavage mediated by 3-Y354H alters
the kinetics with which reovirus particles escape host cell
endosomes, we took advantage of the fact that reovirus dis-
assembly is abrogated by preventing the pH drop required
for efficient cathepsin cleavage when intact particles are still
resident in endosomes (7, 38). We adsorbed monolayers of
L929 cells with variant reovirus strains at 4 °C for 1 h to
synchronize viral attachment, warmed the cells to 37 °C, and
added ammonium chloride at various intervals following
FIGURE 5. Infectivity of reovirus variants. Purified virions of variant viruses were generated from independent cultures of L929 cells (4 108 cells) using
CsCl gradient centrifugation. Particle number was quantified using the equivalence of 1 A260  2.1  10
12 particles/ml. The titer of each preparation was
determined by plaque assay. The results are presented as particle/pfu ratio. Data points indicate independent viral purifications.
FIGURE 6.Resistanceof reovirus variants to inactivationbyheat. Purified virions of reovirus variantswere diluted to a concentration of 2 108 particles/ml
in virion storage buffer and incubated at 55 °C for 60min. At 15-min intervals, samples were removed and placed on ice for 15min. Titers were determined by
plaque assay. Results are presented as the percentage of mean viral titer of untreated samples per interval of incubation, for triplicate experiments. Error bars
indicate S.D.; *, p 0.05 in comparison with T3D.
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warming to prevent endosome acidification. Cells were incu-
bated overnight and scored for viral infectivity by indirect
immunofluorescence (Fig. 7). Variant viruses containing the
3-Y354H mutation, with the exception of T3D-
3G198E,Y354H, escaped ammonium chloride blockade as
much as 60 min earlier than either T3A or T3D. These find-
ings indicate that enhanced outer capsid protease sensitivity
accelerates access of reovirus to the cytoplasm for subse-
quent steps in its replication cycle.
Residue 198 Second-site Changes—One of the variant
viruses, T3D-3S233L,Y354H, could be recovered only in
combination with a glycine-to-tryptophan substitution at
position 198. In addition, multiple isolates of T3D-
3I347T,Y354H contained de novo glycine-to-valine muta-
tions at position 198. To determine whether these second-
site mutations affect reovirus disassembly, we tested the
effect of E64 treatment on the replication of variants con-
taining these alterations (Fig. 8). Viruses containing either
Val-198 or Trp-198 in the context of Y354H had modestly
enhanced E64 sensitivity in comparison with that of T3D-
3Y354H. In particular, introduction of Val-198 restored the
E64 sensitivity of T3D-3G198V,I347T,Y354H to that of
T3D. The E64 sensitivity of T3D-3G198W,S233L,Y354H
was intermediate between that of T3D and T3D-3Y354H,
although T3D-3G198W,S233L,Y354H produced lower
peak titers in the absence of protease inhibitor than did T3D.
These findings underscore the importance of residue 198 in
determining 3 stability and suggest that the molecular basis
of Y354H suppressionmay differ depending on the biochem-
ical nature of the amino acid at that position.
DISCUSSION
Nonenveloped viruses must undergo particle disassembly to
initiate an infectious cycle. The rate-limiting step in reovirus
disassembly is the enzyme-mediated cleavage of 3 protein in
endosomes of infected cells (7, 11, 14, 17, 18). Surface features
of 3 that influence its capacity to serve as an enzyme substrate
are not well understood. A single mutation in reovirus T3D 3
protein, Y354H, enhances susceptibility of the reovirus virion
to protease and confers viral resistance to protease inhibitors
(14, 22, 24, 39). Structural evidence suggests that enhanced sus-
ceptibility to protease conferred by Y354H is due to an intra-
molecular rearrangement of domains in 3 that enhances
access to internal protease cleavage sites (22). However, this
model has not been explicitly tested. Selection of reovirus
mutants under conditions that diminish endosomal protease
activity yields viruses containing the 3-Y354H mutation (14,
24, 39), suggesting that capsid-destabilizing mutations are
advantageous in certain settings. The importance of capsid sta-
bility in other phases of the reovirus life cycle is unclear.
In this study, we identified a new surface determinant of reo-
virus capsid stability located at position 198 in 3. To our
knowledge, reovirus strain T3A is the only field isolate strain
reported to date that contains a histidine at position 354 (25).
Based on our previous understanding of the phenotype of virus
strains containing 3-Y354H, we anticipated that T3A would
be resistant to protease inhibitors anddisplay enhanced suscep-
tibility to proteases in comparison with T3D. Surprisingly, we
found that T3A has E64 sensitivity similar to that of T3D
despite the presence of His-354 in 3. We also observed that
T3A and T3D have similar in vitro disassembly kinetics when
treated with the endosomal protease cathepsin L. Based on
these observations, we hypothesized that other residues in T3A
3 that differ from T3D 3 suppress the Y354H phenotype.
We used plasmid-based reverse genetics to generate a panel
of reovirus variants to test the contributions made by each
T3A-T3D polymorphic residue to capsid stability in an other-
FIGURE 7. Kinetics of ammonium chloride bypass by reovirus variants.
Monolayers of L929 cells were adsorbed with reovirus variants at an m.o.i. of
25 pfu/cell at 4 °C. After adsorption for 1 h, the inoculumwas removed, fresh
prewarmedmediumwas added, and cellswerewarmed to 37 °C. At the times
shown after adsorption, ammonium chloride was added to a final concentra-
tion of 25 mM. After incubation at 37 °C for 20 h, cells were fixed with metha-
nol at20 °C, and infectivity was assessed by indirect immunofluorescence.
The results are presented as the percentage of cells infected, normalized to
untreated wells, for triplicate experiments. Error bars indicate S.D.
FIGURE 8. E64 sensitivity of reovirus strains with second-site mutations.
Monolayers of L929 cellswerepreincubated for 4h inmediumsupplemented
with orwithout E64 at the concentrations shown. Themediumwas removed,
and cells were adsorbed with reovirus strains at an m.o.i. of 2 pfu/cell. After
adsorption for 1 h, the inoculum was removed, and fresh medium with or
without E64 was added. After incubation at 37 °C for 24 h, cells were frozen
and thawed twice, and viral titers were determined by plaque assay. The
results are presented as the mean viral yields, calculated by dividing titer at
24 h by titer at 0 h for each concentration of E64, for triplicate experiments.
Yields of less than zero are not shown. Error bars indicate S.D.
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wise isogenic background that includesY354H.Despite numer-
ous attempts, a virus containing an aspartate-to-threonine
change at position 28, T3D-3D28T,Y354H, could not be
recovered. Amino acid 28 is located in a virion-proximal
domain of 3 (Fig. 1) that is important for interactions of 3
with 1 during virion assembly (40). It is possible that muta-
tions at position 28 impair interactions between3 and1 (40),
hindering recovery of T3D-3D28T,Y354H. The recovered
variant viruses had no overt defects in replication or specific
infectivity (Fig. 5). All of the T3A-T3D variant viruses are resis-
tant to cysteine protease inhibitor E64 and thus phenocopy
T3D-3Y354H, except the virus containing a glycine-to-gluta-
mate change at position 198, T3D-3G198E,Y354H. Yields of
T3D-3G198E,Y354H aremarkedly diminished in cells treated
with E64. Concordantly, all members of the T3A-T3D variant
panel except T3D-3G198E,Y354H display kinetics of diges-
tion by cathepsin L similar to T3D-3Y354H. Moreover, we
also observed that all of the variant viruses escape an endosomal
infectivity block more rapidly than T3A or T3D, again except-
ing T3D-3G198E,Y354H. Together, these results provide
strong evidence that suppression of the Y354H phenotype in
T3A is solely attributable to the glycine-to-glutamate polymor-
phism at position 198.
Another virus, T3D-3S233L,Y354H, could be recovered
only with an accompanying glycine-to-tryptophan mutation
at position 198. In addition, four of the seven T3D-
3I347T,Y354H clones sequenced contained a second-site
mutation at position 198, specifically, a glycine-to-valine sub-
stitution. We found that T3D-3G198W,S233L,Y354H and
T3D-3G198V,I347T,Y354H had increased E64 susceptibility
in comparison with that of T3D-3Y354H, although neither
virus was as sensitive to this protease inhibitor as was T3A or
T3D. The observation of two different, independently arising
mutations at position 198 in 3 supports the conclusion that
residue 198 is a key determinant of3 protease susceptibility. It
is plausible thatmutations at positions 233 and 347 enhance the
selection of Y354H-suppressive mutations, perhaps by further
destabilizing 3.
The 3 C terminus is thought to control the rate of 3 cleav-
age by restricting protease access to cleavage sites located inter-
nally within the protein (16, 22, 40). The C-terminal domain of
3 localizes to a solvent-exposed surface of the 3/1 hetero-
hexamer and is not predicted to directly interact with other
viral proteins (40). There is some structural evidence suggest-
ing that the Y354H mutation accelerates 3 cleavage by dislo-
cating the 3 C terminus, affording easier access to internal
cleavage sites (22). The observation that residue 198 suppresses
Y354H indirectly supports this model (Fig. 9). The 3 C termi-
nus (red) overlies the putative cathepsin L cleavage sites (black),
located between residues 243–244 and 250–251. Substitution
of Tyr-354 in the C terminus (green) with histidine, a basic
amino acid, may disrupt hydrophobic interactions required for
proper folding of the 3 C terminus. Low resolution cryo-EM
reconstructions of 3-Y354H reveal added density in a hinge
region between the virion-proximal and virion-distal 3 lobes
that is absent in T3D 3 (22). This increase in density may
represent the dislocated C terminus of the molecule. Residue
198 in 3 is located on a loop directly opposed to residue 354.
It is possible that the glycine-to-glutamate polymorphism
observed in T3A stabilizes the C terminus through charge-
charge interactions with His-354. Substitution of residue 198
with hydrophobic amino acids, such as tryptophan and valine as
observed in this study, may also stabilize the 3 C terminus,
perhaps by steric interactions that limit its mobility. Our find-
ing that alterations at positions 233 and 347 elicit compensa-
tory hydrophobic mutations at position 198 suggests that more
complex intramolecular rearrangements of 3 may occur in
those viruses. Interestingly, a virus selected for growth in the
presence of E64, D-EA3, contains two mutations in 3, the
expected Y354H and a glycine-to-arginine change at position
198 (39). In that study, Arg-198 failed to suppress Y354H, per-
haps because it fails to neutralize the basic charge of His-354.
Although our results suggest that3 residue 198 is a key surface
determinant of reovirus outer capsid stability, the ready selec-
tion of mutations at position 198 that incorporate amino acids
with a range of biochemical propertiesmay point to subtle roles
FIGURE 9. Residues 198 and 354 define an amino acid network regulating3 proteolysis. The virion-distal domain of T3D 3 is shown. The C terminus is
depicted in red. Glu-198 andHis-354 aremodeled in yellow and green, respectively, and are drawn in stick representation. The amino acids corresponding to the
two putative cathepsin L cleavage sites, residues Val-243-Thr-244 and Gly-250-His251 (16), are shown in black in stick representation.
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for residue 198 either inmaintaining capsid stability or in other
aspects of reovirus replication.
The observation that 3-Y354H is rare in circulating reovi-
rus strains and exists coincident with suppressor mutations in
T3A3 suggests that reovirus strains suffer a fitness penalty for
mutations that destabilize the outer capsid. The reovirus life
cycle involves fecal-oral transmission between infected hosts, a
step that requires some degree of resistance to degradation.
Viruses with diminished outer capsid stability may have
decreased viability outside a mammalian host, which would
reduce their likelihood of encountering a new host. We note
that viruses containing uncompensated 3-Y354H lose titer
more rapidly at elevated temperature than T3A or T3D (Fig. 6),
suggesting that such virusesmay have diminished environmen-
tal persistence or decreased infectivity from fomite surfaces.
However, it is possible that destabilization of the outer capsid
adversely affects other aspects of viral replication or virus-host
interactions. The optimum stability of reovirus capsid struc-
tures may also depend on the specific proteolytic milieu of the
various physiological compartments encountered by viral par-
ticles during the course of infection. More work is necessary to
define the precise constraints on reovirus capsid stability
throughout the viral life cycle. The findings reported in this
study identify a network of residues that determine the stability
of reovirus 3 and provide insight into mechanisms used by
nonenveloped viruses to maintain optimum capsid stability.
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ABSTRACT 18 
 19 
The double-stranded RNA virus, mammalian reovirus, displays broad cell, tissue, and host 20 
tropism. A critical checkpoint in the reovirus replication cycle resides within viral cytoplasmic 21 
inclusions, which are biosynthetic centers of genome multiplication and new particle assembly. 22 
Replication of strain type 3 Dearing (T3) is arrested in Madin-Darby canine kidney (MDCK) 23 
cells at a step subsequent to inclusion development and prior to formation of genomic double-24 
stranded RNA. This phenotype is primarily regulated by viral replication protein μ2. To 25 
understand how reovirus inclusions differ in productively and abortively infected MDCK cells, 26 
we used confocal immunofluorescence and thin-section transmission electron microscopy (TEM) 27 
to probe inclusion organization and particle morphogenesis. Although no abnormalities in 28 
inclusion morphology or viral protein localization were observed in T3-infected MDCK cells 29 
using confocal microscopy, TEM revealed markedly diminished production of mature progeny 30 
virions. Compared to T3-T1M1, a productively replicating reovirus strain, T3 inclusions were 31 
less frequent, smaller, and contained decreased numbers of complete particles. T3 replication 32 
was enhanced when cells were cultivated at 31ºC, and inclusion ultrastructure at low-temperature 33 
infection more closely resembled that of a productive infection. These results indicate that 34 
particle assembly in T3-infected MDCK cells is defective, possibly due to a temperature-35 
sensitive structural or functional property of μ2. Thus, reovirus cell tropism can be governed by 36 
interactions between viral replication proteins and the unique cell environment that modulate 37 
efficiency of particle assembly.  38 
 39 
40 
 3
INTRODUCTION 41 
 42 
A common strategy shared by numerous viruses is the formation of specialized sites within a 43 
host cell to compete viral replication. Animal double-stranded (ds) RNA viruses generate 44 
nonmembranous intracytoplasmic structures—termed inclusions or factories—that have a 45 
characteristic morphology, contain viral proteins and RNA, and constitute the presumed site of (-46 
)-strand RNA synthesis and particle assembly (11, 35, 48). We are studying replication 47 
mechanisms of the dsRNA virus, mammalian orthoreoviruses (reovirus), to better understand the 48 
function of viral inclusions and how these novel organelles influence viral tropism. 49 
Reoviruses are nonenveloped, double-shelled, icosahedral particles containing a genome 50 
of 10 dsRNA segments (40). The viral replication cycle is entirely cytoplasmic. Following 51 
internalization of virions, the viral outer capsid disassembles to generate transcriptionally active 52 
core particles (3, 15, 49), which are released into the cytoplasm and synthesize full-length, 53 
message-sense, capped and nonpolyadenylated ssRNAs (32, 42, 45). Viral inclusions are 54 
detectable as early as 4 h post-infection by confocal immunofluorescence microscopy, lack a 55 
delimiting membrane, and contain viral proteins and dsRNA, virion particles at various stages of 56 
morphogenesis, and at late times of infection, paracrystalline arrays of virion particles (12, 13, 57 
37). Studies of viral inclusions in infected cells and viral inclusion-like structures formed by 58 
ectopic protein expression indicate that higher-order multimers of viral nonstructural protein 59 
μNS establish inclusions by forming an essential matrix to which μ2, nonstructural protein σNS, 60 
and other viral structural proteins are recruited (1, 4, 5, 7-9, 13, 16, 17, 22, 23, 26, 27, 34, 37, 41, 61 
43, 44, 46). The μNS, μ2, and σNS proteins participate in inclusion formation and maturation as 62 
indispensable components of viral replication (23). However, the nature of ribonucleoprotein 63 
 4
(RNP) intermediates linking the initial round of viral gene expression to the emergence of mature 64 
progeny virions has been only partially defined. 65 
Although viral RNA assortment, genome replication, secondary transcription, and 66 
particle formation are presumed to occur within reovirus inclusions (2, 13, 14, 29, 30, 37, 58, 59), 67 
individual steps of particle assembly remain largely unknown. However, this process likely 68 
begins with assortment of positive-sense viral RNAs by a specific mechanism. Available data are 69 
congruous with an assembly model wherein equimolar amounts of the 10 viral mRNAs associate 70 
with nonstructural and core proteins and condense to form “replicase particles” (2, 14) capable of 71 
synthesizing complementary negative-sense RNA to generate the dsRNA genome. Populations 72 
of particles with distinctive complements of viral RNA and protein, as well as specific 73 
transcriptional activities (i.e., positive- or negative-strand synthesis), can be separated 74 
physiochemically and are thought to represent intermediates on a pathway toward virion 75 
assembly (29, 30, 58, 59). Current concepts of sequential steps in virion assembly are rooted 76 
mainly in biochemical analyses of these subvirion forms. However, the proposed assembly 77 
intermediates have not been correlated with specific morphogenic events in viral inclusions.  78 
Reovirus inclusions are implicated functionally as determinants of viral cell tropism (33), 79 
where tropism is defined as the range of hosts, tissues, and cells productively infected. Reovirus 80 
strains type 1 Lang (T1) and type 3 Dearing (T3) display differential capacity to replicate in 81 
Madin Darby canine kidney (MDCK) cells (33, 39). Strain T1 replicates efficiently, while T3 82 
replicates poorly. Analysis of recombinant reovirus strains derived from reverse genetics 83 
revealed that the M1-encoded μ2 protein of strain T1 in a T3 genetic background independently 84 
promotes reovirus replication in MDCK cells (33). The L1-encoded λ3 protein is a modulator of 85 
μ2 effects on replication efficiency, although λ3 does not display an independent association 86 
 5
with replication capacity in MDCK cells. Furthermore, the influence of λ3 on μ2-mediatied 87 
replication efficiency is manifest only in the T1 genetic background. These findings indicate that 88 
μ2 is the primary determinant of reovirus replication capacity in MDCK cells and λ3 is a 89 
conditional co-regulator of infectivity dependent on the viral genetic context. In the same study, 90 
we found that the μ2-sensitive step in replication occurs at a point in the reovirus life cycle 91 
subsequent to primary rounds of viral transcription and translation but prior to dsRNA synthesis, 92 
which suggests that μ2 and λ3 mediate differences in strain-specific replication efficiency at a 93 
life-cycle stage occurring within viral inclusions. 94 
The reovirus RNA-dependent RNA polymerase (RdRp) is thought to be composed of two 95 
subunits, λ3 and μ2. The λ3 protein is the RdRp catalytic subunit (47, 50, 56), and numerous 96 
biochemical, structural, and genetic studies indicate that μ2 lies proximal to λ3 and forms a 97 
subunit of the fully assembled polymerase complex (6, 10, 21, 31, 36, 54, 56). The μ2 protein 98 
also represents an essential component of viral inclusions required for productive viral 99 
replication (24, 34). It binds inclusion-forming protein μNS (9) and determines strain-specific 100 
differences in inclusion morphology—filamentous or globular—based on the relative capacity to 101 
bind microtubules and tether inclusions to the cytoskeleton (34). Although the μ2 protein 102 
coordinates diverse events during the reovirus replication cycle, a mechanistic understanding of 103 
the role of μ2 in replication remains unknown, primarily because its functions have not been 104 
linked to specific steps in the viral life cycle.  105 
In work described here, we used confocal immunofluorescence and transmission electron 106 
microscopy to more precisely define the role of μ2 protein in productive reovirus replication and 107 
virion particle production. The results indicate that particle assembly in T3-infected MDCK cells 108 
is defective and dependent on μ2 protein in a cell type-specific and temperature-dependent 109 
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manner. Thus, permissivity of some cell types to reovirus infection is governed by interactions 110 
between viral replication proteins and the unique cell environment that promote genesis of 111 
functional viral inclusions. 112 
113 
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MATERIALS and METHODS  114 
 115 
Cells and viruses. L929 (L) cells were grown in Joklik’s modified Eagle’s minimal essential 116 
medium (Lonza, Walkersville, MD) supplemented to contain 5% fetal calf serum (Cellgro, 117 
Manassas, VA), 2 mM L-glutamine (Gibco, Grand Island, NY), 100 U/ml penicillin (Gibco), 100 118 
μg/ml streptomycin (Gibco), and 0.25 μg/ml amphotericin B (Sigma, St. Louis, MO). MDCK 119 
cells were grown in DMEM supplemented to contain 4.5 μg/ml sodium pyruvate (Cellgro), 10% 120 
fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin G, 100 μg/ml streptomycin, and 0.25 121 
μg/ml amphotericin B. Strains T3 and T3-T1M1 were recovered by reverse genetics as described 122 
(22, 25). Viral titers were determined by plaque assay using L cells (51).  123 
 Quantification of virus infectivity. Monolayers of L cells or MDCK cells 124 
(approximately 5 x 105 cells) seeded in 24-well plates (Corning, Tewksbury, MA) were adsorbed 125 
with virus at a multiplicity of infection (MOI) of 2 PFU/cell at room temperature (RT) for 1 h. 126 
The viral inoculum was removed, cells were washed with PBS, fresh medium was added, and 127 
cells were incubated at 31ºC or 37ºC for various intervals, followed by removal to -80ºC. Viral 128 
titers in cell lysates were determined by plaque assay. Viral yield was calculated as the difference 129 
between log10 titer at the indicated time points and log10 titer at 0 h. 130 
 Immunofluorescence detection of reovirus infection. L cells plated on untreated glass 131 
coverslips and MDCK cells plated on poly-L-lysine (Sigma)-treated glass coverslips in 24-well 132 
plates were adsorbed with virus at an MOI of 20 PFU/cell. Following incubation at 37ºC for 24 h, 133 
cells were fixed with 10% formalin and stained with guinea pig σNS-specific (4) and either 134 
rabbit μNS-specific (23), rabbit μ2-specific (57), mouse σ3-specific (4F2, [52]), mouse μ1-135 
specific (8H6, [52]), or rabbit λ2-specific (7F4, [52]) antibodies, followed by Alexa 488-136 
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conjugated goat anti-guinea pig secondary antibody (Invitrogen, Eugene, OR), Alexa 546-137 
conjugated goat anti-rabbit secondary antibody (Invitrogen), or Alexa 546-conjugated goat anti-138 
mouse antibody (Invitrogen). ToPro3 (Invitrogen) was used to stain the nucleus. Images were 139 
acquired using a Zeiss LSM 510 META inverted confocal microscope. 140 
Electron microscopy. L cells or MDCK cells grown in T75 flasks (Corning) were 141 
adsorbed at RT for 1 h with virus at an MOI of 100 PFU/cell. Following adsorption, cells were 142 
incubated at 31ºC or 37ºC for 24 or 72 h. Cells were trypsinized, pelleted, washed with PBS, 143 
fixed at room temperature for at least 1 h with 2.5% glutaraldehyde buffered with 0.1 M sodium 144 
cacodylate, and stored at 4ºC. Following fixation, cells were washed with 0.1 M sodium 145 
cacodylate, postfixed in 1% osmium tetroxide/0.1 M sodium cacodylate for 1 h, washed in 0.1 M 146 
sodium cacodylate, and dehydrated using a graded series of ethanols. After dehydration, cells 147 
were subjected to two changes of propylene oxide and embedded in epoxy resin. Ultra-thin (65-148 
70 nm) serial sections were obtained using a Leica Ultracut microtome and collected on copper 149 
grids. Samples were contrast stained with 2% uranyl acetate followed by Reynold’s lead citrate 150 
and examined using a Phillips CM10 transmission electron microscope or FEI T-12 transmission 151 
electron microscope operated at 80 KeV.  152 
Quantification of TEM images. The fraction of cytoplasm containing virion particles or 153 
inclusion matrix in electron micrographs was quantified using point counting stereology (53). 154 
Images were collected in a systematic, unbiased fashion using a FEI T-12 transmission electron 155 
microscope at a magnification of 30,000x. Thirty-six images were collected for each sample. A 156 
grid of points was superimposed over the images (grid size 43 x 43 nm), and points overlying 157 
cytoplasm or virus-specific material were counted. The volume of virus-occupied cytoplasm was 158 
calculated by dividing the number of points that superimposed on virus-specific material by the 159 
 9
total number points on cytoplasm. Particle diameters were measured using ImageJ 160 
(http://rsb.info.nih.gov/ij/index.html). A Student’s t-test was used to determine statistical 161 
significance of differences among groups. The fraction of viral inclusion matrix occupied by 162 
particles was calculated from the images collected for point counting. Particle area was estimated 163 
by assuming that particles are spherical and calculating area using πr2, where r is half the mean 164 
diameter of mature and empty particles measured using imageJ. Areas of mature and empty 165 
particles were calculated independently using their respective diameters and combined to yield 166 
total particle area.167 
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RESULTS 168 
 169 
Reovirus replication in MDCK cells. Our previous studies of T3-infected MDCK cells 170 
revealed that inclusions produced by strain T3 display normal morphologic and kinetic 171 
development despite an apparent functional abnormality leading to arrest of replication (33). To 172 
more precisely define viral inclusion composition and ultrastructure in T3-infected MDCK cells, 173 
we used both confocal immunofluorescence microscopy and thin-section TEM. Strain T3-T1M1, 174 
containing the T1 M1 gene in an otherwise T3 genetic background, served as a reference for 175 
efficient μ2-regulated reovirus replication. Consistent with our previous results (33), T3-T1M1 176 
replicated to high titers, whereas T3 exhibited minimal titer increase over a 48 h incubation 177 
interval (Fig. 1A).  178 
Viral protein recruitment in MDCK cells. To determine whether protein recruitment to 179 
inclusions differs in productively and non-productively infected cells, we visualized individual 180 
viral proteins using confocal microscopy. Nonstructural proteins σNS and μNS physically 181 
associate in the formation of an inclusion scaffold (27). In cells infected with T3 or T3-T1M1, 182 
σNS and μNS displayed co-localization, forming large inclusions with usual strain-dependent 183 
morphology (globular for T3 and filamentous for T3-T1M1 [34]) at 24 h post-infection (Fig. 1 B, 184 
C). No alterations in σNS or μNS localization were apparent in T3-infected cells. These data 185 
indicate that the viral proteins required to form inclusions are properly recruited and assembled 186 
in T3-infected MDCK cells. 187 
We next examined the localization of viral core proteins μ2 and λ2 and outer-capsid 188 
proteins μ1 and σ3 in T3- and T3-T1M1-infected MDCK cells (Fig. 2A) and L cells (Fig. 2B). In 189 
MDCK cells, the μ2 and λ2 proteins of both T3 and T3-T1M1 were found throughout the 190 
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cytoplasm and concentrated in viral inclusions (Fig. 2A). A similar distribution of these proteins 191 
was observed in L cells. Outer-capsid protein σ3 was highly abundant in both T3- and T3-T1M1-192 
infected MDCK cells. It was found distributed throughout the cytoplasm, colocalized with σNS 193 
in inclusion puncta, and frequently in the nucleus (Fig. 2A). The distribution of σ3 in L cells was 194 
similar except for reduced distribution to the nucleus compared with MDCK cells. Outer-capsid 195 
protein μ1 was observed diffusely throughout the cytoplasm and in punctate structures associated 196 
with inclusions (Fig. 2). Fewer μ1-containing punctate structures were observed in T3- vs. T3-197 
T1M1-infected MDCK cells (Fig. 2A). However, this quantitative difference correlated with 198 
diminished levels of μ1 expression overall. Viral proteins also were visualized at earlier times 199 
post-infection. Inclusions were less developed, but patterns of protein distribution were similar to 200 
those observed at 24 h (data not shown). In summary, no qualitative differences in the 201 
distribution of non-structural, core, and outer-capsid viral proteins were discernable in 202 
comparison of T3 - and T3-T1M1-infected MDCK cells, indicating that viral protein recruitment 203 
to inclusions occurs normally for both strains. 204 
Ultrastructural analysis of viral inclusions in MDCK cells. As confocal microscopy 205 
did not reveal overt abnormalities in the morphology or viral protein composition of T3 206 
inclusions in MDCK cells, we used thin-section TEM to visualize viral particles within 207 
inclusions. In both T3- and T3-T1M1-infected cells, mature virion particles (i.e., containing 208 
electron-dense centers representing genomic viral RNA [13, 38]) and empty virion particles were 209 
observed in a variety of arrangements. Some sections contained only a few scattered mature 210 
virions, whereas others contained large groups of viral particles surrounded by material having a 211 
consistency clearly distinct from cytoplasm. The latter structures presumably correspond to the 212 
filamentous or globular inclusions observed using confocal microscopy; we refer to these as 213 
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particle-containing inclusions. Representative images of particle-containing inclusions in T3-214 
T1M1-infected MDCK cells are shown in Fig. 3A. These large aggregates of virions contain a 215 
significant fraction of complete particles in paracrystalline array. In marked contrast, T3 particle-216 
containing inclusions were less frequent, smaller, displayed decreased organization, and 217 
harbored fewer mature particles. Inclusions containing T3 particles like those shown in Fig. 3A 218 
were rare and required extensive searching to locate. The size, frequency, and particle content of 219 
T3 and T3-T1M1 inclusions in L cells were similar to each other and to those in T3-T1M1-220 
infected MDCK cells (Fig. 3B).  221 
To systematically confirm our impressions of T3 and T3-T1M1 inclusion ultrastructural 222 
morphology, we quantified certain features of inclusions captured in electron micrographic 223 
images. The fraction of cytoplasm containing virion particles or inclusion matrix was measured 224 
using the point counting stereology method (53). We defined the viral fraction of cytoplasm to be 225 
viral particles and surrounding milieu (i.e., inclusion matrix) that was clearly distinct from 226 
cytoplasm. Structures resembling viral inclusions but devoid of viral particles were counted as 227 
cytoplasm since we could not be certain that these were of viral origin. However, such “empty 228 
inclusions” were infrequent. In T3-T1M1-infected MDCK cells, 19.2% of the cytoplasm was 229 
occupied by inclusion matrix, whereas this fraction was only 2.9% in T3-infected cells (Table 1). 230 
The corresponding values in L cells were 27.8% and 14.9%, respectively. The proportion of 231 
inclusion matrix occupied by particles was 11.2% and 17.8% in T3- and T3-T1M1-infected 232 
MDCK cells, respectively, and 23.4% and 32.1% in L cells. These data are consistent with our 233 
observation that particles within inclusions of T3-infected MDCK cells were less densely packed. 234 
Finally, we determined the ratios of complete and empty particles in inclusions formed in both 235 
cell types. The fraction of complete particles in T3- and T3-T1M1-infected MDCK cells was 236 
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36.3% and 76.7%, respectively. The corresponding values in L cells were 79.7% and 94.9%, 237 
respectively. The smaller fraction of inclusion matrix observed in T3-infected MDCK cells 238 
suggests that particle assembly is defective and dependent on μ2 protein. While T3 infection of L 239 
cells resulted in lower fractional inclusion matrix, particle density, and particle maturity vs. T3-240 
T1M1, differences in the fraction of inclusion matrix and mature particles were clearly more 241 
pronounced in MDCK cells infected with these strains. Furthermore T3 particles assumed 242 
definite order in inclusions of L cells, unlike the irregular arrangements typical of T3-infected 243 
MDCK cells. Taken together, qualitative and quantitative TEM analysis of reovirus inclusions 244 
under conditions of productive and abortive infection of MDCK cells points to viral assembly as 245 
a μ2-sensitive step in viral replication. 246 
 While examining the ultrastructure of reovirus inclusions in MDCK cells, we observed 247 
that empty T3 particles appeared smaller than empty T3-T1M1 particles. Therefore, we 248 
quantified and compared the diameters of complete and empty particles. A high-magnification 249 
image of virion particles in T3-T1M1-infected MDCK cells (Fig. 4) illustrates the specific 250 
diameter measurements recorded: (1) electron-dense centers of mature particles, (2) outer rim of 251 
mature particles, and (3) outer rim of empty particles. Large numbers of observations (110-417) 252 
for each category were made to statistically validate the size differences. The mean inner 253 
diameter of mature T3 and T3-T1M1 particles in both MDCK and L cells was ~ 38 nm, whereas 254 
the mean outer diameter of mature particles was ~ 72 nm (MDCK cells) or 71 nm (L cells) 255 
(Table 2). In contrast, the mean diameter of empty particles in T3-infected MDCK cells was 256 
significantly less than the empty-particle diameters in T3-T1M1-infected MDCK cells, 67.3 257 
±0.27 nm vs. 73.5 ±0.34 nm, respectively. Diameters of empty particles of T3 and T3-T1M1 in L 258 
cells, 71.2 ±0.40 nm vs. 72.0 ±0.42 nm, respectively, were not significantly different. These 259 
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results reveal a difference in the size of T3 and T3-T1M1 empty particles produced in MDCK 260 
cells but not L cells, indicating that some aspect of T3 particle assembly in MDCK cells follow 261 
an anomalous path. Furthermore, these findings are consistent with a μ2-associated block to 262 
morphogenesis of mature T3 virions in MDCK cells.  263 
Replication of reovirus at low temperature. A previous study suggested that the T3 μ2 264 
protein is subject to temperature-dependent misfolding (28), which led us to consider whether 265 
strain-dependent differences in viral replication efficiency in MDCK cells might be influenced 266 
by the temperature of infection. To test this hypothesis, viral titers were monitored in MDCK 267 
cells (Fig. 5A, 5B) and L cells (Fig. 5C, 5D) infected with either T3 or T3-T1M1 and incubated 268 
at either 31ºC (Fig. 5A, 5C) or 37ºC (Fig. 5B, 5D) for 96 h post-infection. Replication of T3 in 269 
MDCK cells at 31ºC greatly exceeded that at 37ºC, closely approaching the yield of T3-T1M1 at 270 
31ºC. In L cells infected at 31ºC, T3 displayed significantly lower yield at 24 h post-infection 271 
compared to T3-T1M1, but attained a similarly high level of replication at later times post-272 
infection. T3-T1M1 replicated efficiently in both cell types at 31ºC. However, the rise in titer 273 
was delayed relative to 37ºC. Taken together, these results indicate that replication of T3 in 274 
MDCK cells is temperature-dependent. 275 
We used thin-section TEM of MDCK cells infected at the lower temperature to determine 276 
whether enhanced replication kinetics of T3 in MDCK cells at 31ºC correlates with restoration of 277 
normal inclusion ultrastructure. At 72 h post-infection, large particle-containing inclusions 278 
enclosing mature and empty particles were observed in both T3- and T3-T1M1-infected cells 279 
(Fig. 6). The fraction of cytoplasm occupied by viral inclusion matrix was 17% and 28% in T3- 280 
and T3-T1M1-infected cells, respectively, while the proportion of inclusion matrix occupied by 281 
particles was 12.7% in T3-infected cells and 16.8% in T3-T1M1-infected cells (Table 3). 282 
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Complete particles comprised 29.7% and 36.3% of total virions in T3- and T3-T1M1-infected 283 
cells, respectively. The substantial increase in the fraction of inclusion matrix from 2.9% to 17% 284 
in T3-infected MDCK cells incubated at 31ºC vs. 37ºC provides further evidence that the 285 
restriction to T3 replication in MDCK cells relaxes at low temperature. Additionally, the mean 286 
diameters of empty particles in MDCK cells infected with T3 (72.6 ±0.29 nm) and T3-T1M1 287 
(71.9 ± 0.20 nm) were equivalent at reduced incubation temperature (Table 4). Thus, lowering 288 
the temperature of infection partially relieved μ2-mediated restriction of T3 replication in 289 
MDCK cells and reversed the block to mature particle assembly, consistent with the hypothesis 290 
that the conformational state of μ2 influences efficiency of the reovirus life cycle through a 291 
mechanism involving virion morphogenesis.  292 
293 
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DISCUSSION 294 
 295 
A common strategy of virus replication is formation of neo-organelles—i.e., inclusions—that 296 
concentrate and protect viral components required for genome multiplication and particle 297 
assembly. An understanding of viral inclusion composition and organization is essential to 298 
illuminate strategies by which viruses direct a successful replication program. In this study, we 299 
characterized a post entry-determined, strain-specific replication defect in MDCK cells to 300 
enhance knowledge of critical activities within reovirus inclusions that depend on the particular 301 
cell environment. Our findings suggest that reovirus tropism for some types of cells is governed 302 
by interactions between viral replication proteins and cell-type-specific factors that favor 303 
development of inclusions capable of generating fully assembled infectious particles. 304 
  Original studies of reovirus replication in MDCK cells revealed a genetic association of 305 
polymerase proteins μ2 and λ3 with viral replication efficiency (39). We subsequently showed 306 
that the μ2-sensitive step of replication in these cells occurs following the formation of viral 307 
inclusions but prior to dsRNA synthesis, leading us to propose that reovirus strain-specific 308 
replication efficiency in MDCK cells is determined at a post-entry replication checkpoint 309 
responsive to the composition of the viral polymerase complex (33). Here, we report findings of 310 
a more comprehensive analysis of viral protein trafficking to inclusions conducted to determine 311 
whether one or more inclusion components displays abnormal localization in non-productively 312 
infected MDCK cells. Using confocal immunofluorescence microscopy, no discernable cell-313 
type-specific differences in the distribution of μ2, other major inclusion proteins μNS and σNS, 314 
core protein λ2, or outer-capsid proteins μ1 and σ3 were observed in T3-infected MDCK cells 315 
(Figs. 1, 2A). Although a relative reduction (compared with T3-T1M1) in the expression of μ1 316 
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was observed, the significance of this reduction to T3 replication in MDCK cells is unclear as 317 
expression of all viral proteins markedly declines at late times post-infection (33). Thus, results 318 
of our confocal microscopy studies confirm the expected pattern of viral protein localization to 319 
T3 inclusions in MDCK cells, indicating structurally or functionally abnormal interactions within 320 
the inclusion that prevent production of infectious progeny.  321 
TEM analysis of MDCK cells infected with T3 revealed a much smaller fraction of 322 
cytoplasm containing particles and inclusion matrix compared with strain T3-T1M1 (2.9% vs. 323 
19.2%) (Fig. 3, Table 1). Mature particles with electron-dense (i.e., genome-containing) centers 324 
and empty particles were observed in MDCK cells infected with either T3 or T3-T1M1. 325 
However, the mature fraction of T3 particles was less than that of T3-T1M1 (36% vs. 77%) 326 
(Table 1). Assembly intermediates that escape the restrictive step appear competent to reach full 327 
structural maturity, consistent with the finding that conditions can be modified to permit partial 328 
relief of the restriction to T3 replication in MDCK cells. Collectively, the substantial decrease in 329 
particle-containing inclusion matrix and mature virion particles suggest that assembly of T3 330 
particles is restricted in MDCK cells, leading to a significant reduction in viral yield. It is 331 
possible that decreased protein synthesis leads to diminished mature particle yields in T3-332 
infected cells. However, we think our results are more consistent with a model wherein 333 
replication fails due to inefficient production of replicase particles. We previously observed that 334 
new T3 virion proteins are expressed through 12 h post infection in MDCK cells (33). 335 
Additionally results of the current study confirm that no overt impediments exist to the 336 
morphogenesis of T3 inclusions in these cells, and we found no obvious abnormalities in the 337 
levels or localization of T3 protein relative to T3-T1M1 (Figs. 1, 2). Biochemical analysis of 338 
reovirus RNA synthesis has demonstrated that 80-95% of viral mRNA is transcribed by progeny 339 
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particles made in the infected cells (55), and these transcripts serve as templates for protein 340 
translation during latter portions of the viral life cycle (40). Taken together, results from our 341 
work and other published studies best support the conclusion that diminished viral RNA and 342 
protein production in T3-infected MDCK cells is secondary to a defect in particle assembly. 343 
Although results of confocal microscopy studies indicate that a majority of cells are 344 
infected (Figs. 1, 2), not all TEM sections contained identifiable viral structures. We defined 345 
inclusions in electron micrographs by the presence of virion particles. Structures resembling 346 
particle-free inclusions were rarely observed, and inclusion matrix could not be determined with 347 
complete confidence in the absence of particles. It is possible that our TEM method lacks the 348 
sensitivity necessary to identify particle-free inclusion matrix. Alternatively, the large difference 349 
in section thickness between the two methods (900 nm confocal z-slice vs. 70 nm EM thin 350 
section) may explain preferential detection of infected cells using confocal microscopy.  351 
The observation that empty particles are smaller in T3- vs. T3-T1M1-infected MDCK 352 
cells offers corroborating evidence of aberrant assembly of T3 virion particles. It is not known 353 
whether empty particles represent precursors to mature virions or replication byproducts, but the 354 
latter possibility is generally favored (18, 40). In either case, these structures inevitably share 355 
some assembly steps with complete virion particles and highlight the potential for a global μ2-356 
dependent defect in particle assembly. Possible explanations for the smaller size of empty T3 357 
particles include missing or stoichiometrically incorrect protein subassemblies or misfolding of 358 
key protein constituents. The cell-type-specific nature of this phenotype further suggests that 359 
discrete cellular factors are essential to coordinate successful particle maturation. 360 
TEM ultrastructural analysis reveals a 6.6-fold decrease in the fraction of cytoplasm 361 
containing virion particles or inclusion matrix in T3-infecected MDCK cells in comparison to 362 
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T3-T1M1 (Table 1). This difference correlates with an approximate 100-fold decrease in T3 viral 363 
yield compared with T3-T1M1 (Fig. 5). Numerous factors may contribute to disproportionate 364 
changes in virion production as measured by TEM and viral plaque assay. First, the mature, and 365 
presumably infectious, fraction of virion particles is significantly less in T3-infected (36%) vs. 366 
T3-T1M1-infected (77%) MDCK cells. Also, TEM almost exclusively identifies intracellular 367 
virus, whereas replication experiments measure both intracellular and released virus. Finally, the 368 
two analytical methods are subject to non-equivalent sampling bias. For example, in the 369 
replication experiments, virus particles moving randomly in a fluid matrix are equally likely to 370 
undergo sampling in a plaque titration assay, in contrast to TEM-based virus detection, where 371 
virion particles are immobilized within structures that have non-uniform boundaries and 372 
represent fewer members of the total virus population for quantification. These technical 373 
differences could account in part for the greater discriminatory power of a viral replication assay 374 
compared with TEM for enumeration of viable virion particles.  375 
The capacity of T3 to replicate in MDCK cells at 31ºC provides insight into a possible 376 
mechanism of the μ2-regulated replication phenotype. The T3 μ2 protein is highly ubiquitylated 377 
in a temperature-dependent manner, and ubiquitylation is reduced when the temperature of viral 378 
infection is lowered (28). These findings suggest that T3 μ2 misfolds at higher temperature and 379 
raise the possibility that temperature-sensitive conformations of μ2 influence a critical early step 380 
in viral assembly. The μ2 ubiquitylation phenotype segregates with a polymorphism at amino 381 
acid position 208 (28), while temperature-dependent replication efficiency in MDCK cells is 382 
regulated by amino acid position 347, without detectable contribution by the residue at position 383 
208 (33). The effect of amino acid variability at position 347 on μ2 conformational states has not 384 
been examined. However, reversal of the block to T3 replication at decreased temperature 385 
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suggests that residue 347 modulates a temperature-sensitive property of μ2, possibly protein-386 
folding, which in turn governs reovirus strain-specific interactions with the host-cell environment 387 
during viral assembly. These interactions could involve stimulation of replication complexes 388 
containing T1 μ2 or inhibition of complexes containing T3 μ2. Alternatively, the replication 389 
block could be passive in nature, caused by a failure of T3 μ2 to successfully interact with 390 
cellular factors. In either model, conformational variation in μ2 could conceivably influence a 391 
critical association of viral and host-cell factors required for virion assembly.  392 
T3 replication phenotype in MDCK cells is similar to that of reovirus strain tsH11.2, 393 
which contains lesions in μ2 protein that restrict viral replication to low temperature. Like T3 394 
infection of MDCK cells, tsH11.2 synthesizes normal amounts of ssRNA but displays 395 
significantly diminished dsRNA production and secondary translation (10). However, unlike T3 396 
infection of MDCK cells, tsH11.2 μ2 does not concentrate in viral inclusions at restrictive 397 
temperature (26). Thus, the replication block to tsH11.2 might operate through mechanisms 398 
affecting μ2 localization. Although the precise step in viral replication blocked in tsH11.2 may 399 
differ from or complement that of T3 in MDCK cell at non-permissive temperature, both of these 400 
models of conditional reovirus replication confirm the importance of μ2 protein for progression 401 
of the viral life cycle beyond primary rounds of RNA and protein synthesis.  402 
Reovirus inclusions are generally thought to contain cellular proteins repurposed for viral 403 
use. Identities of these molecules remain mostly unknown. Early studies using electron 404 
microscopy identified inclusion-associated cytoskeletal elements, including coated microtubules 405 
and thick, kinked fibrils interspersed among viral particles (13, 16). Known cellular proteins 406 
recruited to reovirus inclusions include chaperone Hsc70 (20) and clathrin (19). The roles played 407 
by these proteins in inclusion formation and function await further investigation. A 408 
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comprehensive study of cellular factors required for reovirus replication, in particular those 409 
required for inclusion development and maturation, will further define post-entry mechanisms of 410 
viral tropism and the precise activities of μ2 and other viral replication proteins in virion 411 
morphogenesis.  412 
In summary, we used microscopic techniques to characterize functionally abnormal 413 
reovirus inclusions that form in non-permissive cells to more fully understand the role played by 414 
μ2 in promoting productive viral replication and tropism for host cells. Findings made in this 415 
study establish virion particle assembly as a μ2-regulated step in the reovirus replication program 416 
and suggest that a temperature-sensitive property of μ2, perhaps protein conformation, controls 417 
key events within inclusions that culminate in assembly of mature particles. Additional 418 
characterization of this system may identify novel cellular regulators of reovirus infection that 419 
participate in virion morphogenesis and serve as determinants of viral cell tropism.  420 
421 
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FIGURE LEGENDS 592 
 593 
FIG 1. Reovirus replication and inclusion formation. (A) MDCK cells were adsorbed with T3 594 
or T3-T1M1 at an MOI of 2 PFU/cell, and viral titers in cell lysates were determined at the times 595 
shown by plaque assay using L cells. Results represent the mean of triplicate experiments. Error 596 
bars indicate S.D. (B, C) MDCK cells were adsorbed with T3 (B) or T3-T1M1 (C) at an MOI of 597 
100 PFU/cell, fixed at 24 h post-infection, stained with anti-σNS (green) and anti-μNS (red) 598 
antibodies and ToPro3 (blue, nuclear), and imaged using confocal microscopy. Scale bar, 50 μm. 599 
 600 
FIG 2. Distribution of reovirus proteins μ2, σ3, μ1, and λ2 in infected cells. MDCK cells (A) 601 
and L cells (B) were absorbed with either T3 or T3-T1M1 at an MOI of 20 PFU/cell, fixed at 24 602 
h post-infection, stained with anti-σNS (green) and anti-μ2, anti-σ3, anti-μ1, or anti-λ2 (red) 603 
antibodies. Nuclei were visualized using ToPro3 (blue). Images were captured using confocal 604 
microscopy. Scale bar, 20 μm. 605 
 606 
FIG 3. Ultrastructural analysis of viral inclusions. MDCK cells (A) and L cells (B) were 607 
adsorbed with either T3 or T3-T1M1 at an MOI of 100 PFU/cell and fixed at 24 h post-infection. 608 
Ultra-thin sections (65-70 nm) were examined using transmission electron microscopy. Boxed 609 
regions correspond to high-magnification images shown below. Scale bars: low-magnification 610 
images, 2 μm; high-magnification images, 500 nm. 611 
 612 
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FIG 4. High-magnification image of T3-T1M1-infected MDCK cells. The diameter of the 613 
inner electron dense center of complete particles (Inner), the outer diameter of complete particles 614 
(Outer), and outer diameter of empty particles (Empty) are demarcated by horizontal bars.  615 
Scale bar, 100 nm.  616 
 617 
FIG 5. Temperature-dependence of reovirus replication in MDCK cells. MDCK cells (A, B) 618 
or L cells (C, D) were adsorbed at an MOI of 2 PFU/cell and incubated at 31ºC (A, C) or 37ºC 619 
(B, D) for the times shown. Viral titers in cell lysates were determined by plaque assay using L 620 
cells. Viral yields were calculated as the difference between log10 titer at the indicated times and 621 
log10 titer at 0 h. Results represent the mean of triplicate experiments. Error bars indicate S.D. *, 622 
P < 0.05 in comparison to T3-T1M1 (Student’s t test). 623 
 624 
FIG 6. Ultrastructural analysis of viral inclusions in MDCK cells infected at low 625 
temperature. MDCK cells were adsorbed with either T3 or T3-T1M1 at an MOI of 100 626 
PFU/cell, incubated at 31ºC, and fixed at 72 h post-infection. Ultra-thin sections (65-70 nm) 627 
were examined using transmission electron microscopy. Boxed regions correspond to high-628 
magnification images shown below. Scale bars: low-magnification images, 2 μm; high-629 
magnification images, 500 nm. 630 
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 631 
Table 1. Quantitative analysis of reovirus replication using thin-section electron 
micrographs of reovirus-infected MDCK and L cells* 
Cell type Virus 
strain 
Fraction of 
cytoplasm 
containing virion 
particles or inclusion 
matrix  
Fraction of viral 
inclusion matrix 
occupied by 
particles 
Mature 
fraction of 
virion particles 
MDCK T3 2.9% 11.2% 36.3% 
MDCK  T3-T1M1 19.2% 17.8% 76.7% 
L  T3 14.9% 23.4% 79.7% 
L  T3-T1M1 27.8% 32.1% 94.9% 
*36 images examined for each sample condition  632 
 633 
 634 
 635 
Table 2: Quantification of viral particle diameters in reovirus-infected MDCK and L cells 
Cell 
type 
Virus 
strain 
Mature particle 
outer diameter 
(nm)* 
 
n§ 
Mature particle 
inner diameter 
(nm) 
 
n 
Empty particle 
outer diameter 
(nm) 
 
n 
MDCK T3 72.3 ± 0.44  110 38.3 ± 0.22 116 67.3 ± 0.27 306 T3-T1M1 72.0 ± 0.21# 311 37.9 ± 0.12# 323 73.5 ± 0.34& 177 
L T3 71.3 ± 0.24 380 38.5 ± 0.11 417 71.2 ± 0.40 119 T3-T1M1 71.0 ± 0.22# 385 38.3 ± 0.11# 413 72.0 ± 0.42# 138 
*Values represent mean ± S.E.M. 636 
§n, number of particles measured 637 
#t-test, not significant (vs. T3) 638 
&t-test, P < 0.0001 (vs. T3) 639 
 640 
 641 
Table 3. Quantitative analysis of reovirus replication at 31ºC using thin-
section electron micrographs of reovirus-infected MDCK cells* 
Virus 
strain 
Fraction of cytoplasm 
containing virion 
particles or inclusion 
matrix 
Fraction of viral 
inclusion matrix 
occupied by 
particles 
Mature fraction 
of virion 
particles 
T3 17.2% 12.7% 29.7% 
T3-T1M1 28.0% 16.8% 36.3% 
*36 images examined for each sample condition 642 
 643 
 644 
 645 
 646 
 647 
 648 
 649 
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Table 4. Quantification of viral particle diameters following infection of MDCK cells at 
31ºC 
Virus 
strain 
Mature particle 
outer diameter 
(nm)* 
 
n§ 
Mature particle 
inner diameter 
(nm) 
 
n 
Empty particle 
outer diameter 
(nm) 
 
n 
T3 71.9 ± 0.35 203 38.0 ± 0.16 225 72.6 ± 0.29 284 
T3-T1M1 71.5 ± 0.23# 306 37.9 ± 0.13# 312 71.9 ± 0.20# 472 
*Values represent mean ± S.E.M. 650 
§n, number of particles measured 651 
#t-test, not significant (vs. T3) 652 
 653 
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